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resumo 
 
 
A Proteína Fosfatase Tipo1 (PP1) é uma proteína ubíqua, especifica para 
resíduos de serina/treonina, que interage de uma forma mutuamente exclusiva 
com uma variedade de proteínas reguladoras. Estas actuam como substratos, 
inibidores, chaperoninas, proteínas âncora ou indutoras de especificidade e 
são muitas vezes multifuncionais, mediando um vasto conjunto de eventos 
celulares. Uma maior complexidade é originada pela existência de três genes 
que codificam várias isoformas da PP1, organizadas tanto espacialmente 
como temporalmente e cuja localização intracelular pode ser alterar de forma 
dinâmica. A PP1 está envolvida em múltiplos processos de grande relevância 
fisiológica (por ex. aprendizagem, memória e neurotransmissão) e patológica 
(envelhecimento, doença de Alzeimer e outras doenças neurodegenerativas). 
No entanto, ainda não estão completamente esclarecidas todas as importantes 
interacções de relevância fisiológica, bem como a localização intracelular onde 
essas interacções ocorrem.  
Esta tese teve como objectivo a identificação de proteínas expressas no 
cérebro humano que interagem com a isoforma α da PP1, usando o sistema 
Dois-Híbrido (YTH) de Levedura. Através desta técnica foram obtidos 298 
clones positivos, permitindo a identificação de 74 proteínas que ligam a PP1α. 
Entre as quais algumas eram proteínas já conhecidas por interagirem com a 
PP1, outras nunca antes tinham sido associadas à PP1 e várias eram 
proteínas ainda não caracterizadas. Foi feito um estudo mais detalhado para o 
clone mais abundante neste rastreio, Chr9orf75, que corresponde a uma 
proteína não descrita até agora. A ligação da proteína Chr9orf75 à PP1 foi 
confirmada através de várias técnicas e a sua localização subcelular e co-
localização com a PP1α foi estudada por imunocitoquímica. Os resultados aqui 
obtidos abrem novas perspectivas para o estudo da proteína Chr9orf75, a sua 
ligação à PP1 e localização subcelular. De modo geral, pode-se concluir que 
os resultados deste rastreio permitiram definir o interactoma do cérebro 
humano da PP1α, validando a técnica YTH como um meio de estudo para 
melhor compreender as funções da PP1 e a sua regulação em diferentes 
eventos celulares. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
abstract 
 
The ubiquitous serine/threonine-specific Protein Phosphatase  1 (PP1) interacts 
in a mutually exclusive manner with a variety of proteins that function as 
substrates, inhibitors, chaperones, anchoring proteins, or substrate-specifiers 
and are often multifunctional, mediating a wide range of cellular events. Further 
complexity is provided by the existence of three PP1 genes encoding various 
isoforms that are organized both spatially and temporally, and can change their 
intracellular localization dynamically. PP1 is involved in multiple processes of 
great physiological (e.g. learning, memory and neurotransmitter signaling) and 
pathological (aging, Alzheimer’s disease and other neurodegenerative 
conditions) relevance. However, many physiologically important interactions 
remain to be established, as well as the exact intracellular locations where 
those interactions take place.  
This thesis focused on the identification of human brain PP1α interacting 
proteins using the Yeast Two-Hybrid (YTH) system. With this technique 298 
positive clones were recovered, allowing the identification of 74 proteins that 
bind PP1α. Among them are some already well known PP1 interacting proteins, 
other proteins never before associated with PP1 and several uncharacterized 
proteins.  A more detailed study was performed for the most abundant clone in 
the screen, Chr9orf75, a novel and undescribed protein. Chr9orf75 binding to 
PP1 was confirmed by several techniques and its subcellular localization and 
co-localization with PP1α studied by immunocytochemistry. The results 
obtained provided new insights on Chr9orf75 protein binding to PP1 and 
subcellular localization. In general, it may be conclude that the results of this 
screen allowed an initial characterization of the human brain PP1α interactome, 
simultaneously validating the YTH system as a mean to study and understand 
PP1 functions and regulation in different cellular events. 
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1.1 PROTEIN PHOSPHORYLATION 
 
 
The correct targeting and localization of proteins to specific subcellular compartments 
represent an important biological mechanism for regulating cellular function. Increasing 
evidence underlines the importance of macromolecular signalling complexes, where 
functionally related proteins are arranged in close proximity. Therefore, elucidating the 
molecular composition of these signalling complexes represents a fundamental step 
toward understanding the function of biological systems. Protein kinases and 
phosphatases are key players in the regulation of numerous cellular processes, and they 
exert their effects precisely through those signal transduction processes. 
One of the most widespread mechanisms for the post-translational regulation of proteins 
involves either the addition of phosphate groups via the transfer of the terminal phosphate 
from ATP to an amino acid residue by protein kinases, or their removal by protein 
phosphatases (Figure 1).  
 
 
 
Figure 1- Reversible protein phosphorylation, covalent modification via the transfer of the 
terminal phosphate from ATP to an amino acid residue of the target protein. 
 
The human genome encodes approximately 30000 proteins, one third of which is believed 
to be regulated by reversible protein phosphorylation (Johnson and Hunter 2005). Thus, 
the antagonistic actions of protein kinases and protein phosphatases are of equal 
importance in determining the degree of phosphorylation of each substrate protein.  
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The reversible phosphorylation of proteins is a post-translational modification and 
ubiquitous cellular regulatory mechanism that can regulate activity, subcellular localization 
and the binding affinity or association of the phosphorylated molecule, by inducing 
conformational changes. Protein kinases and protein phosphatases are often themselves 
phosphorylated in response to a myriad of extracellular and intracellular signals. An 
important feature of kinases and phosphatases is that a single molecule is able to activate 
many substrate molecules, thus allowing for amplification of the initial signal. 
Virtually, all signal transduction pathways are regulated, at some level, by 
phosphorylation, making phosphorylation relevant to most, if not all, areas of cell 
signalling and neuroscience research. Different classes of protein kinases and 
phosphatases act specifically on serine/threonine residues or tyrosine residues. All protein 
kinases belong to a single gene superfamily but, in contrast, protein phosphatases are 
divided into distinct and unrelated protein/gene families.  
Cellular health and vitality are dependent on the fine equilibrium of protein 
phosphorylation systems, since reversible protein phosphorylation is the major metabolic 
control mechanism of eukaryotic cells. Not surprisingly, many diseases and dysfunctional 
states are associated with the abnormal phosphorylation of key proteins. Indeed, cancer 
and other proliferative diseases, inflammatory diseases, metabolic disorders and 
neurological diseases are among those in which protein phosphorylation plays an 
important role. Thus, kinases and phosphatases are of interest to researchers involved in 
drug discovery, because of their broad relevance to health and disease. 
In neurodegenerative diseases such, as Alzheimer’s disease, there is evidence for 
abnormal regulation of protein phosphorylation. Altered activities and protein levels of 
several specific kinases suggest that abnormal phosphorylation contributes to the 
pathogenesis of these diseases. In Alzheimer’s disease, neurofibrillary degeneration 
results from the aggregation of abnormally phosphorylated Tau protein into paired helical 
filaments. Protein kinase A and glycogen synthase kinase 3 β are likely to be key kinases 
involved (Delobel et al. 2002), and protein phosphatase 2A is thought to be the main Tau 
phosphatase (Planel et al. 2001). Furthermore, activation of protein kinase C, or 
inactivation of  protein phosphatase 1, leads to a relative increase in the utilization of the 
non-amyloidogenic pathway for Alzheimer’s amyloid precursor protein processing (Gandy 
and Greengard 1994; da Cruz e Silva et al. 1995a).  
Other neurodegenerative diseases that may result from abnormal phosphorylation include 
Parkinson’s disease and Huntington’s disease. α-Synuclein has been implicated in the 
pathogenesis of Parkinson’s disease, and is a major component of Lewy bodies (a major 
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anatomical hallmark of Parkinson’s disease). α-Synuclein was demonstrated to be 
constitutively phosphorylated indicating that its function may be regulated by 
phosphorylation/dephosphorylation mechanisms (Okochi et al. 2000). Motor and cognitive 
deficits in Huntington’s disease are likely caused by progressive neuronal dysfunction 
preceding neuronal cell death. Synapsin I is one of the major phosphoproteins regulating 
neurotransmitter release. In mice expressing the Huntington’s disease mutation synapsin I 
is abnormally phosphorylated suggesting that an early impairment in its phosphorylation 
may alter synaptic vesicle trafficking and lead to defective neurotransmission in 
Huntington’s disease (Lievens et al. 2002).  
Altered phosphorylation has also been implicated in the etiology and/or symptoms of  
many other disorders such as heart failure (Neumann 2002) and diabetes (Sridhar et al. 
2000). Therefore, protein phosphorylation systems represent attractive targets for 
diagnostics and therapeutics of several neurodegenerative and other diseases. 
 
 
1.1.1 Protein phosphatases 
 
The initial classification of protein phosphatases (PPs), according to their phospho-
aminoacid substrates, the serine/threonine (Ser/Thr-specific) and the tyrosine (Tyr-
specific) phosphatases led to the establishment of four classes of Ser/Thr-specific protein 
phosphatases, based on their enzymatic properties (Ingebritsen and Cohen 1983). Even 
though the four have overlapping substrate specificities in vitro, they can be distinguished 
by the use of inhibitor proteins and by their dependence on metal ions (Table 1). Although 
widely used, this initial classification does not reflect the actual phylogenetic relationship 
between the different Ser/Thr phosphatases. 
The elucidation of complete cDNA and amino acid sequences allowed the separation of 
the Ser/Thr-specific protein phosphatases into two distinct gene families: the 
PhosphoProtein Phosphatases or PPP family (including PP1/PP2A/PP2B) and the PPM 
family (of metal dependent phosphatases) like PP2C (Table 1). The PPP family members 
(PP1, PP2A and PP2B) display high sequence similarities between their catalytic 
domains. The application of recombinant DNA techniques to the field also led to the 
identification of new protein phosphatases (PP4, PP5, PP6, PPZ, PPY,etc) and to the 
discovery of different isoforms (Berndt et al. 1987; da Cruz e Silva and Cohen 1987a; da 
Cruz e Silva et al. 1987; Cohen et al. 1988; da Cruz e Silva et al. 1988; da Cruz e Silva et 
al. 1995b; Fardilha et al. 2004). 
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Table 1 - Gene families and corresponding functional classification of the serine/threonine-
specific protein phosphatases. 
PP1 
Dephosphorylates preferentially the beta subunit of phosphorylase kinase 
Inhibited by I-2, phospho-I-1 and phospho-DARPP-32 
PP2A 
Dephosphorylates preferentially the alpha subunit of phosphorylase kinase 
Not inhibited by I-2, phospho-I-1 or phospho-DARPP-32 
Activity not affected by divalent cations 
PPP 
PP2B 
Dephosphorylates preferentially the alpha subunit of phosphorylase kinase 
Not inhibited by I-2, phospho-I-1 or phospho-DARPP-32 
Activity dependent on calcium ions and stimulated by calmodulin 
PPM PP2C 
Dephosphorylates preferentially the alpha subunit of phosphorylase kinase 
Not inhibited by I-2, phospho-I-1 or phospho-DARPP-32. 
Activated by magnesium ions. 
 
The remarkable degree of evolutionary conservation of these enzymes is undoubtedly 
related to their essential role in the regulation of fundamental cellular processes (Barford 
et al. 1998b; Barford and Neel 1998; Cohen 2002). 
Among the Ser/Thr protein phosphatases, PP1 forms a major class and is highly 
conserved among all eukaryotes examined to date (Lin et al. 1999). Three genes are 
known to encode PP1 catalytic subunits, termed PP1α, PP1β and PP1γ, and PP1γ is 
known to undergo tissue-specific processing to yield an ubiquitously expressed PP1γ1 
isoform  and a testis enriched PP1γ2 isoform (da Cruz e Silva et al. 1995b) (Figure 2).  
Two genes are known to encond PP2A catalytic subunits (da Cruz e Silva and Cohen 
1987b), termed PP2Aα and PP2Aβ (da Cruz e Silva et al. 1987; da Cruz e Silva and 
Cohen 1987b), and three known PP2B genes (PP2Bα, PP2Bβ, PP2Bγ) are also subject to 
complex regulation to yield several alternatively spliced isoforms from each (Figure 2). 
Other previously unknown phosphatase catalytic subunit isoenzymes were also 
discovered, from a variety of tissues and species, that were termed novel phosphatases 
(da Cruz e Silva et al. 1988), such as PP4, PP5 and PP6 (Cohen 1997) that are present in 
all mammalian tissues examined. In contrast, human PP7 is tissue specific and was found 
in the human retina (Huang and Honkanen 1998). 
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Figure 2 – Phylogenic tree depicting the degree of similarity between the known phosphatases 
based on their primary amino acid sequence. PP1-PP7 belong to a single gene family (PPP) 
that is structurally distinct from the PPM family (PP2C) (Honkanen and Golden 2002). 
 
Diversification of protein Ser/Thr phosphatases during evolution can be largely attributed 
to an increase in the number of interacting proteins that determine when and where the 
phosphatases are active. On the other hand, protein Ser/Thr kinases appear to have used 
a different diversification strategy, largely based on a gradual increase in the number of 
catalytic subunits. Thus, in spite of the of the huge difference in the number of catalytic 
subunits of mammalian protein Ser/Thr kinases (ca. 1000) and phosphatases (ca. 100), 
the number of holoenzymes for these two classes of enzymes may be more or less 
balanced (Bollen 2001; Ceulemans and Bollen 2004).  
There are approximately 25 genes encoding Ser/Thr protein phosphatases (Cohen 2004), 
and each phosphatase may have more than 300 physiological substrate proteins, which 
may increase considering each protein may have various phosphorylation sites as 
substrates.  
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1.1.2 Protein phosphatase 1 - PP1 
 
PP1 is a ubiquitous eukaryotic enzyme that regulates a variety of cellular events through 
the dephosphorylation of multiple substrates. This multifunctionality of PP1 is due to its 
association with different regulators and/or targeting subunits. The levels of PP1 are 
thought not to change in response to most physiological stimuli. It was proposed that the 
general PP1 holoenzymes functions are centered on the rational use of energy, the 
recycling of protein factors and a reversal of the cell to a basal and/or energy-conserving 
state (Ceulemans and Bollen, 2004). When nutrients are abundant PP1 stimulates the 
synthesis of glycogen and also allows the recycling of transcription and splicing factors, 
the return to basal levels of protein synthesis and the relaxation of actomyosin fibers. PP1 
also is important in recovering from stress but induces apoptosis in extreme situations. 
PP1 promotes the exit from mitosis and maintains cells in G1 or G2. 
Post-translational regulation of mammalian PP1 can be accomplished in several ways:  
 PP1 binds to other proteins that modulate PP1 activity and/or target PP1 to different 
substrates. Such heterodimers may be parte of larger multimeric protein complexes 
(Hubbard and Cohen 1993; Barford et al. 1998a; Bollen 2001; Cohen 2002; Ceulemans 
and Bollen 2004); 
 Many regulatory subunits of PP1 are regulated by phosphorylation, thus also affecting 
PP1; 
 PP1 catalytic subunits can undergo direct inhibitory phosphorylation by cyclin-
dependent kinases (Cdks) (Dohadwala et al. 1994; Yamano et al. 1994; Kwon et al. 
1997; Liu et al. 1999), Nek2 (Helps et al. 2000) and KPI-2 (Wang and Brautigan 2002). 
The PP1 family, with three major 37 kDa catalytic subunit isoforms, exhibit 90% or greater 
identity in overall amino acid composition (Figure 3), is expressed in virtually all 
mammalian cells (Sasaki et al. 1990; Barker et al. 1994) and the different isoforms can all 
be expressed in the same cell (Puntoni and Villa-Moruzzi 1997).  
The PP1 isoforms are highly conserved across their large catalytic domain, but are 
divergent at the N- and C-termini (Figure 3). Thus, regulatory proteins bind to the unique 
C-terminus of the PP1 isoforms to direct their isoform specific activities. To perform 
dephosphorylation reactions that are important in time and space, the diverse functions of 
PP1 must be independently regulated. For this reason, the regulatory subunits are 
believed to be much more specific for individual functions and are therefore better targets 
for examining specific pathways.  
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PP1gamma1       MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLK 60 
PP1gamma2       MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLK 60 
PP1alpha        MSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLK 60 
PP1beta         MADG-ELNVDSLITRLLEVRGCRPGKIVQMTEAEVRGLCIKSREIFLSQPILLELEAPLK 59 
                *:*  :**:**:* *****:*.:*** **: * *:****:******************** 
 
PP1gamma1       ICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFL 120 
PP1gamma2       ICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFL 120 
PP1alpha        ICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFL 120 
PP1beta         ICGDIHGQYTDLLRLFEYGGFPPEANYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFL 119 
                ********* **************:*********************************** 
 
PP1gamma1       LRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDL 180 
PP1gamma2       LRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDL 180 
PP1alpha        LRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDL 180 
PP1beta         LRGNHECASINRIYGFYDECKRRFNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDL 179 
                ***********************:************************************ 
 
PP1gamma1       QSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHD 240 
PP1gamma2       QSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHD 240 
PP1alpha        QSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHD 240 
PP1beta         QSMEQIRRIMRPTDVPDTGLLCDLLWSDPDKDVQGWGENDRGVSFTFGADVVSKFLNRHD 239 
                ***************** *************** ***************:**:***::** 
 
PP1gamma1       LDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAE 300 
PP1gamma2       LDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAE 300 
PP1alpha        LDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAD 300 
PP1beta         LDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGGMMSVDETLMCSFQILKPSE 299 
                ****************************************.*****************:: 
 
PP1gamma1       KKK---------PNATRPVTPPRG------MITKQAKK-------- 323 
PP1gamma2       KKK---------PNATRPVTPPRVGSGLNPSIQKASNYRNNTVLYE 337 
PP1alpha        KNKGKYGQFSGLNPGGRPITPPRN-------SAKAKK--------- 330 
PP1beta         KKAKYQYG---GLNSGRPVTPPRT--------ANPPKKR------- 327 
                            *:            . **:****          :  :   
Figure 3 – Analysis of homology among of PP1 isoforms using a CLUSTAL W multiple sequence 
alignment. 
 
Over the last decade, PP1 has been implicated in many cellular processes, including, but 
not limited to, cell cycle control, apoptosis, transcription, adhesion, motility, metabolism, 
memory and HIV-1 viral transcription. However, very few PP1 physiological substrates 
have been established so far. Besides proteins engaged in glycogen metabolism, muscle 
contraction and protein synthesis, that were recognized as PP1 substrates early on, more 
recently, PP1 was found to dephosphorylate a number of proteins important for cell 
proliferation and survival. For example, the tumour suppressor pRb, lamin B, Bad, Aurora 
and focal adhesion kinase (Thompson et al. 1997; Ayllon et al. 2000; Helps et al. 2000; 
Hsu et al. 2000; Fresu et al. 2001; Katayama et al. 2001; Meraldi and Nigg 2001; Berndt 
2003; Margolis et al. 2003; den Elzen and O'Connell 2004). 
The three-dimensional structure of PP1c (Figure 4) was first resolved over a decade ago 
and highlighted key features of a bimetallic catalytic centre, but also an overall pattern of 
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protein  folding conserved in other protein Ser/Thr phosphatases was revealed (Griffith et 
al. 1995; Das et al. 1996; Cohen 2002; Yang et al. 2005; Xu et al. 2006; Cho and Xu 
2007).  
 
 
 
 
Figure 4 - Secondary structure elements of PP1, the catalytic site and invariant residues. Metal 
ions M1 (Fe2+) and M2 (Mn2+) are shown as purple spheres and the tungstate ion is indicated. 
(Egloff et al. 1995) 
 
Subsequent studies co-crystallized PP1c with synthetic peptides or fragments derived 
from targeting or regulator subunits (Egloff et al. 1997; Terrak et al. 2004). These 
crystallization studies identified a site, some distance from the catalytic centre, where 
sequences homologous to RVxF, found in most PP1 regulators, interact and facilitated the 
identification of additional PP1 regulators. The structures also highlighted interactions 
along the C-terminus of PP1c that impart isoform specificity to some PP1 interacting 
proteins. Some mammalian PP1c proteins have a 25-27 amino acid C-terminal region that 
contains a Cdk phosphorylation motif (T P P / Q R) (Ishii et al. 1996), the threonine 
residue of which (T320 in human PP1α) has been show to be important for G1 progression 
in cell cycle (Dohadwala et al. 1994; Berndt et al. 1997; Liu et al. 1999).  
The large majority of PP1 interacting proteins contain a degenerate, so-called RVxF-motif 
that conforms to the consensus sequence [RK]-x0-1-[VI]- [FW], where x denotes any 
residue and  any residue except proline (Bollen 2001; Wakula et al. 2003). This motif 
binds with high affinity to a hydrophobic channel that is remote from the catalytic site of 
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PP1. The binding of the RVxF-motif has itself no major effects on the conformation or 
activity of PP1 (Egloff et al. 1997). However, RVxF-mediated anchoring of PP1 promotes 
the occupation of secondary, lower affinity binding sites and this often does affect the 
activity and/or substrate specificity of PP1 (Bollen 2001; Wakula et al. 2003). The RVxF-
motif is present in about one third of all eukaryotic proteins but only a small fraction are 
PP1-binding proteins. It seems that RVxF-consensus sequences function as PP1 
interaction sites only when they are present in a flexible and exposed loop that can be 
modelled into a β-strand. Additionally, other low affinity binding regions on the PP1 
regulators further strengthen the binding. 
Another PP1 binding motif has been described, F-X-X-R-X-R, that also appears to exist in 
several PP1 interactors (Ayllon et al. 2002). Recently, another generic PP1-binding motif 
was identified, the SILK-motif: [GS]-IL-[KR]. It was first described for I2, a specific PP1 
inhibitor (Lin et al. 2005; Hurley et al. 2007).  This motif is present in nearly 10% of 
proteins containing the RVxF-motif and is normally N-terminal to it. The SILK and RVxF-
motifs are functionally interchangeable and can both be essential for PP1 anchoring. 
The existence of common binding sites for the regulatory subunits explains why a 
relatively small protein such as PP1c can interact with numerous different regulatory 
proteins and why the binding of most regulatory subunits is mutually exclusive. The 
relative abundance of each isoform may be an important factor in determining the 
composition of numerous PP1 holoenzymes and the relative contribution of each PP1c 
isoform to different biological functions. A possibility is that holoenzymes containing the 
same binding subunit but different PP1c isoforms may have distinct functions (Rudenko et 
al. 2004).  
The broad in vitro substrate specificity of PP1 leads to the idea that the enzymatic 
specificity is mainly dictated by the interacting subunits. Thus, a complete understanding 
of PP1 function requires the identification of the associated subunits that direct PP1c 
specific functions, as well as functional analysis of PP1 holoenzymes. A variety of 
approaches has identified close to 100 mammalian proteins known to interact with PP1. 
These PP1 interacting proteins function as inhibitors, substrate specifiers, and substrate 
targeting proteins, or a combination thereof. Sometimes PP1 interactors are themselves 
substrates for associated PP1 (Bollen 2001; Ceulemans and Bollen 2004). Given the 
number of protein phosphatases and phosphoprotein substrates encoded in the human 
genome, a large number of PP1 interacting proteins surely remain to be discovered. 
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1.1.3 Protein phosphatase 1α - PP1α 
 
PP1α is one of the three mammalian catalytic subunits isoforms of PP1 and by binding to 
different partners has been shown to participate in a large variety of events, such as 
metabolism, cell division, apoptosis, protein synthesis, transcription and neuronal 
signalling. PP1α, like the other PP1 isoforms, can also be inhibited by natural occurring 
toxins such as tautomycin, cantharidin, calyculin A, okadaic acid, and microcystin-LR (da 
Cruz e Silva 1997). 
PP1α activity can be modulated directly by post-translational modification of the catalytic 
subunit by phosphorylation. Some mammalian PP1 isoforms contain a TPPR sequence at 
the C-terminus that can be phosphorylated by Cdks, with concomitant inhibition of the 
catalytic activity. Indeed, PP1α catalytic subunit is phosphorylated at Thr-320, a Cdk 
consensus site, as cells approach and traverse S-phase (Dohadwala et al. 1994; Berndt 
et al. 1997; Liu et al. 1999). It has also been reported that the activities of the PP1α and 
PP2A are inhibited by tyrosine phosphorylation of the C-terminus Tyr-306 catalyzed by c-
src, v-src, and v-abl (Johansen and Ingebritsen 1986; Chen et al. 1992; Villa-Moruzzi and 
Puntoni 1996). Ionizing radiation causes dephosphorylation of Thr-320 on PP1α resulting 
in its activation (Guo et al. 2002). This event was shown to be dependent on ATM (Ataxia 
Telangiectasia Mutated) kinase, the gene product that is deficient in the human autosomal 
recessive disease (ataxia telangiectasia).  
PP1α is expressed ubiquitously. At the protein level PP1α was found to be more highly 
expressed in brain, testis and lung than in other peripheral tissues analysed as heart, 
liver, intestine, kidney, spleen, adrenal gland and skeletal muscle. PP1α was also shown 
to be extensively expressed in cortex, basal ganglia, hippocampus and thalamus (da Cruz 
e Silva et al. 1995b; Herzig and Neumann 2000; Luss et al. 2000).  
Mammalian PP1α, PP1β and PP1γ1 localize to distinct subcellular locations in 
mammalian cells (Andreassen et al. 1998; Trinkle-Mulcahy et al. 2001; Lesage et al. 
2005). In the brain the mRNAs for PP1α, PP1β and PP1γ1 were found to be particularly 
abundant in hippocampus and cerebellum (da Cruz e Silva et al. 1995b). At the protein 
level  PP1α and PP1γ1 were found to be more highly expressed in brain than in peripheral 
tissues, with the highest levels being measured in the striatum, where they were shown to 
be relatively enriched in the medium-sized spiny neurons (da Cruz e Silva et al. 1995b). At 
the electron microscopic level, PP1 immunoreactivity was demonstrated in dendritic spine 
heads and spine necks, and possibly also in the postsynaptic density (Ouimet et al. 1995). 
PP1 immunoreactivity has also been reported in human hippocampal neuronal cytoplasm 
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(Pei et al. 1994). In addition, most neuronal nuclei were not immmunoreactive for PP1γ1 
but were usually strongly immunoreactive for PP1α (Ouimet et al. 1995). It is thought that 
such specific localization and function is mediated by the regulators that bind the PP1c 
isozyme with different affinities.  
One unresolved issue is the extent to which different PP1c isoforms interact with distinct 
regulatory proteins. Neurabin I and Neurabin II/Spinophilin were identified to bind PP1γ1 
and PP1α, but not PP1β (MacMillan et al. 1999; Terry-Lorenzo et al. 2002), and several 
PP1α and PP1γ1 specific regulators have been identified in mouse fetal lung epithelial 
cells (Flores-Delgado et al. 2007). In human erythrocytes, the powerful oxidant ONOO- 
down regulates the activity of PP1α through tyrosine phosphorylation. Human erythrocytes 
express both PP1α and PP2A, but results indicate that only PP1α is a substrate of the 
peroxynitrite-activated fgr tyrosine kinase (Mallozzi et al. 2005). 
Of all mammalian tissues, the brain expresses the highest levels of protein kinases and 
phosphatases, and PP1 is highly expressed both in neurons and glia (da Cruz e Silva et 
al. 1995b; Ouimet et al. 1995). It is increasingly evident that protein phosphorylation is a 
fundamental process associated with memory, learning and brain function, with prominent 
roles in the processing of neuronal signals and in short-term and long-term modulation of 
synaptic transmission. In neurodegenerative disorders, such as Alzheimer’s disease, 
there is evidence for abnormal regulation of protein phosphorylation, which appears to 
contribute to the pathogenesis of such diseases (Wagey and Krieger 1998). An impaired 
balance of cellular phosphorylation, including abnormalities in both expression and activity 
levels of kinases and/or phosphatases, has been reported to occur in Alzheimer’s disease 
(Gandy 1994; Gandy et al. 1994; da Cruz e Silva et al. 1995a; Tian and Wang 2002). 
Even though PP1 is involved in the regulation of numerous cellular processes, relatively 
little is known about specific and nonredundant functions of the different PP1c isozymes. 
In mice, PP1γ, probably the testis-enriched splice variant PP1γ2, has a nonredundant 
function in spermatogenesis, as PP1γ knockout male mice are viable but sterile with 
defects in spermatogenesis, while knockout female mice are viable and fertile (Varmuza 
et al. 1999). Presumably, the somatic and female germ line functions of PP1γ are 
redundant with PP1α and/or PP1β. No knockout analysis exists for the other PP1c genes, 
although PP1α was shown to have a specific function in murine lung growth and 
morphogenesis (Hormi-Carver et al. 2004).  
It is important, when considering the involvement of protein phosphatases in 
neurodegenerative diseases and other disorders, to notice that phosphatases play 
important roles in numerous physiological and cellular events and exist in macromolecular 
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signalling complexes in association with specific regulatory subunits. So, it is clear the 
usefulness of considering their regulatory subunits as possible targets for therapeutic and 
diagnostic approaches. 
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1.2 YEAST TWO-HYBRID SYSTEM 
 
 
The Yeast Two-Hybrid (YTH) assay was developed by Fields and colleagues (Fields and 
Song 1989) in the late 80´s and has since become one of the most popular tools used in 
molecular biology. The original description of the YTH assay introduced the idea of 
splitting into two domains a specific transcription factor, whose activity could be 
reconstituted via the interaction of heterologous proteins fused to those two domains. The 
results of the test assay led to the suggestion that this approach might be applicable to the 
identification of new interactions, via screening of libraries of activation domain-tagged 
proteins, which was shown to be feasible (Chien et al. 1991). 
The Two–Hybrid concept also proved to be remarkably malleable, with adaptations that 
detected protein-DNA, protein-RNA, or protein-small molecule interactions that are 
dependent on post-translational modifications that occur in cell compartments other than 
the nucleus, or that yield signals other than transcription of a reporter gene (Vidal and 
Legrain 1999). 
 
 
1.2.1 Principle of the Yeast Two-Hybrid system 
 
The monosaccharide galactose is imported into the cell and converted to galactose-6-
phosphate by six enzymes (GAL1, GAL2, PGM2, GAL7, GAL10, MEL1), which are 
transcriptionally regulated by the proteins Gal80, Gal3 and Gal4, the latter of which plays 
the central role of DNA-binding transactivator. Gal80 binds Gal4 and inhibits its 
transcriptional ability. Gal3, in the presence of galactose, binds and causes a 
conformational change in Gal80, which then allows Gal4 to function as a transcriptional 
activator. Gal4 like other transcriptional activators is a modular protein that needs both 
DNA-binding (BD) and activation (AD) domains. 
In a Gal4-based Two-Hybrid assay a bait gene is expressed as a fusion with the GAL4 
DNA-BD (bait), while another gene or cDNA is expressed as a fusion with the GAL4 DNA-
AD (prey) (Fields and Song 1989; Chien et al. 1991). The Two-Hybrid technique exploits 
the fact that Gal4 cannot function as a transcription activator unless physically bound to 
an activation domain, through an interaction that does not need to be covalent. A Two-
Hybrid assay is performed by expressing the two fusion proteins in yeast. The prey and 
bait constructs are introduced, by co-transformation or mating, into yeast strains 
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containing the appropriate “Upstream Activating Sequence” (UAS) proximal to a reporter 
gene. The reporter gene is expressed if a binding interaction occurs between the DNA-BD 
fused protein and the DNA-AD fused protein. Each Gal4 responsive gene contains a UAS 
target site, when Gal4 binds the UAS transcription is activated from a downstream 
promoter.  By linking the Gal4 UAS with other metabolic genes (e.g. ADE2, HIS3, MEL1 
and lacZ) and by eliminating the wild type GAL4 gene, researchers have developed yeast 
strains that change phenotype when Gal4 is activated. Although the Gal4 DNA-BD can 
bind the UAS, it cannot activate transcription by itself. Transcription is activated only when 
the other half of the protein, Gal4 DNA-AD, joins the DNA-BD at the UAS (Figure 5).  
 
 
Figure 5 - The Yeast Two-Hybrid system. Two fusion proteins are expressed in yeast: GAL4 
DNA-binding domain (BD) fused to a bait protein, PP1α in the present work, and GAL4 activation 
domain (AD) fused to a prey protein, a human brain library in this case. The BD-bait hybrid 
protein can bind to upstream activation sites (UAS) but cannot activate transcription. The AD-
prey protein cannot recognize the UAS, thus, alone is not capable of initiating transcription. 
When the bait and the prey interact, the BD and AD are brought together and can activate 
reporter gene transcription. 
 
When using a large scale screen, a plasmid library, expressing cDNA-encoded AD-fusion 
proteins, can be screened by introduction into a yeast strain. These larger scale Two-
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Transcription 
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Hybrid approaches typically rely on interaction by yeast mating (Finley and Brent 1994; 
Serebriiskii et al. 2001b).  
When the two transformant cultures, from compatible yeast strains, are matted to each 
other, diploid cells containing four reporter genes (HIS3, ADE2, MEL1 and lacZ) are 
originated. If the protein interaction occurs, transcription of the reporter genes is activated 
allowing growth on nutritional selection media and expression of α-galactosidase (MEL1 
product) and β-galactosidase (lacZ product). Hence, high-stringency selection uses 
medium lacking tryptophan, leucine, histidine and adenine, and also the presence of X-α-
Gal. The selection of positive clones with the five reporter genes TRP1, LEU2, HIS3, 
ADE2 and MEL1 was designed to reduce the number of false positives, since the various 
reporter genes are under the control of distinct UAS and TATA boxes. An additional 
benefit of using yeast mating is that diploid cells are more tolerant to expression of toxic 
proteins and yield less false positives, since the diploids have reporter genes less 
sensitive to transcription (Kolonin 2000). 
 
 
1.2.2 Advantages and Limitations of the Yeast Two-Hybrid System 
 
Disadvantages 
 
 An obvious problem would arise if the protein of interest was capable of activating 
transcription on its own (auto-activation). It is, therefore, imperative to test the 
transcriptional activity of the protein of interest, in preliminary experiments. 
 The use of fusion proteins may change the conformation of the prey or bait, which may 
consequently alter activity or binding. Nevertheless, few problems have been reported 
with tagged proteins, perhaps due to their modular nature, where domains can fold 
independently, often allowing the introduction of artificial modules.  
 A major concern of testing protein-protein interactions using a heterologous system 
such as yeast, is the fact that some interactions may depend on specific post-
transcriptional modifications, such as disulfide bridge formation, glycosylation, or 
phosphorylation, which may not occur properly or at all in the yeast system (Fields and 
Sternglanz 1994).  
 Since the fusion proteins in the Two-Hybrid system must be targeted to the nucleus, 
extracellular proteins or proteins with stronger targeting signals may be at a disadvantage. 
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 It has been shown that certain protein domains may interact better than the full length 
protein, perhaps due to the lack of certain folding restraints. Since library screening 
selects for optimized reactions, one may obtain a false representation. This problem can 
be minimized by using libraries enriched for full-length cDNAs in the correct reading 
frame. 
 Given that the Two-Hybrid assay relies on reporter activity, it cannot be excluded that a 
third protein may be bridging the prey and the bait. Although unlikely, this possibility 
should not be excluded. 
 Certain proteins, when expressed in the yeast system or targeted to the nucleus, may 
become toxic. Other proteins may degrade essential yeast proteins or proteins whose 
presence is required for the assay. Such genes may be counter-selected for during growth 
and may distort the results obtained. 
 The identification of false binding partners presents itself as the main disadvantage of 
the Two-Hybrid assay. Even though two proteins can interact, it is not certain that they will 
interact in physiological conditions. Therefore, the biological relevance of the proteins 
identified must always be confirmed using alternative methodology. 
 
Advantages 
 
 The yeast Two-Hybrid system has a clear advantage over classical biochemical or 
genetic methods, in that it is an in vivo technique.  
 The use of the yeast host, as it bears a greater resemblance to higher eukaryotic 
systems, is an advantage over systems based on bacterial hosts. 
 The Two-Hybrid system has minimal requirements to initiate screening, since only the 
cDNA of the gene of interest is needed. 
 In signalling cascades, weak and transient interactions are often very important. The 
YTH system provides a sensitive method for detecting those interactions because such 
interactions are significantly amplified due to transcriptional, translational and enzymatic 
events. Such interactions may not be biochemically detectable, but even so be critical for 
proper cell functions (Guarente 1993; Estojak et al. 1995). 
 The Two-Hybrid assay is also useful for the analysis of known interactions. It can be 
used to pinpoint specific residues critical for protein interaction and to evaluate protein 
variants for the relative strength of their interactions (Yang et al. 1995). 
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 Interactions can be measured semi-quantitatively using the YTH system, allowing 
discrimination between high, intermediate, and low-affinity binding, the power of which 
correlates with that of in vitro approaches . 
 Although the Two-Hybrid assay was predicted to be limited to the study of cellular 
proteins, given that extracellular proteins often undergo modifications such as 
glycosylation or disulfide cross-links that are not expected to occur in the yeast nucleus, 
there have been various reported successes with extracellular receptor/ligand complexes.  
 Two-Hybrid screens are sometimes termed "functional screens", since if at least one of 
the proteins screened has a known function in a well-defined pathway, it might provide a 
functional hint in the current interaction. 
 Although there are certain disadvantages involving the Two-Hybrid assay, the most 
convincing argument for its use is the speed and ease by which the molecular 
mechanisms of many signalling cascades have been defined using this technique. 
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1.3 AIMS OF THIS THESIS 
 
Taking into account all the roles that have been attributed to PP1 based on its binding 
subunits, it is extremely important to identify novel PP1α binding proteins which may play 
critical regulatory and targeting roles for. Moreover, relatively little is known about isoform 
specific PP1 regulators. The Yeast Two-Hybrid (YTH) systems provide a sensitive method 
for detecting relatively weak and transient protein interactions. 
The main goal of this thesis was to identify the proteins expressed in human brain that 
interact with PP1α, since it is known to be highly and specifically enriched in dendritic 
spines. Ultimately, the identification of hitherto uncharacterised PP1α interacting proteins 
may address novel functions of PP1α in brain and PP1 associated diseases. It was hoped 
that this work could lead to the potential identification of new therapeutic targets for 
neurodegenerative disorders and aging. Thus, the specific aims of this thesis were: 
 
 To identify proteins expressed in human brain that interact with the PP1α isoform using 
the Yeast Two-Hybrid system – the human brain PP1α interactome. 
 
 To select proteins of interest by careful analysis of the identified proteins by 
bioinformatic methods. 
 
 To confirm the interaction of such proteins with PP1α and other PP1 isoforms. 
 
 
In order to identify potential PP1 interacting and regulating proteins, and to characterize 
the PP1α human brain interactome a large scale screen for PP1α binding proteins was 
performed, using the Yeast Two-Hybrid (YTH) system (Fardilha et al. 2004).  A total of 76 
proteins were identified from the 298 positive clones obtained, that are expressed in 
human brain and bind PP1α. 
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2  YEAST-TWO HYBRID SCREENING BY 
YEAST MATING 
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2.1 INTRODUCTION 
 
 
In order to find new interactions between PP1α and other proteins a screen using the 
MATCHMAKER GAL4 Two-Hybrid System was carried out using a human brain cDNA 
library (Clontech). The transformants were assayed for HIS3, ADE2 and MEL1 reporter 
gene activation after first clearing bait protein expression by immunoblotting, following 
preparation of yeast protein extracts.  
The YTH screen was performed by yeast mating, instead of the more common 
cotransformation protocol. By using the yeast mating protocol more unique positive clones 
are obtained due primarily to the “jump-start” that the new diploids receive before being 
plated on selective medium. Diploid yeast cells are also more resistant than haploid cells 
and can tolerate better the expression of toxic proteins. Additionally, in diploids, the 
reporters are less sensitive to transcription activation than in haploids, thus reducing the 
incidence of false positives from transactivating baits. 
The Gal4 System identifies the interaction between two proteins by reconstituting active 
Gal4 protein. The two proteins involved are expressed as fusion proteins with the Gal4 BD 
and AD. The two plasmids containing these constructs were introduced into yeast strains 
AH109 and Y187, containing the upstream activation sequences from the GAL1-GAL10 
regions, which promote transcription of the MEL1 gene. When interaction occurs between 
the DNA-BD and DNA-AD fusion proteins, MEL1 is transcribed, resulting in the 
development of blue colour for the strain when plated in medium containing X-gal (a 
chromogenic substrate). The yeast host lacks functional GAL4 and GAL8 genes. 
The vector used to insert the bait cDNA encoding PP1α, was Clontech’s GAL4 binding 
domain expression vector pAS2-1 (see Appendix III). pAS2-1 has several characteristics 
that make it suitable for YTH usage. It has the GAL4-BD, two independent yeast and 
bacteria replication origins, confers ampicillin and cycloheximide resistance and allows the 
yeast to grow without tryptophan in the culture media. It also has a multiple cloning site 
useful for inserting the bait cDNA. 
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2.2 MATERIAL AND METHODS 
 
 
All solutions compositions are described in Appendix I. 
 
 
2.2.1 Construction of the bait plasmid 
 
The pAS2-1 vector was digested with the restriction enzymes BamHI and EcoRI. The 
PP1α coding insert was generated by PCR, with the EcoRI and BamHI restriction sites 
incorporated into the primers used. The PCR product was sequentially digested with 
BamHI and EcoRI and then ligated to the previously prepared vector. Plasmid DNA was 
analysed with a convenient restriction endonuclease, namely HindIII. The resulting 
plasmid, named pAS-PP1α, was fully sequenced to check the orientation of the PP1α 
sequence, to validate the reading frame of the fusion protein, did to ensure it did not 
contain any mutations introduced by the PCR process. This part of the work was partly 
carried out in collaboration with Ana Paula Vintém and Carla Lopes. 
 
 
2.2.2 Expression of the bait protein in yeast 
 
In order to verify the ability of the recombinant construct to drive PP1α expression, it was 
transformed into yeast strain AH109. The transformed cells were grown on appropriate 
media (see below) and PP1α expression was confirmed by immunobloting of the 
corresponding protein extracts.  
 
2.2.2.1 Yeast transformation with plasmid DNA  
 
Preparation of competent yeast cells 
One yeast colony was inoculated into 1 mL of YPD medium in a 1.5 mL microtube and 
vortexed vigorously to disperse cell clumps. The culture was transferred into a 250 mL 
flask containing 50 mL of YPD and incubated at 30º C with shaking at 230 rpm overnight, 
until it reached stationary phase with OD600nm > 1.5. Enough of this culture (20-40 mL) was 
transferred into 300 mL YPD in a 2 L flask to yield an OD600nm= 0.2-0.3. The culture was 
incubated at 30º C with shaking at 230 rpm, until OD600nm = 0.4-0.6, and then centrifuged 
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at 2,200 rpm for 5 min, at RT, and the supernatant was discarded and the cells 
resuspended in 25 mL H2O. The cells were recentrifuged and the pellet was resuspended 
in 1.5 mL of freshly prepared, sterile 1X TE/LiAc.  
 
Yeast transformation- Lithium acetate (LiAc)-mediated method 
In a microtube 200 ng of plasmid DNA were added to 100 µg of salmon testes carrier 
DNA. Then, 100 µL of freshly prepared competent cells were added to the microtube, 
followed by 600 µL of sterile PEG/LiAc (40% PEG 4000/ 1X TE/ 1X LiAc). The solution 
was incubated at 30º C for 30 min with shaking (200 rpm). After adding 70 µL of DMSO 
the solution was mixed gently and then heat-shocked for 15 min in a 42º C water bath. 
The cells were chilled on ice and pelleted by centrifugation for 5 sec at 14,000 rpm and 
resuspended in 0.5 mL of 1X TE buffer. The cells (100 µL) were then plated in the 
appropriate SD selection medium (e.g. SD/-Trp for the plasmid pAS2-1), and incubated at 
30º C for 2-4 days, until colonies appear. 
 
2.2.2.2 Expression of proteins in yeast  
 
Preparation of yeast cultures for protein extraction 
A colony of the previously transformed yeast was inoculated into 5 mL of the appropriate 
SD selection medium and incubated at 30º C with shaking at 230 rpm overnight. As a 
negative control an untransformed yeast colony was inoculated in YPD. The overnight 
cultures were vortexed and separately added to 50 mL aliquots of YPD. These cultures 
were incubated at 30º C with shaking (220 rpm) until OD600nm = 0.4-0.6. At this point the 
cultures were quickly chilled by pouring them into a prechilled 50 mL centrifuge microtube 
halfway filled with ice. The tubes were immediately centrifuged at 1,000 g for 5 min at       
4º C. The supernatant was discarded and the cell pellet was washed in 50 mL of ice-cold 
water. The pellet was recovered by centrifugation at 1,000 g for 5 min at 4º C and 
immediately frozen by placing tubes in liquid nitrogen.  
 
Preparation of protein extracts 
The cell pellet, prepared as previously described, was quickly thawed by resuspending 
each one in 100 µL of prewarmed cracking buffer (60º C) per 7.5 OD600 units of cells 
(OD600 of a 1 mL sample multiplied by the culture volume). The samples were briefly 
thawed in a 60º C water bath. After 15 min an additional aliquot (1 µL of 100X PMSF per 
100 µL of cracking buffer) of the 100X PMSF stock solution was added to the samples 
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and every 7 min thereafter during the procedure. Each cell suspension was transferred 
into a 1.5 mL microtube containing 80 µL of glass beads per 7.5 OD600 units of cells. The 
samples were heated at 70º C for 10 min to release the membrane-associated proteins. 
Then, the microtubes were vortexed vigorously for 1 min and centrifuged at 14,000 rpm 
for 5 min at 4º C. The supernatants were transferred to fresh microtubes and placed on 
ice. The pellets were boiled for 5 min, vortexed for 1min and centrifuged again, with the 
resulting supernatants being combined with the previous. The samples were boiled and 
loaded immediately on a gel. 
 
SDS-PAGE  
In order to visualize the fusion protein GAL4-BD/PP1α, with a calculated molecular weight 
around 58 kDa, a 12% acrylamide gel was used (Table 2). 
 
Table 2 - Composition of the running and stacking gels for SDS-PAGE. 
Components Running gel (12%) Stacking gel (3.5%) 
Water 10.35 mL 6.60 mL 
30%Acryl./8%Bisacryl. 12.00 mL 1.20 mL 
4X LGB 7.50 mL - 
5X UGB - 2.00 mL 
SDS 10% - 100.0 µL 
10% APS 150.0 µL 100.0 µL 
TEMED 15.0 µL 10.0 µL 
 
The 12% running gel was prepared by sequentially adding the components indicated on 
Table 2 (APS and TEMED were added last, as they initiate the polymerising process). The 
solution was then carefully pipetted down the spacer into the gel sandwich, leaving some 
space for the stacking gel. Then, water was carefully added to cover the top of the gel and 
the gel was allowed to polymerise for 1 hr. The stacking gel was prepared according to 
Table 2. The water was poured out and the stacking gel was added to the sandwich; a 
comb was inserted and the gel was allowed to polymerise for 30 min. Then, the samples 
were prepared by the addition of ¼ volume of loading gel (LB) buffer. The microtube was 
boiled and centrifuged, the combs removed and the wells filled with running buffer. The 
samples were carefully applied into the wells that were filled with running buffer, and the 
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samples were run at 45 mA until the bromophenol blue from the LB reached the bottom of 
the gel. 
 
2.2.2.3 Immunoblotting 
 
For immunoblotting the tank transfer system was used as follows: 3MM blotter paper was 
cut to fit the transfer cassette and a nitrocellulose membrane of the gel size was also cut. 
The gel was removed from the electrophoresis device and the stacking gel removed and 
discarded. The transfer sandwich was assembled under transfer buffer to avoid trapping 
air bubbles. The cassette was placed in the transfer device filled with transfer buffer. 
Transfer was allowed to proceed overnight at 200 mA. Afterwards, the transfer cassettes 
were disassembled; the membrane carefully removed and allowed to air dry prior to 
further manipulations.  
 
Immunodetection by enhanced chemiluminescence (ECL)  
ECLTM is a light emitting non-radioactive method for the detection of immobilised antigens, 
conjugated directly or indirectly with horseradish peroxidase-labelled antibodies. In order 
to visualize the fusion protein GAL4 DNA-BD/PP1α the blots was probed with a polyclonal 
antibody (CBC2C), which recognizes human PP1α (da Cruz e Silva et al. 1995b). 
The membrane was soaked in 1X TBS for 10 min. Non-specific binding sites were blocked 
by immersing the membrane in 5% low fat milk in TBST for 1 hr. After washing with 1X 
TBST, the membrane was incubated with a solution of the primary (anti-PP1α) antibody 
diluted in 3% low fat milk in TBST for 1 hr with shaking. After three washes of 10 min each 
in 1X TBST the membrane was incubated with a solution of the anti-rabbit secondary 
antibody diluted (1:5000) in 3% low fat milk in TBST for 1 hr with shaking. The membrane 
was then washed 3 times for 10 min. 
Subsequently the membrane was incubated for 1 min at RT with the ECL detection 
solution (a mixture of equal volumes of solution 1 and solution 2 from the ECL kit 
(Amersham), approximately 0.125 mL/cm2 membrane). Inside the dark room, the 
membrane was gently wrapped with cling-film, eliminating all air bubbles and placed in a 
film cassette and an autoradiography film (XAR-5 film, KODAK) was placed on the top. 
The cassette was closed and the blot exposed for short periods of time. The film was then 
removed and developed in a developing solution, washed in water and fixed in fixing 
solution. If needed, a second film was exposed more or less time according to the first 
result. 
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2.2.3 Library screening by yeast mating 
 
A human brain cDNA library was screened to identify neuronal interacting partners for 
PP1α. By using a pretransformed library the most costly and time-consuming steps of 
library screening are optimized. These include, constructing the library, amplifying the 
library in E. coli, isolating the library DNA, performing the library-scale transformation of 
yeast strain Y187, plating the transformation mixture and harvesting the transformants at 
high viability and density in freezing medium. 
A concentrated overnight culture of the bait strain (AH109 + pAS-PP1α) was prepared by 
inoculating a colony of the bait strain into 50 mL of SD/-Trp medium and incubating it at 
30º C overnight with shaking at 250 rpm. The next day, when OD600>0.8, the culture was 
centrifuged at 1,000 g for 5 min, the supernatant was decanted and the pellet was 
resuspended in the residual liquid (5 mL) by vortexing. Just prior to use, a frozen aliquot 
(1 mL) of the library culture (Pretransformed Human Brain MATCHMAKER cDNA Library, 
Clontech) was thawed in a room temperature water bath. The library was gently mixed 
and 10 µL were set aside for later tittering (see below). The entire bait strain culture was 
combined with the 1 mL library aliquot in a 2 L sterile flask, 45 mL of 2X YPDA were 
added and gently swirled. This culture was incubated at 30º C for 20-24 hr, with shaking 
at 40 rpm. After 20 hr of mating a drop of the mating culture was checked under a phase-
contrast microscope to check for the presence of zygotes, thereafter allowing the mating 
to proceed for more 4 hr. The mating mixture was transferred to a sterile 50 mL tube and 
the cells spun at 1,000 g for 10 min. The mating flask was rinsed twice with 2X YPDA     
(50 mL) and the rinses were combined and used to resuspend the first pellet. The cells 
were centrifuged again at 1,000 g for 10 min, the pellet resuspended in 10 mL of 0.5X 
YPDA and the total volume (cells + medium) was measured. Half of the library mating 
mixture was plated on SD/QDO (SD without Leu, Trp, Ade and His), and the other half on 
SD/TDO (SD without Leu, Trp and His), at 200 µL per 150 mm plate. For mating efficiency 
controls, 100 µL of 1:10,000, 1:1,000; 1:100 and 1:10 dilutions of the mating mixture were 
plated in 100 mm SD/-Leu, SD/-Trp and SD/-Leu/-Trp plates. All plates were incubated at 
30º C until colonies appeared, generally 3-8 days on TDO and 8-21 days on QDO 
medium. Then, growth of the control plates was scored and the mating efficiency and 
number of clones screened were calculated. All positive clones were replated twice in 
SD/QDO medium containing X-α-Gal and incubated at 30º C for 3-8 days. True positives 
form blue colonies. The master plates were sealed with parafilm and stored at 4º C. 
Glycerol stocks were prepared for all the positive clones. 
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2.2.3.1 Library tittering 
 
A library aliquot (10 µL) was transferred to 1 mL of YPDA in a 1.5 mL microtube – dilution 
A (dilution factor 10-2). 10 µL from dilution A were added to 1 mL of YPDA in another 
microtube and mixed gently – dilution B (dilution factor 10-4). From dilution B, 100 µL were 
spread onto three SD/-Leu plates. All the plates were incubated at 30º C for 3 days after 
which the number of colonies was counted. The titter of the library was calculated using 
the following expression: [#colonies]/[plating volume (mL)x dil factor] = cfu/mL. 
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2.3 RESULTS 
 
 
The plasmid pAS-PP1α was fully sequenced to check the orientation of the PP1α 
sequence, in order to validate the reading frame of the fusion protein (Figure 6) 
 
 
 
 
Figure 6 – pAS-PP1α construct sequence analysis, EcoRI restriction sequence used for insertion 
with the starting codon ATG in frame is  highlighted in blue colour.  
 
 
The fusion protein GAL4-BD-PP1α from the protein extracts was detected with an anti-
PP1α antibody (da Cruz e Silva et al. 1995b) and an anti-rabbit secondary antibody 
conjugated to peroxidase. A protein extract from rat brain was used as a positive control 
and as a negative control the protein extract from the untransformed yeast strain (Figure 
7). 
 
 
 
 
Figure 7 – Immunoblot analysis of AH109 
yeast protein extracts, probed with anti-PP1α 
antibody. Lane 1: protein extract from rat 
cortex; lane 2: untransformed yeast control; 
lane 3: yeast transformed with pAS-PP1α. The 
arrows indicate PP1α in lane 1, at 37 kDa and 
BD-PP1α fusion protein in lane 3, at 58 kDa. 
 
  1        2        3 
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When probed with the anti-PP1α antibody, PP1α was detected in rat cortex (Figure 6, lane 
1). Unspecific bands were also detected in the protein extract from untransformed yeast 
cells (Figure 6, lane 2). A band of the expected molecular mass (58 KDa) was only 
detected in the protein extract from yeast cells containing the pAS-PP1α plasmid (Figure 
6, lane 3), demonstrating that this strain expresses the fusion protein. 
The BD-PP1α protein was also tested for transcriptional activation of the reporter genes. 
The bait construct did not activate transcription from the UAS (the DNA sequence that is 
recognized by GAL4-BD), as detected by lack of growth of yeast cells containing the bait 
plasmid pAS-PP1α on selective media SD/-Trp-His, SD/-Trp-His-Ade and SD/-Trp-His-
Ade/X-α-Gal (data not shown). 
Once yeast cell expression of the fusion protein GAL4-BD-PP1α was confirmed as well as 
its inability to initiate transcription of the reporter genes by it self, the Yeast Two-Hybrid 
screen was performed. After transforming the bait plasmids into the appropriate yeast 
strain, AH109 (mat a), the next step was to obtain the desired library pretransformed in a 
yeast strain of the opposite mating type. A pretransformed pACT-2 library in the yeast 
strain Y187 (mat α) containing human brain cDNA sequences fused to the GAL4 
transactivation domain was used. 
The mating culture was checked under a phase-contrast microscope to check for the 
occurrence of zygotes (Figure 8), indicative that mating was occurring as expected. 
 
 
 
 
Figure 8 – Zygote formation in the mating 
mixture with its typical three-lobed shape. The 
small lobe in the middle is the budding diploid 
cell (arrow), the other two lobes are the two 
haploid (parental) cells. This picture was taken 
using an inverted microscope in phase 
contrast mode, during the mating event (40X 
magnification). 
 
To calculate de number of clones screened the following equation was used [# cfu/mL of 
diploids X resuspension volume]. To calculate the mating efficiency the following equation 
was used [# cfu (in SD –Leu/-Trp) X 1000µL/mL/ volume plated (µL) x dilution factor] / [# 
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cfu (in SD -Trp) X 1000µL/mL/ volume plated (µL) X dilution factor] X 100. A summary of 
the results obtained is presented below in Table 3. 
 
Table 3 - Results from the Yeast Two-Hybrid screen. 
Positive clones 
Mating efficiency 
(% diploids) Clones screened 
298 30.25 1,72×107 
 
In the YTH screen 495 clones were initially obtained, 446 from SD/TDO and 49 from 
SD/QDO media. All the colonies were re-streaked in SD/QDO plates in order to test for 
the expression of the nutritional reporter genes HIS3 and ADE2. These clones were 
further tested for MEL1 expression, another reporter gene, by growing these putative 
primary positive clones in SD/QDO medium with X-α-Gal. True positive clones produce a 
blue colour (Figure 9), resulting in a total of 298 true positive clones, thus identified in this 
screen. Of these, 258 were originated from SD/TDO and 40 from SD/QDO media. The 
positive clones were named 1-298 T or Q as they were obtained from TDO or QDO 
media, respectively. 
 
 
 
 
Figure 9 – Positive clones identified in the 
YTH screen, recovered from the original 
SD/TDO or SD/QDO plates. MEL-1 expression 
of the positive clones obtained in the YTH 
screen is detected by the formation of blue 
colonies in the presence of X-α-GAL. White 
colonies represent false positives that grew on 
SD/QDO medium but could not turn blue in the 
presence of X-α-GAL. 
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2.4 DISCUSSION 
 
 
As with all detection methods, the YTH system is known to result in the detection of some 
false positives. This was a relatively serious problem in the early days of the YTH method 
but the elimination of such false positive results has been greatly improved in recent 
times. False positive signals result from cells in which the reporter genes are active even 
though the bait and prey do not interact. There are several classes of false positives. For 
example, false positives may arise from a prey that interacts with DNA upstream of the 
reporter genes or with proteins that interact with promoter sequences. These two classes 
of false positives can be eliminated by the use of more than one reporter gene under the 
control of different promoters, as was the case with the present work. Another inherent 
problem with the system is that not all proteins will be efficiently folded and/or post-
translationaly modified in the yeast nucleus, which may result in the protein not interacting 
with the true partner. In the same way, the protein may adopt a different tertiary structure 
when expressed as fusions with the transcription factor domains. Also, some proteins may 
be toxic when expressed as fusions in yeast, inhibiting growth when expressed at high 
levels. This can be avoided to some extent by the use of inducible expression plasmids. 
Other false positive results include interactions that occur in the YTH screen but not in a 
physiological context, because the partners are not expressed in the same cellular or 
subcellular environment at the same time. 
The credibility of interactions identified in an YTH screen should be evaluated through 
supplementary data from other sources. By this means, the verification of a putative 
interaction can be achieved in a variety of ways. One approach is to mix the recombinant 
proteins and verify binding in vitro through a variety of biochemical assays. Another 
approach is to express both proteins in mammalian cells by transfection and analyse 
interactions by immunoprecipitation studies. However, even if co-immunoprecipitation is 
successful, there is still the possibility that the proteins only interact under the conditions 
used. So, a crucial validation of the Two-Hybrid results is to prove that the two proteins 
exist in the same subcellular environment, by doing immunoprecipitation in the tissue of 
interest. 
In the present work, the PP1α bait vector was successfully constructed, shown to drive 
PP1α expression in yeast and to be unable to drive reporter gene expression  by it self. It 
was then used successfully to screen a human brain cDNA library, thus defining the 
human brain PP1α interactome. By screening 1,72×107 clones from a human brain cDNA 
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library with PP1α as bait 298 positive clones were obtained as accessed by their ability to 
grow on SD/QDO selective media and to turn blue in the presence of X-α-Gal. 
The following chapter will deal with the analysis and the characterization of the positives 
obtained. Although it was expected most of the 298 positives to encode true PPα 
interacting proteins, some may prove to be false positives. Further work will be required to 
define the relevant physiological interactors. 
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3  CHARACTERIZATION OF THE POSITIVE 
CLONES 
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3.1 INTRODUCTION 
 
 
The majority of the PP1 binding proteins that have been identified to date were discovered 
using the YTH method. Frequently, when performing a YTH screen, only few clones are 
selected and further characterized. Using such an approach many of the rarer positive 
clones are never analyzed, and some important potential interacting proteins may be 
missed. 
In this screen, 298 positive clones were obtained and we decided to analyse all in order to 
identify not only the most abundant interactions but also the more interesting ones, even 
though they may have been detected only once or twice in the screen. This does not 
mean they are not important but may simply reflect the low abundance of the mRNA in the 
library used or its low abundance in the tissue from which the library was made.  
All positive clones were partially sequenced, their identity was verified by comparison to 
the Genbank database and preliminary analysis was performed on all the positives 
identified. Some of the identified PP1α interacting proteins were chosen for further study. 
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3.2 MATERIALS AND METHODS 
 
 
All solutions compositions are described in Appendix I. 
 
 
3.2.1 Plasmid isolation from yeast 
 
3.2.1.1 Yeast plasmid extraction by the “Boiling” method 
 
A single yeast colony was grown in SD/QDO medium and 3 mL of yeast cells were 
pelleted for 3 min at 14000 rpm and resuspended in 100 µL of STET solution. About     
300 µL of 0.5 mm acid-washed glass beads (Sigma) were added and vortexed on high for 
6-8 min. After adding 100 µL of STET solution  the tubes were boiled for 3 min. After chill 
on ice, the tubes were centrifuged for 10 min at 14000 rpm at 4º C.  The supernatant was 
transferred into a new microtube, 500 µL of ammonium acetate 7.5 M was added and 
mixed briefly and the tubes were incubated for 1-2 hrs at -20º C. The tubes were, then, 
centrifuged for 20 min at 14000 rpm and 4º C and the supernatant transferred to new 
tubes containing 200 µL of ice cold ethanol. After spinning down for 10 min at 14000 rpm 
and 4º C, the supernatant was removed and the tubes rinsed with 200 µL of 70% ethanol. 
Another 5 min centrifugation was performed and the pellet was dried in a vacuum device. 
The pellet was resuspended in 15 µL of sterile 20 µg/mL RNase solution.    
 
 
3.2.2 Bacteria transformation 
 
3.2.2.1 Preparation of E. coli competent cells 
 
A single colony of E. coli XL1-Blue was incubated in 10 mL of SOB medium at 37º C 
overnight. Then, 1 mL of this culture was used to inoculate 50 mL of SOB and the culture 
was incubated at 37º C with shaking at 220 rpm for 1-2 hr, until OD550nm=0.3. The culture 
was cooled on ice for 15 min and centrifuged at 4,000 rpm at 4º C for 5 min. The 
supernatant was discarded and the pellet resuspended in 15 mL of Solution I. After 
standing on ice for 15 min, the cells were centrifuged at 4,000 rpm for 5 min at 4º C and   
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3 mL of Solution II were added to resuspend the cell pellet. The cells were immediately 
divided in 100 µL aliquots and stored at -80º C. 
 
3.2.2.2 Bacteria transformation with plasmid DNA 
 
Competent cells (100 µL) were thawed on ice and 1-50 ng of DNA were added to the cells 
and gently swirled. The microtube was incubated on ice for 20 min and heat shocked at 
42º C for 90 sec. The microtubes were then incubated on ice for 30 min before adding     
0.9 mL of SOC medium. The tubes were subsequently incubated at 37º C for 30 min with 
shaking at 220 rpm. The culture was centrifuged at 14,000 rpm and the supernatant 
discarded. The cells were then resuspended in 100 µL of the selective medium and 
spread on the appropriate agar medium. The plates were incubated at 37º C for 16 hr until 
colonies appeared. Control transformations were also performed in parallel. These always 
included a negative control transformation without DNA and a positive control 
transformation with 1 ng of a control plasmid, such as pAS2-1. 
 
 
3.2.3 Analysis of the positive plasmids by restriction digestion and 
sequencing  
 
In order to screen for the recombinant plasmid in the transformants, the plasmid DNA was 
extracted from several isolated bacterial colonies and digested with the restriction 
endonuclease HindIII, and the fragments produced were separated by agarose gel 
electrophoresis. 
The vector used (pACT-2) produces a characteristic pattern of fragments that allows its 
differentiation from colonies resulting from transformation by the bait vector. Plasmids 
generating DNA fragments characteristic of the pACT-2+library insert digested with HindIII 
were further analysed by sequencing  with the GAL4-AD primer (Clontech; see Appendix 
IV). 
A search for similar sequences in the Genbank database was performed using the BLAST 
algorithm [Basic Local Alignment Search Tool, (Altschul et al. 1990)]. 
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3.2.3.1 Isolation of plasmids from transformants 
 
Method 1 – Alkaline lysis “mini-prep” 
A  single bacterial colony was transferred into 3 mL of LB medium containing ampicillin 
(100 µg/mL) and incubated overnight at 37º C with vigorous shaking (220-250 rpm).      
1.5 mL of this culture were transferred into a microtube and centrifuged at 14,000 rpm for             
1 min at 4º C and the supernatant was discarded. The cell pellet was resuspended in      
100 µL of ice-cold solution I by vigorous vortexing. Then, 200 µL of freshly prepared 
solution II were added to the microtube that was mixed by inverting several times. 
Keeping the microtube on ice, 150 µL of ice-cold solution III were added and again the 
microtube inverted several times. The microtube was then allowed to stand on ice for 5 
min, centrifuged at 14,000 rpm for 10 min at 4º C and the supernatant transferred to a 
clean microtube. The DNA was precipitated by adding 2 volumes of ice-cold ethanol. The 
mixture was vortexed and placed at -20º C for 30 min. After centrifugation at 14,000 rpm 
for 10 min at 4º C, the supernatant was completely removed and the pellet washed with 
70% ethanol. Following centrifugation, the pellet was allowed to air-dry for 10 min. The 
DNA was dissolved in DNAase-free H2O containing RNAase (20 µg/mL) and stored at -
20º C. 
 
Method 2 – QIAGEN “miniprep” 
The bacterial pellet was obtained as described above. The pellet was then resuspended in 
250 µL of buffer P1, 250 µL of buffer P2 were added and the microtube was mixed by 
gently inverting until the solution became viscous and slightly clear. Afterwards, 350 µL of 
buffer N3 were added and the microtube was repeatedly inverted until the solution 
became cloudy. The microtube was centrifuged for 10 min and the resulting supernatant 
was applied to a QIAprep spin column placed in a microtube. After a 1 min centrifugation 
the flow-through was discarded. The column was washed by adding 0.75 mL of buffer PE 
and centrifuged for 1 min to discard the flow-through, and then a subsequent 1 min 
centrifugation to remove residual wash buffer. Finally, the column was placed in a clean 
microtube and 50 µL of H2O were added to elute the DNA by centrifuging for 1 min having 
let it stand for 1 min. This method gives a cleaner DNA preparation than Method 1 and 
with better yields. This method was used when the DNA was subsequently to be 
processed for DNA sequencing. For enzymatic restriction the first method was more 
commonly employed. 
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3.2.3.2 Restriction fragment analysis of DNA 
 
Plasmid DNAs were analysed through the digestion with a convenient restriction 
endonuclease, namely HindIII (New England Biolabs). For plasmid DNA digestion the 
manufacturer’s instructions were followed. In a microtube the following components were 
added: 
 
100 µg/mL DNA 
1X reaction buffer (specific for each restriction enzyme)  
1 U/µg DNA of restriction enzyme 
 
The mixture was incubated at the appropriate temperature (37º C for HindIII) for a few hrs. 
 
3.2.3.3 Electrophoretic analysis of DNA 
 
The electrophoresis apparatus was prepared and the electrophoresis tank was filled with 
enough 1X TAE to cover the agarose gel. The appropriate amount of agarose was 
transferred to an Erlenmeyer with 50 mL 1X TAE. The slurry was heated until the agarose 
was dissolved and allowed to cool to 60º C before adding ethidium bromide to a final 
concentration of 0.5 µg/mL. The agarose solution was poured into the mold and the comb 
was positioned. After the gel became solid the comb was carefully removed and the gel 
mounted in the tank. The DNA samples were mixed with the 6X loading buffer (LB) and 
the mixture was loaded into the wells of the submerged gel using a micropipette. Marker 
DNA (1kb ladder or λ-HindIII fragments) of known size was also loaded onto the gel. The 
lid of the gel tank was closed and the electrical cables were attached so that the DNA 
migrated towards the anode. The gel was run until the bromophenol blue had migrated the 
appropriate distance through the gel. At the end, the gel was examined under UV light and 
photographed or otherwise analysed on a Molecular Imager (Biorad).   
 
3.2.3.4 DNA sequencing 
 
All the DNA samples to be sequenced followed the same protocol. If the DNA had been 
obtained by the “alkaline lysis miniprep” method and had not been purified by QIAGEN 
miniprep spin column, then it was purified in a QIAquick spin column (QIAGEN DNA 
Purification Kit) as described bellow, before being processed for sequencing. 
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QIAGEN DNA Purification 
Briefly, 5 volumes of buffer PB were added to 1 volume of the solution to be purified and 
mixed. The QIAquick spin column was placed in a collection microtube and the sample 
was applied to the column and centrifuged for 1 min at 14000 rpm to bind the DNA. The 
flow-through was discarded and the column was washed with 0,75 mL of buffer PE, 
centrifuged for 1 min at 14000 rpm and the flow-through discarded. The column was 
placed back in the same microtube and centrifuged again to remove traces of washing 
buffer. Then, the column was placed in a clean microtube, 50 mL of H2O were added and 
allowed to stand for 1 min. To elute the DNA the column was centrifuged for 1 min at 
14000 rpm. The DNA was stored at -20º C. 
 
Sequencing PCR reaction 
In a 0,2 mL microtube the following components were mixed: 
 
500 ng dsDNA  
4 µL Ready Reaction Mix* 
10 pmol primer 
H2O to a final volume of 20 µL 
 
* Ready Reaction Mix is composed of dye terminators, deoxynucleoside triphosphates, 
AmpliTaq DNA polymerase, FS, rTth pyrophosphatase, magnesium chloride and buffer 
(Applied Biosystems). 
 
This reaction mixture was vortexed and spun down for a few seconds. The PCR was then 
performed using the following conditions: 
 
 96º C 1 min 
96º C 30 sec 
 42º C 15 sec          
 60º C 4 min              25 cycles 
 
Afterwards, the samples were purified by ethanol precipitation. Briefly, 2.0 µL of 3 M 
sodium acetate (pH 4.6) and 50 µL of 100% ethanol were added to the reaction 
microtube. The microtube was vortexed and incubated at RT for 20 min to precipitate the 
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extension products. The microtube was then centrifuged at 14,000 rpm for 20 min at RT. 
After discarding the supernatant 250 µL of 70% ethanol were added, the microtube was 
briefly vortexed and recentrifuged for 5 min at 14000 rpm at RT. The supernatant was 
discarded and the pellet dried. After this procedure the DNA was sent to the sequencing 
facility where there is an Automated DNA Sequencer (ABIPRISM 310, Applied 
Biosystems). 
 
 
3.2.4 Yeast colony hybridization 
 
In order to reduce the number of clones that needed to be sequenced, all positives 
resulting from the screen were subjected to colony hybridization using appropriate 
oligonucleotides. 
 
3.2.4.1 Filter preparation 
 
The nitrocellulose filter was placed on an agar plate containing the nutritional selective 
media QDO. Using autoclaved toothpicks isolated colonies were patched onto the filter, 
including positive and negative controls, already confirmed by sequencing. The filter was 
incubated overnight at 30º C. Pieces of 3MM Whatman paper were cut, with the same 
size of the filters, placed in Petri dishes and then soaked with 6 mL of freshly made 
SCE/DTT/Lyticase solution. The filters were lifted from the growth media and placed (cell 
side up) on the satured paper avoiding the formation of air bubbles. The Petri dish was 
covered and placed into a plastic bag and incubated overnight at 30º C. Filter sized pieces 
of 3MM paper were cut, placed in Petri dishes and soaked, avoiding the formation of 
bubbles, with 6 mL of each one of the different treatment solutions. Then the filters were 
placed on the following solutions, for the given times: Lysis solution, 5 min; Denaturing 
solution, 10 min; Neutralizing solution, 5 min and Washing solution, 3 times 5 min. The 
filters were placed on a sheet of 3MM paper to dry for an hr and then were UV cross 
linked (2 times autocross link for 30 sds) or baked for 1 hr in a 80º C vacuum oven, 
between pieces of 3MM paper. The filters were stored between pieces of 3MM paper and 
kept in the dark. 
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3.2.4.2 Probe preparation and labelling 
 
The probe DNA was separated in a 1% low melting agarose gel at 4º C and 50 V. Part of 
the gel was stained with etidium bromide (0.2 µg/mL) and aligned with the non stained 
part of the gel in order to cut the appropriate band. The cutted band was placed in a pre-
weighted tube. Water was added in a ratio of 3 mL/g of gel slice and placed in a boiling 
water bath for 7 min and stored at -20º C. Just before use the sample was re-boiled for 3 
min and stored at 37º C (for 10-30 min) until the labelling reaction.  
For DNA probe labelling the High Prime DNA Labeling Kit (Roche) was used to label      
25 ng of template DNA adding sterile water to a final volume of 8 µL. A control reaction 
was performed side by side with control DNA. The reaction mixture was obtained by 
mixing the 8 µL of DNA , on ice, with 4 µL of high prime reaction mixture, 3 µL of dATP, 
dGTP, dTTP mixture and 5 µL of 50 µCi [α33P]dCTP, 3000Ci/mmol, aqueous solution. 
After 2 hrs of incubation, at 37º C, the reaction was stopped by adding 2 µL of 0.2M EDTA 
(pH 8.0) solution and by heating to 65º C for 10 min. The probe was, then, purified using a 
push column beta shield device and Nuctrap probe purification columns (Stratagene).  
 
3.2.4.3 Filter Hybridization 
 
The filters were floated in destilled water and once completely wet were submerged for a 
few min. Afterwards the filters were transferred to 3xSSC/0.1%SDS/1mMEDTA solution at 
45º C for 15 min. After rubbing the filters to remove cell debris, they were left in the same 
solution for another 15 min with shaking.  Then the filters were incubated in hybridization 
solution (0.1 mL/cm2) at the hybridization temperature (65º C) in a glass hybridization 
bottle for 1 hr, making sure that there were no air bubbles and the solution was evenly 
distributed all over the filter. 
The radioactively labelled DNA probe was denatured at 100º C for 5 min and then quickly 
chilled on ice. The labelled probe was added to the hybridization solution in the proportion 
of 1-2x106 cpm/mL and the hybridization was performed overnight at 65º C. The filter was 
rinsed with wash solution 1 (2xSSC/0.05%SDS) pre-warmed to 60º C, two times for 15 
min. Then the filters were rinsed again with solution 1, at 65º C for 5 min, and with wash 
solution 2 (0.1xSSC/0.1%SDS) for another 5 min at 65º C. Then filters were removed from 
the hybridization bottles, the excess solution was removed without letting the filters dry, 
and were immediately covered with plastic wrap and exposed using a phosphor imaging 
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screen, or alternatively were exposed to X-ray films at -70º C with two intensifying 
screens. 
 
3.2.4.4 Probe Striping 
 
The filters were placed in pre-heated sterile 0.5% SDS solution to 100º C, making sure 
that the air exposal was minimal, for filters not to dry, and were incubated for 10 min with 
frequent shaking. Then the solution was left to cool down for about 10 min, the filters were 
removed and left to air dry and were finally stored at -20º C. The filters thus processed 
may be re-hybridized several times with different probes. 
 
 
3.2.5 Verifying protein interactions by yeast co-transformation 
 
To verify protein interactions, a small-scale LiAc yeast transformation procedure was 
performed, as previously described, combining the bait plasmid pAS-PP1α with specific 
positive clones isolated from the AD/library. The AD/library and pAS-PP1α plasmids to be 
tested were co-transformed into AH109 and selected on SD/-Leu-Trp. In parallel, co-
transformation with the vectors pAS2-1 and pACT-2 was performed as a negative control. 
The association of murine p53 (encoded by plasmid pVA3) and SV40 large T antigen 
(plasmid pTD1) served as a positive control. To confirm protein-protein interactions, the 
fresh diploid colonies were assayed for growth on SD/QDO plates and for X-α-Gal activity.  
 
 
3.2.6 Preparation of the  pC9orf75-GFP  construct 
 
For a translational fusion of the clone Chr9orf75 cDNA with a reporter gene encoding GFP 
(pEGFP vector, Appendix III), the cDNA of Chr9orf75 was amplified by PCR using specific 
primers (Appendix IV). To that end, cDNA of clone 100T was used, since it contains the 
complete coding sequence of the corresponding protein. As the EGFP-tag is C-terminal, 
the stop codon of the protein was eliminated with the primers used.  
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3.2.6.1  PCR reaction 
 
PCR reactions were performed using Pfu DNA Polymerase (Promega), a high fidelity 
polymerase that ensures that few or no mutations are introduced as a result of the PCR. 
In a 0.2 mL microtube the following components were added: 
 
0,5 µL (50 ng) DNA template 
1 µL (10 pmol) Primer Chr9orf75-F4 
1 µL (10 pmol) Primer Chr9orf75-R5 
2 µL (10 mM) dNTPs mixture 
5 µL (10X) Pfu Buffer 
0,5 µL Pfu 
H2O to a final volume of 50 µL 
 
The PCR amplification condition used are described below: 
 
94º C 5 min 
 
94º C 1 min 
 50º C 2 min               
 72º C 2 min              10 cycles 
 
94º C 1 min                     
 72º C 4 min              15 cycles 
  
72º C 2 min                
 
Amplification was confirmed by running a 5 µL PCR reaction aliquot in a 1% agarose 
electrophoresis gel. The PCR products were ethanol precipitated, as previously described.  
 
3.2.6.2 DNA restriction digestions 
 
For subcloning of Chr9orf75 in the pEGFP mammalian expression vector, the PCR 
product and pEGFP vector were digested with EcoRI and SalI (New England Biolabs), at 
37º C. For the DNA digestion the manufacturer’s instructions were followed. 
Characterization of Human Brain Protein Phosphatase 1α Interacting Proteins Using the Yeast Two Hybrid System 
 
 
   Mestrado em Microbiologia Molecular 2008 
Centro de Biologia Celular  - 57 - 
The digestions were performed sequentially, although in the same buffer, for several hrs. 
The first enzyme used (EcoRI) was heat inactivated, then BSA was added and also the 
second enzyme (Sal I).  In a microtube the following components were added: 
 
100 µg/mL DNA 
1X reaction buffer (appropriate for both restriction enzymes)  
1X BSA (Bovine Serum Albumin) 
1 U/µg DNA of restriction enzyme 
Water for a final volume of 150 µL 
 
Afterwards, the digested DNAs were precipitated, as described before, resuspended in 
water and quantified by analysis in a 1% agarose electrophoresis gel.  
 
3.2.6.3 DNA ligation of cohesive termini 
 
Ligation of EcoRI SalI digested pEGFP vector and Chr9orf75 was carried out overnight at 
16º C using bacteriophage T4 DNA ligase (Promega), in a final volume of 20 µL. 
Additional control reactions were also set up (Table 4). 
 
Table 4 - pEGFP vector and Chr9orf75 ligation reactions 
Tube Vector (ng) Chr9orf75 (ng) Ligase (µL) Buffer (µL) 
Negative Control - - - 2 
Positive Control 
20 
(non cutted) - - 2 
Vector (unligated) 20 - - 2 
Vector (ligated) 20 - 1 2 
Ligation 1:3 ratio 20 16,6 1 2 
Ligation 1:5 ratio 20 27,6 1 2 
Ligation 1:10 ratio 20 55,3 1 2 
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Bacteria transformation for each ligation product was performed as described before, and 
cells were plated on agar medium plates, with the appropriate antibiotic (Kanamycin       
30 µg/mL), and incubated at 37º C for 16-18 hrs, until colonies appeared. Control 
transformations were also carried out in parallel, as described in Table 4, including a 
negative control transformation without DNA and a positive control transformation with   
1,0 ng of the control plasmid. 
Bacterial plates were screened for transformant colonies, a single colony was transferred  
to a tube containing 5 mL of liquid LB/Kanamycin medium and incubated overnight at     
37º C and 220 rpm. Subsequently, isolation of plasmids from transformants was 
performed using the “Miniprep” method, already described. In order to confirm the 
insertion of Chr9orf75 in the pEGFP vector restriction digestion reactions were performed 
using BamHI, EcoRI and SalI restriction enzymes. The pEGFP vector was also digested 
as a control. After digestion electrophoretic analysis of the DNA was carried out to identify 
those that yielded the expected bands. The next step was to confirm the correctness of 
the open reading frame of the fusion protein, by DNA sequencing. 
 
3.2.6.4 Sequencing of the  pC9orf75-GFP  vector 
 
All DNA samples to be sequenced were processed using the same protocol, as described 
before. In this case, two additional primers, one forward and one reverse (see Appendix 
V), were also used for sequencing procedures.  
Thus the  pC9orf75-GFP DNA fusion was confirmed in the correct reading frame as well 
as the entire coding sequence. 
 
3.2.6.5  pC9orf75-GFP  DNA amplification and purification 
 
The Promega Pure YieldTM Plasmid Midiprep System was used for  pC9orf75-GFP 
construct DNA purification. A single-transformant cell 200 mL culture was pelleted by 
centrifugation at 4000 g for 10 min at RT. The cells pellet was resuspended in 6 mL of cell 
resuspension solution by manually disrupting the pellet with a pipette. Next, 6 mL of cell 
lysis solution were added to the cells; mixed by gently inverting the tube and left to 
incubate for 3 min at RT. Then, 10 mL of Neutralization Solution were added and 
immediately mixed by gentle tube inversion; the lysate was allowed to sit for 3 min. After 
this initial procedure DNA Purification by Centrifugation was the chosen protocol. A blue 
PureYieldTMClearing Column was placed on top of a 50 mL plastic tube, the lysate was 
transferred to the column and allowed to incubate for 2 min. The column assembled to the 
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tube was then centrifuged at 1500 g for 5 min, at RT.  A white PureYieldTM Binding 
Column was assembled in a new 50 mL tube and the filtered lysate was transferred to this 
column and centrifuged at 1500 g for 3 min, at RT. The column was washed by adding 5 
mL of Endotoxin Removal Wash solution and centrifugating at 1500 g for 3 min, at RT. 
After that, 20 mL of Column Wash solution were added and the column centrifuged was 
performed at 1500 g for 5 min, at RT. The flowthrough was discarded and an additional 10 
min, 1500 g centrifugation was performed, at RT. Excess ethanol was removed by tapping 
the column on a paper towel. Afterwards, the column was placed in a new 50 mL 
disposable plastic tube and 800 µl of Nuclease-Free Water were added to the centre of 
the column. After 1 min standing, the DNA was eluted by centrifugation at 1500 g for 5 
min. Two 400 µl DNA aliquots were purified by ethanol precipitation and its concentration 
and 260/280 nm purity ratio calculated by densitometry measurements. 
 
 
3.2.7 Cell culture and transfection 
 
A cervical cancer cell line (HeLa cells) was the model system used in this study. HeLa 
cells were grown in Minimal Essential Medium with Earle's salts and GlutaMAX (MEM, 
Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco), 1% MEM Non-Essential 
aminoacids (Gibco, Invitrogen) and 100 U/mL penicillin and 100 mg/mL streptomycin 
(Gibco). Cultures were maintained at 37º C and 5% CO2. Cells were subcultured 
whenever ≈ 95% confluence was reached.  
 
3.2.7.1 Transfection with Lipofectamine 2000 
 
Lipofectamine 2000 (Invitrogen) is a cationic liposome formulation that functions by 
complexing with nucleic acid molecules, allowing them to overcome the electrostatic 
repulsion of the cell membrane and to be taken by the cell. This method of DNA delivery 
in culture cell lines is well described (Dalby et al. 2004). 
Cells were grown in complete MEM until 85 - 95% confluence and on the transfection day 
the culture medium was replaced with complete medium (antibiotic/antimycotic-free). The 
appropriate amount of DNA for each plate/well was diluted in Opti-MEM (serum- and 
antibiotic/antymicotic-free) (Table 5). The Lipofectamine 2000 reagent was diluted 
appropriately in the same medium, and the tubes were left to rest for 5 min. The DNA 
solution was added to the Lipofectamine solution drop by drop, and the solution was 
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mixed by gentle bubbling with the pipette. In order to form the DNA-lipid complexes, the 
tube was allowed to rest for 25 - 30 min at RT. Then what the complexes solution was 
directly added into the cell medium, drop by drop and with gentle rocking of the plate. The 
cells were further incubated at 37º C/5% CO2 for the indicated transfection time, prior to 
cell collection or fixation. 
 
Table 5 – HeLa cells transfection reagents.  
Culture Plates 
Medium 
w/o serum 
(plate) 
DNA (µg) Lipofectamine 
2000 (µL) 
Medium 
w/o serum 
(tube) 
100 mm plate  15 mL 8 50 1500 µL 
35 mm 6-wells  2.0 mL 2 10 250 µL 
 
 
 
3.2.8 Immunoprecipitation procedure 
 
After 24 hrs transfection, HeLa cells were washed once with PBS 1X and then collected 
with 1.2 mL of lysis buffer containing a protease inhibitor cocktail. Using a cell scrapper, 
cells were detached from the plate and collected in a microtube already on ice. The 
samples were sonicated for 10 seconds three times intercalating the samples in order not 
to over-heat them. After BCA protein quantification described previously, mass normalized 
lysates were precleared with 25 µl Protein A Sepharose beads (Pharmacia) for 1 hr at     
4º C with agitation. After centrifuging for 5 min at 10000 g at 4º C, the supernatant was 
transferred to a new microtube with 50 µl of Sepharose beads and the primary antibody 
(anti-PP1α or anti-PP1γ) was added and incubated overnight with shaking at 4º C.  
The mixture was then centrifuged for 1 min at 4º C at 10000 g and the pellet washed four 
times with 500 µl of washing solution, for 15 min with agitation at 4º C and then 
centrifugations were performed. After the last wash, the tubes were centrifuged for 10 min 
at 18000 g and 4º C, and the supernatant was fully discarded. The beads were then 
resuspended in 60 µl of fresh Loading Buffer/1% SDS; boiled for 10 min and frozen at       
-20º C. 
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Lysates were collected and the appropriate volume of 10% SDS was added in order to 
obtain a final concentration of 1% SDS. Afterwards, they were boiled for 10 min and 
frozen. 
Immunoprecipitates and lysates were electrophoreted through in a 10% SDS-PAGE gel 
and transferred to a nitrocellulose membrane that was incubated with anti-GFP antibody, 
or anti-PP1α, or anti PP1γ1 antibodies and developed by ECL, as previously described. 
Between the use of the different antibodies (anti-GFP in 1:1000 dilution, anti-PP1α in 
1:2500 dilution and anti-PP1γ1 in 1:5000 dilution) membrane stripping was performed. 
Briefly, the membrane was incubated for 30 min with stripping solution at 50º C and 75 
rpm, washed three times with TBST, for 15 min with agitation, and two times with water 
and left to air dry. 
 
 
3.2.9 Overlay blot assay 
 
The  pC9orf75-GFP  construct, was used for transfect HeLa cells and the corresponding  
lysates containing the fusion protein was separated on a SDS-PAGE gel and transferred 
to a nitrocellulose membrane. For this procedure 25, 50 and 100 µg of total protein 
extracts were loaded on a 10% polyacrilamide gel. The membrane was blocked with 
TBST/5% non-fat milk solution for 1 hr and then overlaid with purified PP1γ1 protein (1 
µg/mL) (Watanabe et al. 2003) in TBST/3% non-fat milk for 1hr. After washing three times 
with TBST, to remove excess protein, the bound PP1γ1 was detected by incubating the 
membrane with anti-PP1γ antibody (1:5000 dilution, in TBST/3% non-fat milk) for 1 hr. 
Immunoreactive bands appeared after incubating with horseradish peroxidase conjugated 
secondary antibody (1:5000 dilution, in 3% non-fat milk in TBST), for 1 hr, and developing 
with ECL. 
 
 
3.2.10 Protein assay 
 
Total protein measurements were carried out using Pierce’s BCA protein assay kit, 
following the manufacturer’s instructions. The method combines the reduction of Cu2+ to 
Cu+ by protein in an alkaline medium (the biuret reaction), with a sensitive colorimetric 
detection of the Cu+ cation using a reagent containing bicinchoninic acid (BCA). The 
purple-coloured reaction product of this assay is formed by the chelation of two molecules 
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of BCA with one Cu+ ion. This water-soluble complex exhibits a strong absorbance at 562 
nm that is linear with increasing protein concentration over a working range of 20 µg/mL to 
2000 µg/mL. At least duplicate microtubes per sample were prepared to be assayed with 
25 µL of each sample plus 25 µL of 1% SDS, or water in the case of immunoprecipitation 
procedures. Microtubes with standard protein concentrations were prepared as described 
below (Table 6).  
Table 6 – Standard curve used in the BCA protein assay method.  
Standard BSA (µL) 10% SDS (µL) H2O (µL) 
Protein mass 
(µg) W.R. (mL) 
P0 - 5 45 0 1 
P1 1 5 44 2 1 
P2 2 5 43 4 1 
P3 5 5 40 10 1 
P4 10 5 35 20 1 
P5 20 5 25 40 1 
P6 40 5 5 80 1 
 
The BSA stock solution used had a concentration of 2 mg/mL. The Working Reagent 
(WR) was prepared by mixing BCA reagent A with BCA reagent B in the proportion of 
50:1. Then, 1 mL of WR was rapidly added to each microtube (standards and samples) 
and the microtubes were incubated at 37 º C for exactly 30 min. Once the tubes cooled to 
RT the absorbance was measured at 562 nm.  A standard curve was obtained by plotting 
BSA standard absorbance vs BSA concentration, and used to determine the total protein 
concentration of each sample. 
 
 
3.2.11 Immunocytochemistry procedure 
 
HeLa cells were grown in 1 M HCl pre-treated glass coverslips pre-coated with 100 µg/mL 
poly-L-ornithine. HeLa cells were cultured until 80-90% confluence was reached and 
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transfected as described above. Each well was washed three times with 1mL serum-free 
MEM medium and then 1 mL of 1:1 MEM/4% paraformaldehyde fixative solution was 
gently added and left to stand for 5 min. Subsequently, 1 mL of fixative solution was gently 
added and left for 30 min. Finally, cells were washed three times with 1mL 1X PBS for 10 
min, with gentle agitation. For permeabilized cells, 1 mL of methanol was added for 2 min 
and, afterwards, 5 washes with 1 mL 1X PBS for 10 min were performed. Blocking was 
carried out for 1 hr with PBS/3%BSA, and then 100 µL of primary antibody diluted 1:500 in 
PBS/3% BSA was added drop by drop onto the cover slip and incubated at RT for 2 hrs.  
After three washes with 1X PBS, the secondary antibody (1:300 dilution) was added using 
the same methodology and incubated for 2 hrs. Finally, three washes were performed and 
coverslips were mounted on microscope glass slides with 1 drop of anti-fading reagent 
containing DAPI for nucleic acid staining (Vectashield, Vector Laboratories). 
Epifluorescence microphotographies were acquired with an Olympus IX-81 inverted 
epifluorescence microscope, equipped with EGFP (Chroma 41020) and Texas Red 
(Chroma 41004) filter cubes for fluorophore microscopy visualization. 
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3.3 RESULTS 
 
 
3.3.1 Preliminary analysis of the positive clones 
 
In order to identify the library insert present in a given positive clone, the plasmid DNA 
was first isolated from yeast. Thus, a mixture of different plasmid DNAs can be isolated 
from a single yeast clone, namely the bait plasmid and one or more library plasmids, 
being that each yeast cell can incorporate more than one library plasmid. Hence, in order 
to obtain single plasmids and pure DNA for sequence analysis, the plasmid DNA isolated 
from yeast cells was used to transform E. coli XL1-Blue. The plasmid DNA obtained from 
the resulting transformants was further analysed by restriction digestion with the 
endonuclease HindIII. The restriction fragments were then separated by agarose gel 
electrophoresis. Figure 10 exemplifies a typical result obtained with this procedure:  
 
 
Figure 10 – HindIII restriction analysis of 
YTH plasmids. Lane M, 1Kb ladder DNA 
marker; Lane 1, pAS2-1 vector 
(4.6+2.2+0.9Kb); Lane 2, pASPP1α bait 
plasmid (4.6+2.2+1.7+0.9 Kb); Lane 3, 
pACT-2 vector (7.4+0.7Kb); Lanes 4,5 and 
6, pACT-2+library inserts [(7.4+(0.7+ 
insert)Kb]. 
 
The same strategy was adopted for each of the 298 positive clones. After identifying 
transformants carrying the cDNA library plasmids, their respective inserts were sequenced 
with the GAL4-AD primer (Appendix IV).  
The nucleotide sequence of each clone (Figure 11) was then converted to FASTA format 
(Figure 12). In this format, the signal “>”in the first line precedes the name or additional 
information on the sequence and the sequence itself starts on the second line. 
 
 
 
 
 
M    1      2     3      4     5     6    M  
3 
2 
1 
Kb 
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Figure 11 – Partial nucleotide sequence obtained for  positive clone 282Q. 
 
 
>Clone 282 
CTGGATGGCCACAGCCCATCTCCCACCTCAGAGAGCAGCGAACCAGACTTAGAATCCCAGTATCC
AGGCTCAGGGAGTATTCCTCCAAACCAGCCCTCTGGTGACCCTCAGCAGCCCAGCCCTGACAGTA
CTGCTGCCCAGAAAGTTGCCACAAGTCCCAAGAGTGCCCTCAAGTCTCCATCTTCCAAGCGTAGG
ACATCTCAGAACTTAAAACTGAGAGTTACCTTTGAGGAGCCTGTGGGCAGATGGAGCAGCCTAGC
CTTGAACTGAATGGAGAAAAGACAAGATAAGGGCAGGACTCTCCAGCGGGACCTCCACAAGTAAC
GAATCGGGGGGATCAACTGAAAAGGCCTTTTGGAGCCTTTCGATCTATCATGGAA 
 
Figure 12 – Partial sequence of clone 282Q converted to FASTA format. 
 
The sequence in FASTA format was then copied to the BLAST window 
(www.ncbi.nlm.nih.gov/BLAST/) (Figure 13) to be compared with the GenBank Database 
of human nucleotide sequences.  
 
 
 
Figure 13 – Blast window where the query sequence for each positive was introduced. 
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The identity of the positive clones isolated was thus obtained. Figure 14 shows a 
representative example of the results obtained for clone 282Q. 
 
 
 
Figure 14 – Blast results for clone 282Q. Alignment with protein synphilin-1A. 
 
 
 
3.3.2 Yeast colony hybridization 
 
Yeast colony hybridization is an efficient mean to screen a large collection of library 
transformants for the presence of an abundant cDNA insert. Transformants carrying the 
same or overlapping library plasmid can be easily identified. For example, to identify 
putative positive spinophilin clones among the large number of transformants obtained, 
the insert of clone 268Q was release by EcoRI digestion and radiolabeled with 32P-ATP 
and hybridised to the full collection of yeast positive colonies arrayed onto nitrocellulose 
membranes. Figure 14 is an example of the results obtained with one of the filters 
hybridized. 
This approach allowed the rapid identification of some of the most abundant positives in a 
short period of time. This method was used not only for spinophilin but also for other 
abundant positives (e.g. Chr1orf 71 and Torsin A interacting protein).  
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Figure 14 – Identification of putative 
Spinophilin positives by colony hybridization. 
 
This technique can be very helpful and fast but the results obtained in this work were not 
always as accurate as expected. In practice, more careful in the arraying of the positives 
on the filters and avoiding excessive colony growth that leads to colony overlap signal 
loss, should improve significantly the results obtained in this powerful technique.  
 
 
3.3.3 Identification of the positive clones 
 
Of the 298 positives obtained all were recovered and definitively identified by partial DNA 
sequence analysis (Table 7). 
 
Table 7 – Complete list of positive clones – The human brain PP1α interactome. 
Clone ID 
No 
Clones 
PP1BM Chr Data Base ID YTH clone ID 
Chr1orf71 25 RVRF 1 NM_152609 
4T,5T,14T,35T,37T,56T, 
71T,109T,110aT,118T,126T, 
128T,132T,146T,201T,202T,205T, 
215T,263Q,269Q,270Q, 
274Q,278Q,284aQ,285Q 
Chr9orf75 45 KISF / RAIRW 9 NM_173691 
13T,40T,41T,43T,53T,65T,74T, 
84T,91T,100T,104T,105T,110bT, 
117bT,129T,139T,142T,148T,149T, 
150T,151T,154T,155aT,164T,169T,170T,
172T,180T,181T,186T,190T,199T,209T, 
221T,223T,228T,232T,235T,237aT, 
239T,265Q,267Q,272Q,292Q,298bQ 
NEK2A 2 KVHF 1 NM_002497 80T,155bT 
PPP1R2 1 - 3 NM_006241 99T 
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PPP1R3C 5 
KRVVF / KNVSF / 
RITF / KIEF 
10 NM_005398 2T, 8T,101T, 
183T,200T 
PPP1R3D 2 RVQF 6 XM_371796 275Q,290Q 
PPP1R3E 1 RVRF 14 XM_927029 130T 
PP1R9B / Spinophilin / 
NeurabinII 
15 RKIHF 17 NM_032595 
9T,63T,87T,94T, 
254T,255T,259Q,266Q, 
268Q,276Q,277Q,279Q, 
280Q,286Q,289Q 
PP1R13A / ASPP2 / 
TP53BP2 
17 RVKF 1 NM_005426 
3T,7T,23T,67T,113T, 
127T140T,156T,173T, 
226T,231T,240T,242T, 
251T,252T,256T,287Q 
PPP1R13B / ASPP1 5 RVRF 14 NM_015316 68T,106T,119T, 
123T,296Q 
PP1R13L 2 - 19 NM_006663 1T,47T 
PPP1R15B 3 KVTF 1 NM_032833 136T,229T,258T 
PPP1R16A 1 KQVLF 8 NM_032902 187T 
KIAA1949 4 KISF 6 BC_066644 6T,81T,124T,233T 
PHACTR3 2 RNIF 20 NM_080672 66T,70T 
RIF1 9 KIAF/ RVSF 2 NM_018151 25T,11T,116T,117aT, 
167T,175T,203T,204T,206T 
STAU 16 KVTF 20 NM_017453 
29T,34T,38T,44T,51T,120T, 
125T,145T,158T,159T,160T, 
174T,176T,197T,243T,245T 
WBP11 1 RKVGF 12 NM_016312 168T 
ZAP3 8 
KEVEF / RGRW / 
RAIGF 
14 NM_019589 10T,19T,20T,58T, 
78T,157T,166T,216T 
ZFYVE9 / SARA 3 RVWF / KVIRW 1 NM_004799 152T,247T,253T 
AATK 1 KAVSF 17 NM_001080395 297Q 
ANKRD15 2 - 9 NM_015158 189T,194T 
AXIN1 4 RVAF / RVEF 3 NM_033027 115T,198T,295Q,298aQ 
BTBD10 1 RHVDF 11 NM_032320 153T 
C1QA 16 - 1 NM_015991 
21T,22T,30T,60T,114T,121T, 
134T,135T,191T,193T,208T, 
213T,214T,218T,227T,241T 
CEP170 1 RILF 1 NM_014812 28T 
CLTC 1 - 17 NM_004859 217T 
CNTN1 2 - 12 NM_001843 85T,92T 
CLCN2 1 - 3 NM_004366 49T 
CKB 1 - 14 NM_001823 103T 
CNP1 1 KIFF 17 NM_033133 179T 
CRKII 1 - 17 NM_005206 250T, 270T 
CXXC1 1 - 18 NM_014593 46T 
CYCS 1 KGIIW 7 NM_018947 246T 
DEAF1 1 - 11 NM_021008 77T 
DCTN1 2 KIKF  /  KVTF 2 
NM_004082 
NM_023019 
138T,171T 
FRMPD4 1 KVRF / KVSF X NM_014728 26T 
GLTSCR2 1 - 19 NM_015710 95T 
IBTK 1 KVSF 6 NM_015525 42T 
IIP45 1 RVTF 1 NM_021933 89T 
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JPH3 1 - 16 NM_020655 55T 
KCTD20 3 RHVDF 6 NM_173562 143T,230T,238T 
LPIN2 1 - 18 NM_014646 108T 
MAP4K4 2 - 2 NM_004834 39T,210T 
NDP 2 - X NM_000266 15T,33T 
PHC1 2 - 12 NM_004426 131T,225T 
PRR16 2 RVRF 5 NM_016644 107T,211T 
PIAS1 1 - 15 NM_016166 73T 
PIAS3 1 - 1 NM_006099 122T 
PREX1 1 KVCF / KVIF 20 NM_020820 64T 
RANBP9 20 RMIHF 6 NM_005493 
11T,69T,79T,82T, 
86T,133T,162T,162T, 
163T,165T,178T,182T, 
207T,212T,224T,236T, 
237bT,244T,248T,249T 
SH3RF2 4 KTVRF 5 NM_152550 141T,144T,177T,264Q 
SLC45A1 1 RNVTF 1 NM_001080397 219T 
SPRED1 1 RHVSF 15 NM_152594 24T 
SNCAIP-1A 6 RVTF 5 DQ_227317 27T,90T,222T, 
281Q,282Q,288Q 
MAL2 1 - 8 NM_052886 112T 
TOR1AIP1 14 
REVRF/ KVNF/ 
KVKF 
1 NM_015602 
12T,31T,36T,45T,50T, 
61T,76T,96T,184T,192T, 
261Q,262Q,271Q,273Q 
UBE2Z 1 - 17 NM_023079 17T 
ULK1 1 - 12 NM_003565 220T 
MAFG 1 - 17 NM_002359 137T 
ZBTB11 1 - 3 NM_014415 52T 
Chr11orf32 1 - 11 BC_040643 185T 
FLJ35856 1 - 12 AK_093175 257T 
KIAA0460 1 RVGW 1 NM_015203 93T 
KIAA1377 9 KLRW 11 NM_020802 59T,75T,97T,102T,260Q, 
188T,195T,196T,284bQ 
LOC648791 1 - 6 XR_018474 291Q 
ZNF827 1 - 4 NM_178835 32T 
C-2190G12 1 - 14 AL_139194 16T 
C2genomic 1 - 2 NW_001838769 54T 
C2genomic 1 - 2 NW_001838818 62T 
C2genomic 1 - 2 NW_001838863 283Q 
C3genomic 1 - 3 NW_001838877 18T 
C4genomic 1 - 4 NW_001838915 48T 
C17genomic 3 - 17 NW_001838448 72T,293Q,294Q 
16S ribosomal RNA 1 - Mit AM_263191.1 88T 
IDH2 1 - 15 NM_002168 57T 
The occurrence of a consensus PP1 binding motif (PP1 BM) is indicated by the corresponding 
sequence. Letters a and b corresponde to two different prey plasmids extracted from the same 
positive clone. 
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The identified positive clones, corresponding to a total of 76 proteins, were divided in five 
groups: proteins already known to interact with PP1 (blue); proteins known in other 
contexts (green); proteins of unknown function present in the database (purple); clones 
present in the database only at the genomic level (yellow) and mitochondrial proteins 
(orange). Inasmuch as several positives corresponded to independent hits on the same 
protein, the human brain PP1α interactome thus defined comprised 74 different proteins, 
two were considered potential false positives. 
All clones were subject to the same analysis: they were partially sequenced, the full length 
sequence present in the database was searched for special features of the amino acid 
sequence using motif search databases and specially for a consensus PP1 binding motif 
([RK]-x0-1-[VI]-{P}[FW]). The number of clones for each identified binding protein varied 
considerably, from 1 clone to 45 clones, and every group type includes positives 
recovered from high and low stringency selection media. 
 
3.3.3.1 Proteins matching known PP1 interactors 
 
In this YTH screen, of the 298 clones identified, 167 (56%) could be assigned to 
previously known PP1 interactors (Table 7, blue), among these there are some well 
established PP1 regulators, such as NEK2A, Spinophilin and ASPP1 (PPP1R13B). This 
group of positives includes also various proteins identified as PP1 interactors, but the 
means by which they regulate PP1 are not yet completely or even at all described. That is 
the case of Chr9orf75, Chr1orf71 and SARA (ZFYVE9). Chr9orf75 and SARA will be 
further discussed below.  
Interestingly, the two most abundant interactors detected in this screen were Chr9orf75, 
with a total of 45 and Chr1orf71, with 25 positives; proteins identified only as mRNAs in 
the GenBank database. 
 
3.3.3.2  Proteins matching other known proteins 
 
With this screen, 41 proteins never before related to PP1 were identified as potential 
PP1α regulators encoded by 108 of the positive clones. This corresponds to 36% of the 
total positives.  RAN binding protein 9 (RANBP9) was the most abundant positive with a 
total of 20 clones identified, Complement component 1, q subcomponent, A chain (C1QA) 
and torsin A interacting protein 1 (TOR1AIP1) were other two abundant positives, with 16 
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and 14 clones, respectively. Two interesting proteins were analysed more toughly and are 
discussed below, they are dynactin-1 (DCTN1) and synphilin-1A (SNCAIP). 
 
3.3.3.3 Unknown proteins 
 
In various cases database searching yielded homologies with sequences annotated in the 
Genbank database as ORFs encoding proteins of unknown function (Table 7, purple). 
This was the case for 14 positives (approximately 5%) encoding 6 proteins. The most 
abundant with in this group was KIAA1377 that was encoded by 9 of the isolated 
positives. 
 
3.3.3.4 Genomic clones 
 
Table 7 (yellow) also lists several positives that only allowed significant homology to 
human genomic clones. While it can not be excluded that these may represent hitherto 
unknown genes encoding novel proteins, further work would be necessary to confirm this. 
In this category fit 9 (approximately 3%) of the independent positives isolated, 
corresponding to homologies to human chromosomes 2, 3, 4, 14 and 17. 
  
3.3.3.5 Mitochondrial clones 
 
Two clones, 88T and 57T, were identified using the GenBank database as 16S ribosomal 
RNA and mitochondrial isocitrate dehydrogenase 2 (IDH2). Isocitrate dehydrogenases 
catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate, is found in the 
mitochondria and plays a role in intermediary metabolism and energy production. This 
protein may tightly associate or interact with the pyruvate dehydrogenase complex. 
Although IDH2 is a nuclear-encoded mitochondrial protein, the interaction with PP1α is 
unlikely to occur in a physiologically relevant context, because the partners are not 
expressed in the same subcellular environment. Mitochondrial clones, including 16S 
rRNA, have previously been described as common false positives in YTH screens 
(Serebriiskii et al. 2001a; Serebriiskii et al. 2001b). The emergence of only two false 
positives can be considered a very good outcome of this screen, in what concerns the 
reliability of the results and considering the high number of clones screened and identified. 
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3.3.4 Functional analysis of the human brain PP1α interactome 
 
In the present work, 74 different human brain proteins were identified by the YTH 
technique that bind and regulate PP1α. The functional distribution of the identified proteins 
is shown in Figure 15. The potential false positive clones (Table 3, in orange) were left out 
of this analysis. The unidentified proteins encoded by the genomic clones (7; Table 7, in 
yellow) plus 6 proteins (Table 3, in purple) have unknown function. Clones matching 
proteins of unknown function correspond to 25% of the total proteins identified. For the 
remainder 75%, the most abundant group corresponds to proteins involved in cell 
signalling processes (18%) followed by proteins involved in splicing and transcription 
(11%), and proteins involved in apoptosis (8%). Known PP1 regulators make up 8% of the 
proteins identified. Other protein functions include components of the cytoskeleton, 
cellular transport, metabolism and energy and cell cycle. 
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Figure 15 – Functional distribution of the human brain PP1α binding proteins identified by the 
Yeast Two-Hybrid method. 
 
 
 
3.3.5 Proteins selected for further study 
 
Four interacting proteins were selected for further confirmation of their interaction with 
PPα. This selection had in consideration several factors, including that all four proteins 
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have at least one canonical PP1 binding motif and two were already reported to be PP1 
interactors. 
The four proteins selected were Chr9orf75, Synphilin-1A, SARA and dynactin-1. 
Chr9orf75 was the most abundant positive in the YTH screen and was reported as a PP1 
interactor, while this work was in progress, although no further information exists 
regarding protein function. Synphilin-1A (Synuclein alpha interacting protein – 1A), an 
alternative splice variant of synphilin-1, interacts with α-synuclein in neuronal tissue and is 
an aggregation-prone protein that causes neuronal toxicity and is involved in 
neurodegenerative disorders. SARA (Smad Anchor for Receptor Activation), is an 
anchoring protein, which recruits Smad2 and Smad3 to the vicinity of the TGF-β receptor, 
being an essential component of Smad-dependent signalling through TGF-β.  SARA was 
previously described as a PP1 interacting protein, nevertheless the means by which that 
interaction occurs is not yet known. Finally, dynactin-1 is a dynein activator that binds to 
both dynein and microtubules. The dynein/dynactin complex is essential for a diversity of 
cellular trafficking events and was related to human neurodegenerative diseases. 
In order to verify the interactions between the four proteins described above (Chr9orf75, 
synphilin-1A, SARA and dynactin) and PP1α, but also to test if they could interact with 
PP1 isoforms γ1 and γ2, a yeast co-transformation assay was performed. Clones 
corresponding to the mentioned proteins (as prey; in the pACT-1 vector) and the three 
PP1 isoforms (as bait; in the pAS2-1 vector) were co-transformed in yeast strain AH109 
and tested in SD/QDO/X-α-gal medium. Additionally, the same clones were co-
transformed with the vector pAS2-1 alone to see if they alone would be capable of 
initiating transcription, in the absence of PP1α. That was not the case for any of them, as 
none was able to grow in SD/QDO and turn blue in the presence of X-α-gal (data not 
shown). 
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3.3.5.1 Synphilin-1A (Synuclein alpha interacting protein – 1A – SNCAIP-1A) 
 
In this YTH screen six positive clones were identified as synphilin-1, by partial sequencing 
(Table 8). Further sequencing of the C-terminus, using the reverse primer 3`-Amplimer 
(Appendix IV), revealed that they correspond to the novel isoform synphilin-1A 
(DQ227317) (Figure 16).   
 
Table 8 - Independent synphilin-1A clones isolated in the YTH screen. 
First Nucleotide (DQ_227317) Positive clones 
946  (in frame) 90T 
1381  (in frame) 27T, 222T, 281T, 282T, 288Q 
 
The first gene linked to Parkinson’s disease encodes α-synuclein, a presynaptic protein 
(Maroteaux et al. 1988), so far with unknown physiological functions. Three missense 
mutations in α-synuclein and gene locus triplication have been found to cause autosomal 
dominant Parkinson’s disease (Polymeropoulos et al. 1997; Kruger et al. 1998; Singleton 
et al. 2003; Zarranz et al. 2004). α-Synuclein was also identified as a major constituent of 
Lewy bodies in sporadic Parkinson’s disease patients (Spillantini et al. 1997) and also in 
inclusions characteristic of other neurodegenerative disorders, such as Diffuse Lewy Body 
disease (Takeda et al. 1998).  
Synphilin contains several protein-protein interaction domains, including ankyrin-like 
repeats, a coiled-coil domain, an ATP/GTP-binding motif, and interacts with α-synuclein in 
neuronal tissue and may play a role in the formation of cytoplasmic inclusions and 
neurodegeneration. Mutations in this gene have been associated with Parkinson's 
disease.  Synphilin-1A is an alternative splice variant of synphilin-1 that lacks exons 3 and 
4 and contains a previously unidentified exon 9A of the SNCAIP gene (Figure 17A). 
However, the transcripts of synphilin-1A and synphilin-1 differ not only by their exon 
content but also by their start codon and initial reading frame. Synphilin-1A lacks exons 3 
and 4 found in synphilin-1, and displays an extra exon between exons 9 and 10. 
Interestingly, the translation of synphilin-1A occurs in a different initial reading frame than 
that of synphilin-1. Nevertheless, the merge of exon 2 with 5 results in a frame shift 
leading to an identical reading frame for both synphilin-1A and synphilin-1 after exon 2. As 
a result, synphilin-1A amino acid sequence differs from synphilin-1 at the N-terminus but 
is the same between exons 5 and 9. Moreover, synphilin-1A has an additional 51 amino 
acid stretch at the C-terminus because of exon 9A insertion (Figure 17B). 
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cgcccgcggccgggccgcattgtgacgtagcggggccgcggcagcgcctccaccgcccgc 
ctacttcggctgaggctgttctgctcctgccgctgcggtccgtcggtcggtcagtcagtc 
ccttcgcgctcctgagccgccggcgcgccgggcgccccgggaatttataagtatttgacc 
gtactcaaaatgtgcaaggaagaataatggaagcccctgaataccttgatttggatgaaa 
ttgactttagtgatgacatatcttattcagtcacatcactcaagacgatcccagaactgt 
             M  T  Y  L  I  Q  S  H  H  S  R  R  S  Q  N  C 
gccgaagatgtgatacgcaaaacgaagacagatcagaatggtcagttggagtgcgtacgc 
 A  E  D  V  I  R  K  T  K  T  D  Q  N  G  Q  L  E  C  V  R 
tggatggtgagcgaaacagaagccattgcagaactgagttgttctaaggattttccaagc 
 W  M  V  S  E  T  E  A  I  A  E  L  S  C  S  K  D  F  P  S 
cttattcattacgcaggttgctatggccaggaaaagattcttctgtggcttcttcagttt 
 L  I  H  Y  A  G  C  Y  G  Q  E  K  I  L  L  W  L  L  Q  F 
atgcaagaacagggcatctcgttggatgaagtagaccaggatggcaacagtgccgttcac 
 M  Q  E  Q  G  I  S  L  D  E  V  D  Q  D  G  N  S  A  V  H 
gtagcctcacagcatggctaccttggatgcatacagaccttggttgaatatggagcaaat 
 V  A  S  Q  H  G  Y  L  G  C  I  Q  T  L  V  E  Y  G  A  N 
gtcaccatgcagaaccacgctggggaaaagccctcccagagcgccgagcggcaggggcac 
 V  T  M  Q  N  H  A  G  E  K  P  S  Q  S  A  E  R  Q  G  H 
accctgtgctccaggtacctggtggtggtggagacctgcatgtcgctggcctctcaagtg 
 T  L  C  S  R  Y  L  V  V  V  E  T  C  M  S  L  A  S  Q  V  
gtgaagttaaccaagcagctaaaggaacaaacagtagaacgtgtcacgctgcagaaccaa 
 V  K  L  T  K  Q  L  K  E  Q  T  V  E  R  V  T  L  Q  N  Q 
ctccaacaatttctagaagcccagaaatcagagggcaagtcactcccttcttcacccagt 
 L  Q  Q  F  L  E  A  Q  K  S  E  G  K  S  L  P  S  S  P  S 
tcaccatcctcacctgcctccagaaagtcccagtggaaatctccagatgcagatgatgat 
 S  P  S  S  P  A  S  R  K  S  Q  W  K  S  P  D  A  D  D  D 
tctgtagccaaaagcaagccaggagtccaagaggggattcaggttcttggaagcctgtca 
 S  V  A  K  S  K  P  G  V  Q  E  G  I  Q  V  L  G  S  L  S 
gcctccagccgggctagacccaaagcaaaagatgaagattctgataaaatcttacgccag 
 A  S  S  R  A  R  P  K  A  K  D  E  D  S  D  K  I  L  R  Q 
ttattgggaaaggaaatctcagaaaatgtctgcacccaggaaaaactgtccttggaattc 
 L  L  G  K  E  I  S  E  N  V  C  T  Q  E  K  L  S  L  E  F 
caggatgctcaggcttcctctagaaattctaaaaagatcccactggagaagagggaactg 
 Q  D  A  Q  A  S  S  R  N  S  K  K  I  P  L  E  K  R  E  L 
aagttagccaggctgagacagctgatgcagaggtcactgagtgagtctgacacagactcc 
 K  L  A  R  L  R  Q  L  M  Q  R  S  L  S  E  S  D  T  D  S 
aacaactctgaggaccccaagactaccccagtgaggaaggctgaccgaccaaggccgcag 
 N  N  S  E  D  P  K  T  T  P  V  R  K  A  D  R  P  R  P  Q 
cccattgtagaaagcgtagagagtatggacagcgcagaaagcctgcacctgatgattaag 
 P  I  V  E  S  V  E  S  M  D  S  A  E  S  L  H  L  M  I  K 
aaacacaccttggcatcagggggacgcaggtttcctttcagcatcaaggcctccaaatcc 
 K  H  T  L  A  S  G  G  R  R  F  P  F  S  I  K  A  S  K  S 
ctggatggccacagcccatctcccacctcagagagcagcgaaccagacttagaatcccag 
 L  D  G  H  S  P  S  P  T  S  E  S  S  E  P  D  L  E  S  Q 
tatccaggctcagggagtattcctccaaaccagccctctggtgaccctcagcagcccagc 
 Y  P  G  S  G  S  I  P  P  N  Q  P  S  G  D  P  Q  Q  P  S 
cctgacagtactgctgcccagaaagttgccacaagtcccaagagtgccctcaagtctcca 
 P  D  S  T  A  A  Q  K  V  A  T  S  P  K  S  A  L  K  S  P  
tcttccaagcgtaggacatctcagaacttaaaactgagagttacctttgaggagcctgtg 
 S  S  K  R  R  T  S  Q  N  L  K  L  R  V  T  F  E  E  P  V 
gtgcagatggagcagcctagccttgaactgaatggagaaaaagacaaagataagggcagg 
 V  Q  M  E  Q  P  S  L  E  L  N  G  E  K  D  K  D  K  G  R 
actctccagcggacctccacaagtaacgaatcgggggatcaactgaaaaggccttttgga 
 T  L  Q  R  T  S  T  S  N  E  S  G  D  Q  L  K  R  P  F  G 
gcctttcgatctatcatggagacactaagtggcaaccaaaacaataataataactaccag 
 A  F  R  S  I  M  E  T  L  S  G  N  Q  N  N  N  N  N  Y  Q 
gcagccaaccagctgaaaacctctacattgcccttgacctcacttgggaggaagacagat 
 A  A  N  Q  L  K  T  S  T  L  P  L  T  S  L  G  R  K  T  D 
gccaagggaaaccctgccagctccgctagcaaaggaaagaataaggcagaaatgtacagc 
 A  K  G  N  P  A  S  S  A  S  K  G  K  N  K  A  E  M  Y  S 
agctgcatcaatctttcctctaacatgctgattgaagagcatctgtgtaacgacacacgg 
 S  C  I  N  L  S  S  N  M  L  I  E  E  H  L  C  N  D  T  R 
cataatgacatcaatagaaaaatgaagaaatcctacagcataaagcacattgctgagcca 
 H  N  D  I  N  R  K  M  K  K  S  Y  S  I  K  H  I  A  E  P 
gagtcaaaagaactcttcttgtaaatcactttttaaattttctctcactgatgccctttg 
 E  S  K  E  L  F  L 
gaaattattggaaatttctggactatcctctttggaaagagaaccatgaaaacaatgcct 
caccagcagaagaacagaatatcaggatgccttaaatttatagtagtagactgtaaaaga 
ttcattttggggtgatatctgtatatataacttgtttttttaaaagatgccgtttaaaag 
catgattgggaaaatgtacgttttttaagagtagattgattcaccctacccacaggacat 
tcaccaagccactgataccattttatatttcatcaattgcatgagtatttgctaatgttg 
attgaacctccctttccccataatgtgggcagatttggctcagctccttcatgagatcag 
gtcagtggtattgtttctgtcaagagtgttttttctgtcatttctactttttgtataaag 
gaaataaaacaatgttaacagccaaaaaaaaaaaaaaaaaaaaa 
Figure 16 – Nucleotide and 
corresponding amino acid sequence 
of synphilin-1A (DQ_227317). PP1 
binding motifs are highlighted in blue 
color (positions 449-452 in a.a. 
sequence). The first nucleotides of 
the positive clones are highlighted in 
red color.  
 
 
Synphilin-1A, a novel synphilin isoform, is an aggregation-prone protein that causes 
neuronal toxicity. The presence of synphilin-1A was demonstrated in Lewy bodies and in 
the insoluble fraction of protein samples obtained from the brains of Diffuse Lewy Body 
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Disease patients (Eyal et al. 2006). Synphilin-1A also binds to α-synuclein, but displays a 
much higher tendency to aggregate compared to synphilin-1. It spontaneously aggregates 
in human dopaminergic cells, recruiting a-synuclein into intracellular inclusions (Eyal and 
Engelender 2006).The findings suggest an important role for synphilin-1A in inclusion-
body formation and its possible involvement in the pathogenesis of Parkinson’s disease. 
 
A
 
 
B 
Figure 17 – Synphilin-1 and synphilin-1A differ in their exon organization and are translated from 
different start codons. (A) Exon organization of the SNCAIP gene, demonstrating the position of 
the previously unidentified exon 9A. (B) Exon organization of synphilin-1A and synphilin-1, with 
the different start codons used for translation. The synphilin-1 transcript via start codon 1 results 
in the generation of a 919-aa protein (gray shading). The synphilin-1A transcript via start codon 2 
results in a different initial amino acid sequence (horizontal stripes), which, distal to the exons 2 
and 5 splice junction, is identical to that of synphilin-1 (gray shading). The 51 amino acids present 
in the C-terminus of synphilin-1A are encoded by exons 9A and 10 (dots), (adapted from Eyal et 
al. 2006). 
 
Synphilin-1, whose function is currently unknown, was initially identified as an α-synuclein-
interacting protein. In normal or physiological conditions, synphilin-1 is predominantly 
expressed in neurons, located in the cytoplasm and presynaptic nerve terminals, and 
associated with synaptic vesicles (Engelender et al. 1999; Ribeiro et al. 2002). However, 
in several neurodegenerative disorders called α-synucleinopathies, such as Parkinson’s 
disease, dementia with Lewy bodies, and multiple system atrophy, synphilin-1 is mainly 
localized in neuronal and glial cytoplasmic inclusions (Wakabayashi et al. 2000; 
Wakabayashi et al. 2002), in which α-synuclein (Spillantini et al. 1997; Wakabayashi et al. 
1997), ubiquitin (Takahashi and Wakabayashi 2001), and the proteasome (Iwatsubo et al. 
1996; Ito et al. 2003) are also present. 
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It was recently found that synphilin-1 is ubiquitylated by the E3 ubiquitin ligase SIAH (Liani 
et al. 2004), which is also present in Lewy bodies of Parkinson’s disease patients. When 
synphilin-1 and SIAH-1 ubiquitin ligase are coexpressed in cells and proteasomal function 
is inhibited, ubiquitylated synphilin-1 inclusions are found in the vast majority of cells (Liani 
et al. 2004) and this process is modulated by GSK3β phosphorylation of synphilin-1 
(Avraham et al. 2005). Two findings further highlight the importance of synphilin-1 in the 
study of Parkinson’s disease. First, synphilin-1 is present in Lewy bodies of Parkinson’s 
disease patients, as well as in inclusion bodies characteristic of other α-synucleinopathies 
(Wakabayashi et al. 2003). Second, two sporadic Parkinson’s disease patients were found 
to carry a missense mutation, R621C, in the gene encoding synphilin-1 (Marx et al. 2003). 
Furthermore, synphilin-1 is a substrate of parkin (Chung et al. 2001) and it is thought to 
link the ubiquitin proteasome system with synaptic function. Synphilin-1 seems to play an 
important role in the formation of Lewy Bodies since coexpression of α-synuclein, 
synphilin-1 and parkin results in the formation of cytoplasmic inclusions which resemble 
Lewy Bodies (Engelender et al. 1999; Chung et al. 2001). 
The identity of the individual molecules that may affect α-synuclein aggregation, the 
molecular etiology of Lewy Body formation, and the resulting impact on neuronal survival 
are still obscure. However, the evidence that the co-expression of α-synuclein and 
synphilin-1 leads to Lewy Body-like inclusion body formation in cultured cells may suggest 
that the functional interaction between these factors is crucial for this process (Engelender 
et al. 1999). Therefore, it is reasonable to predict that the identification of factors that 
regulate the physical and functional interactions between α-synuclein and synphilin-1 will 
help to uncover the molecular etiology of Lewy Body formation and Parkinson’s Disease 
pathogenesis. Casein kinase II (CKII) has been recently reported as a potent kinase that 
phosphorylates both α-synuclein and synphilin-1 and regulates the binding between these 
two proteins (Okochi et al. 2000; Lee et al. 2004). Significantly, the CKII inhibitor, 5,6-
dichrolo-1-β-D-ribofuranosylbenzimidazole, abolishes this interaction and reduces 
inclusion body formation in cell cultures (Figure18). 
Synphilin-1 and synphilin-1A, provide a new model regarding the role of ubiquitylation and 
inclusion body formation in Parkinson`s disease (Figure 18). Synphilin-1A has similar 
phosphorylation sites as synphilin-1 and it is possible that synphilin-1A aggregation is also 
controlled by phosphorylation (Eyal and Engelender 2006; Eyal et al. 2006). Marked 
neurotoxicity was observed with synphilin-1A but not with synphilin-1, indicating that 
synphilin-1A is directly involved in cell death. The attenuation of synphilin-1A toxicity by 
the formation of intracellular inclusions should shed some light on the controversial role of 
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inclusion bodies in neurodegenerative disorders. To date, it is still debatable whether 
inclusion bodies promote or inhibit neuronal toxicity. These findings could suggest a 
cytoprotective role for inclusion bodies (Eyal and Engelender 2006; Eyal et al. 2006). 
 
 
Figure 18 –Schematic representation of synphilin inclusion body formation and the contribution 
of the ubiquitin proteasome system. Ubiquitylation of synphilin-1 by SIAH is essential for its 
accumulation into inclusions upon proteasome inhibition. Parkin also mediates synphilin-1 
ubiquitylation, but it is less efficient than SIAH (Lim et al. 2005). Synphilin-1 inclusions further 
resemble Lewy bodies since they are able to recruit a-synuclein and parkin. Phosphorylation of 
synphilin-1 by GSK3β and CK II was shown to modulate the formation of synphilin inclusions, 
suggesting that phosphorylation of critical proteins, in concert with ubiquitylation, might play a 
role in Lewy body formation. The new synphilin-1 isoform, synphilin-1A, promotes striking 
neuronal toxicity and death, and spontaneously aggregates in dopaminergic cells and neurons. 
Upon addition of proteasome inhibitors, synphilin-1A accumulates into more organized inclusions 
within neurons leading to a marked decrease of its toxicity, and recruiting synphilin-1 and α-
synuclein. It is still unknown whether synphilin-1A requires ubiquitylation for inclusion formation 
or if it is also a target for Siah-1 and parkin. Since proteasomal dysfunction has been implicated 
in the pathogenesis of Parkinson`s disease, accumulation of synphilin proteins into inclusions 
might work as core for Lewy body formation. (Eyal and Engelender 2006) 
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The interaction of all clones with PP1α was corroborated and all interacted also with the 
others two PP1 isoforms (Figure 19).  Light blue colonies also represent positive 
interactions, but took longer to turn blue in the presence of X-α-GAL. Synphilin-1A has a 
PP1 BM (RVTF) predicted by bioinformatic analysis of its sequence that is present in all 
the synphilin-1A positives isolated. 
 
 
Figure 19 – Analysis of the interaction of the 
different positive clones encoding synphilin-1A 
with various PP1 isoforms: α, γ1 and γ2. The 
interaction was tested in SD/QDO/x-α-gal 
medium. Plus and minus represent the 
positive and negative controls, respectively. 
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3.3.5.2 Smad Anchor for Receptor Activation (SARA / ZFYVE9)  
  
Three alternatively spliced transcripts encoding distinct isoforms have been found for this 
gene (ZFYVE9, zinc finger, FYVE domain containing 9) and the three positive clones 
found in this screen (Table 9) encode isoform 3 of SARA (Figure 20), the longest isoform 
(NM_004799). 
 
Table 9 – Independent SARA clones isolated in the YTH screen. 
First Nucleotide (NM_004799) Positive clones 
867  (out of frame) 152T 
998  (out of frame) 253T 
2408  (in frame) 247T 
 
This gene encodes a double zinc finger (FYVE domain) protein (Figure 20) that interacts 
directly with Smad2 and Smad3, which may be involved in Alzheimer's disease (Lee et al. 
2006; Ueberham et al. 2006). Smad proteins transmit signals from transmembrane 
Ser/Thr kinase receptors to the nucleus. The FYVE domains have been identified in a 
number of unrelated signalling molecules and are zinc-containing modules of 60–80 
amino acid residues (Burd and Emr 1998; Patki et al. 1998; Lawe et al. 2000; Gillooly et 
al. 2001; Stenmark et al. 2002).  
Transforming growth factor (TGF)-β is a ubiquitously expressed cytokine that has different 
roles, affecting cellular processes including proliferation, differentiation, apoptosis, fibrosis 
and tumorigenesis (Roberts 1990). TGF-β signalling is initiated when ligand-bound TGF-β 
type II receptor, with a constitutively active kinase, binds to and phosphorylates TGF-β 
type I receptor (Piek et al. 1999; Attisano and Wrana 2000; Wrana 2000; Shi and 
Massague 2003). This phosphorylation, in the type I receptor cytoplasmic GS region, 
leads to its activation and its ability to activate the receptor-regulated Smads (R-Smads), 
Smad2 and Smad3, by C-terminal serine phosphorylation, which then translocate to the 
nucleus and regulates gene expression (Massague 1998; Massague and Chen 2000; 
Massague and Wotton 2000; Wrana 2000; Attisano and Wrana 2002). Once 
phosphorylated, R-Smads associate with Smad4 (Lagna et al. 1996; Zhang et al. 1997), 
and mediate nuclear translocation of the heteromeric complex. In the nucleus, Smad 
complexes then activate specific genes through cooperative interactions with DNA and 
other DNA-binding proteins such as FAST1, FAST2, and Fos/Jun (Chen et al. 1996; Liu et 
al. 1997; Labbe et al. 1998; Zhang et al. 1998; Zhou et al. 1998).  
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a 
tgctgaagcggaggcggccgctgctcgaggatcaaacagagcatactgaatcagcaggac 
tggctggtggtgcagcagacatcatgagtaagcaccgagaagtctgttccttatcacgtg 
tgtaaggggaaaaaggtttaaacaagtctcttaagtggtgtttcctcaccgatggagaat 
                                                    M  E  N   
tacttccaagcagaagcttacaacctggacaaggtgttagatgaatttgaacaaaacgaa 
 Y  F  Q  A  E  A  Y  N  L  D  K  V  L  D  E  F  E  Q  N  E   
gatgaaacagtttcttctactttattggatacaaagtggaataagattctagatccccct 
 D  E  T  V  S  S  T  L  L  D  T  K  W  N  K  I  L  D  P  P  
tctcaccggctgtcatttaaccctactttggccagtgtgaatgaatctgcagtttctaat 
 S  H  R  L  S  F  N  P  T  L  A  S  V  N  E  S  A  V  S  N   
gagtcacaaccacaactgaaagtcttctccctggctcattcagctcccctgaccacagag 
 E  S  Q  P  Q  L  K  V  F  S  L  A  H  S  A  P  L  T  T  E   
gaagaggatcactgtgctaatggacaggactgtaatctaaatccagagattgccacaatg 
 E  E  D  H  C  A  N  G  Q  D  C  N  L  N  P  E  I  A  T  M 
tggattgatgaaaatgctgttgcagaagaccagttaattaagagaaactatagttgggat 
 W  I  D  E  N  A  V  A  E  D  Q  L  I  K  R  N  Y  S  W  D   
gatcaatgcagtgctgttgaagtgggagagaagaaatgtggaaacctggcttgtctgcca 
 D  Q  C  S  A  V  E  V  G  E  K  K  C  G  N  L  A  C  L  P   
gatgagaagaatgttcttgttgtagccgtcatgcataactgtgataaaaggacattacaa 
 D  E  K  N  V  L  V  V  A  V  M  H  N  C  D  K  R  T  L  Q   
aacgatttacaggattgtaataattataatagtcaatcccttatggatgcttttagctgt 
 N  D  L  Q  D  C  N  N  Y  N  S  Q  S  L  M  D  A  F  S  C   
tcactggataatgaaaacagacaaactgatcaatttagttttagtataaatgagtccact 
 S  L  D  N  E  N  R  Q  T  D  Q  F  S  F  S  I  N  E  S  T   
gaaaaagatatgaattcagagaaacaaatggatccattgaatagaccgaaaacagagggg 
 E  K  D  M  N  S  E  K  Q  M  D  P  L  N  R  P  K  T  E  G   
agatctgttaaccatctgtgtcctacttcatctgatagtctagccagtgtctgttcccct 
 R  S  V  N  H  L  C  P  T  S  S  D  S  L  A  S  V  C  S  P   
tcacaattaaaggatgacggaagtataggtagagacccctccatgtctgcgattacaagt 
 S  Q  L  K  D  D  G  S  I  G  R  D  P  S  M  S  A  I  T  S   
ttaacggttgattcagtaatctcatcccagggaacagatggatgtcctgctgttaaaaag 
 L  T  V  D  S  V  I  S  S  Q  G  T  D  G  C  P  A  V  K  K   
caagagaactatataccagatgaggacctcactggcaaaatcagctctcctaggacagat 
 Q  E  N  Y  I  P  D  E  D  L  T  G  K  I  S  S  P  R  T  D   
ctagggagtccaaattccttttcccacatgagtgaggggattttgatgaaaaaagagcca 
 L  G  S  P  N  S  F  S  H  M  S  E  G  I  L  M  K  K  E  P   
gcagaggagagcaccactgaagaatccctccggtctggtttacctttgcttctcaaacca 
 A  E  E  S  T  T  E  E  S  L  R  S  G  L  P  L  L  L  K  P   
gacatgcctaatgggtctggaaggaataatgactgtgaacggtgttcagattgccttgtg 
 D  M  P  N  G  S  G  R  N  N  D  C  E  R  C  S  D  C  L  V  
cctaatgaagttagggctgatgaaaatgaaggttatgaacatgaagaaactcttggcact 
 P  N  E  V  R  A  D  E  N  E  G  Y  E  H  E  E  T  L  G  T  
acagaattccttaatatgacagagcatttctctgaatctcaggacatgactaattggaag 
 T  E  F  L  N  M  T  E  H  F  S  E  S  Q  D  M  T  N  W  K  
ttgactaaactaaatgagatgaatgatagccaagtaaacgaagaaaaggaaaagtttcta 
 L  T  K  L  N  E  M  N  D  S  Q  V  N  E  E  K  E  K  F  L   
cagattagtcagcctgaggacactaatggtgatagtggaggacagtgtgttggattggca 
 Q  I  S  Q  P  E  D  T  N  G  D  S  G  G  Q  C  V  G  L  A 
gatgcaggtctagatttaaaaggaacttgcattagtgaaagtgaagaatgtgatttctcc 
 D  A  G  L  D  L  K  G  T  C  I  S  E  S  E  E  C  D  F  S   
actgttatagacacaccagcagcaaattatctatctaatggttgtgattcctatggaatg 
 T  V  I  D  T  P  A  A  N  Y  L  S  N  G  C  D  S  Y  G M  
caagacccaggtgtttcttttgttccaaagactttaccctccaaagaagattcagtaaca 
 Q  D  P  G  V  S  F  V  P  K  T  L  P  S  K  E  D  S  V  T   
gaagaaaaagaaatagaggaaagcaagtcagaatgctactcaaatatttatgaacagaga 
 E  E  K  E  I  E  E  S  K  S  E  C  Y  S  N  I  Y  E  Q  R   
ggaaatgaggccacagaagggagtggactacttttaaacagcactggtgacctaatgaag 
 G  N  E  A  T  E  G  S  G  L  L  L  N  S  T  G  D  L  M  K   
aaaaattatttacataatttctgtagtcaagttccatcagtgcttgggcaatcttccccc 
 K  N  Y  L  H  N  F  C  S  Q  V  P  S  V  L  G  Q  S  S  P  
aaggtagtagcaagcctgccatctatcagtgttccttttggtggtgcaagacccaagcaa 
 K  V  V  A  S  L  P  S  I  S  V  P  F  G  G  A  R  P  K  Q   
ccttctaatcttaaacttcaaattccaaagccattatcagaccatttacaaaatgacttt 
 P  S  N  L  K  L  Q  I  P  K  P  L  S  D  H  L  Q  N  D  F   
cctgcaaacagtggaaataatactaaaaataaaaatgatattcttgggaaagcaaaatta 
 P  A  N  S  G  N  N  T  K  N  K  N  D  I  L  G  K  A  K  L  
ggggaaaactcagcaaccaatgtatgcagtccatctttgggaaacatctctaatgtcgat 
 G  E  N  S  A  T  N  V  C  S  P  S  L  G  N  I  S  N  V  D   
acaaatggggaacatttagaaagttatgaggctgagatctccactagaccatgccttgca 
 T  N  G  E  H  L  E  S  Y  E  A  E  I  S  T  R  P  C  L  A  
ttagctccagatagcccagataatgatctcagagctggtcagtttggaatttctgccaga 
 L  A  P  D  S  P  D  N  D  L  R  A  G  Q  F  G  I  S  A  R   
aagccattcaccactctgggtgaggtggctccagtatgggtaccggattctcaggctcca 
 K  P  F  T  T  L  G  E  V  A  P  V  W  V  P  D  S  Q  A  P   
aattgcatgaaatgtgaagccaggtttacattcaccaaaaggaggcatcactgcagagca 
 N  C  M  K  C  E  A  R  F  T  F  T  K  R  R  H  H  C  R  A  
tgtgggaaggttttctgtgcttcctgctgtagcctgaaatgtaaactgttatacatggac 
 C  G  K  V  F  C  A  S  C  C  S  L  K  C  K  L  L  Y  M  D   
 
agaaaggaagctagagtgtgtgtaatctgccattcagtgctaatgaatgctcaagcctgg 
 R  K  E  A  R  V  C  V  I  C  H  S  V  L  M  N  A  Q  A  W   
gagaacatgatgagtgcctcaagccagagccctaaccctaacaatcctgctgaatactgt 
 E  N  M  M  S  A  S  S  Q  S  P  N  P  N  N  P  A  E  Y  C   
tctactatccctcccttgcagcaagctcaggcctcaggagctctgagctctccacctccc 
 S  T  I  P  P  L  Q  Q  A  Q  A  S  G  A  L  S  S  P  P  P   
actgtgatggtacctgtgggagttttaaagcaccctggagcagaagtggctcagcccaga 
 T  V  M  V  P  V  G  V  L  K  H  P  G  A  E  V  A  Q  P  R   
gagcagaggcgagtttggtttgctgatgggatcttgcccaatggagaagttgctgatgca 
 E  Q  R  R  V  W  F  A  D  G  I  L  P  N  G  E  V  A  D  A   
gccaaattaacaatgaatggaacttcctctgcaggaaccctggctgtgtcacacgaccca 
 A  K  L  T  M  N  G  T  S  S  A  G  T  L  A  V  S  H  D  P  
gtcaagccagtaactaccagtcctctaccagcagagacggatatttgtctattctctggg 
 V  K  P  V  T  T  S  P  L  P  A  E  T  D  I  C  L  F  S  G  
agtataactcaggttggaagtcctgttggaagtgcaatgaatcttattcctgaagatggc 
 S  I  T  Q  V  G  S  P  V  G  S  A  M  N  L  I  P  E  D  G   
cttcctcccattctcatctccactggtgtaaaaggagactatgctgtggaagagaaacca 
 L  P  P  I  L  I  S  T  G  V  K  G  D  Y  A  V  E  E  K  P   
tcacagatttcagtaatgcagcagttggaggatggtggccctgacccacttgtatttgtt 
 S  Q  I  S  V  M  Q  Q  L  E  D  G  G  P  D  P  L  V  F  V  
ttaaatgcaaatttgttgtcaatggttaaaattgtaaattatgtgaacaggaagtgctgg 
 L  N  A  N  L  L  S  M  V  K  I  V  N  Y  V  N  R  K  C  W   
tgtttcacaaccaagggaatgcatgcagtgggtcagtctgagatagtcattcttctacag 
 C  F  T  T  K  G  M  H  A  V  G  Q  S  E  I  V  I  L  L  Q 
tgtttaccggatgaaaagtgtttgccaaaggatatctttaatcactttgtgcagctttat 
 C  L  P  D  E  K  C  L  P  K  D  I  F  N  H  F  V  Q  L  Y   
cgggatgctctggcagggaatgtggtgagcaacttgggacattccttcttcagtcaaagt 
 R  D  A  L  A  G  N  V  V  S  N  L  G  H  S  F  F  S  Q  S   
ttccttggcagtaaagaacatggtggattcttatatgtgacatctacctaccagtcactg 
 F  L  G  S  K  E  H  G  G  F  L  Y  V  T  S  T  Y  Q  S  L  
caagacctagtactcccaaccccaccttacttgtttgggattcttatccagaaatgggaa 
 Q  D  L  V  L  P  T  P  P  Y  L  F  G  I  L  I  Q  K  W  E   
actccttgggctaaagtatttcctatccgtctgatgttgagacttggagctgaatatcga 
 T  P  W  A  K  V  F  P  I  R  L  M  L  R  L  G  A  E  Y  R   
ctttatccatgcccactattcagtgtcagatttcggaagccattgtttggagagacgggg 
 L  Y  P  C  P  L  F  S  V  R  F  R  K  P  L  F  G  E  T  G   
cataccatcatgaatcttcttgcagacttcagaaattaccagtataccttgccagtagtt 
 H  T  I  M  N  L  L  A  D  F  R  N  Y  Q  Y  T  L  P  V  V  
caaggtttggtggttgatatggaagttcggaaaactagcatcaaaattcccagcaacaga 
 Q  G  L  V  V  D  M  E  V  R  K  T  S  I  K  I  P  S  N  R  
tacaatgagatgatgaaagccatgaacaagtccaatgagcatgtcctggcaggaggtgcc 
 Y  N  E  M  M  K  A  M  N  K  S  N  E  H  V  L  A  G  G  A   
tgcttcaatgaaaaggcagactctcatcttgtgtgtgtacagaatgatgatggaaactat 
 C  F  N  E  K  A  D  S  H  L  V  C  V  Q  N  D  D  G  N  Y   
cagacccaggctatcagtattcacaatcagcccagaaaagtgactggtgccagtttcttt 
 Q  T  Q  A  I  S  I  H  N  Q  P  R  K  V  T  G  A  S  F  F 
gtgttcagtggcgctctgaaatcctcttctggataccttgccaagtccagtattgtggaa 
 V  F  S  G  A  L  K  S  S  S  G  Y  L  A  K  S  S  I  V  E  
gatggtgttatggtccagattactgcagagaacatggattccttgaggcaggcactgcga 
 D  G  V  M  V  Q  I  T  A  E  N  M  D  S  L  R  Q  A  L  R   
gagatgaaggacttcaccatcacctgtgggaaggcggacgcggaggaaccccaggagcac 
 E  M  K  D  F  T  I  T  C  G  K  A  D  A  E  E  P  Q  E  H  
atccacatccagtgggtggatgatgacaagaacgttagcaagggtgtcgtaagtcctata 
 I  H  I  Q  W  V  D  D  D  K  N  V  S  K  G  V  V  S  P  I   
gatgggaagtccatggagactataacaaatgtgaagatattccatggatcagaatataaa 
 D  G  K  S  M  E  T  I  T  N  V  K  I  F  H  G  S  E  Y  K  
gcaaatggaaaagtaatcagatggacagaggtgtttttcctagaaaacgatgaccagcac 
 A  N  G  K  V  I  R  W  T  E  V  F  F  L  E  N  D  D  Q  H  
aattgcctcagtgatcctgcagatcacagtagattgactgagcatgttgccaaagctttt 
 N  C  L  S  D  P  A  D  H  S  R  L  T  E  H  V  A  K  A  F  
tgccttgctctctgtcctcacctgaaacttctgaaggaagatggaatgaccaaactggga 
 C  L  A  L  C  P  H  L  K  L  L  K  E  D  G  M  T  K  L  G   
ctacgtgtgacacttgactcagatcaggttggctatcaagcagggagcaatggccagccc 
 L  R  V  T  L  D  S  D  Q  V  G  Y  Q  A  G  S  N  G  Q  P  
cttccctcgcagtacatgaatgatctggacagcgccttggtgccggtgatccatggaggg 
 L  P  S  Q  Y  M  N  D  L  D  S  A  L  V  P  V  I  H  G  G   
gcctgccagcttagtgagggccccgttgtcatggaactcatcttttatattctggaaaac 
 A  C  Q  L  S  E  G  P  V  V  M  E  L  I  F  Y  I  L  E  N  
atcgtataaacagagaagacttcatttttttctgttcagacttgttgcaacagcagtcat 
 I  V 
acccaaatcatttgcactttaaaactggaagattaagcttttgttaacactattaatggg 
gtggggaatagggtgggagtgggggtttgggagacgggtgggaaagggtggttgggggga 
ccgatgttccataattctaagtcttctatgcattgtccaccaagaagatctgggcagctt 
ctgttcctgcacaacagttatgctatccttgcagctaatccccttctgttactgtttaga 
caagaattccgctcctctctcaagatttacttatggtcatgtgctcagaaatgctcaaat 
gggtacaaccatcaccaagggtgggatgggagggcagaggggaaataaaatataaagcat 
cagttcttgcactctttgtacagaattggtataaaaaggataattccacactgaaaaaaa 
aaaaaaaaa 
Figure 20 – Nucleotide and corresponding amino acid sequence of isoform 3 of SARA. PP1 binding 
motifs are highlighted in blue colour (positions 827-830 and 1307-1311 in a.a. sequence). The first 
nucleotides of the positive clones isolated are highlighted in red colour. The FYVE domain, which is 
thought to bind phosphatidylinositol 3-phosphatase and so to localize SARA to the membrane 
(Tsukazaki et al. 1998), is in green and the minimal Smad-binding domain (Wu et al. 2000) is 
underlined. 
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Although several protein kinases in the TGF-β pathway are known, including the receptors 
themselves, the relevant phosphatases are not yet identified. Serine/threonine protein 
phosphatases are likely involved in the dephosphorylation of these phosphorylated 
signalling components. Also little is known of how Smad interaction with receptors is 
controlled. 
SARA was first described as a novel Smad2 and Smad3 interacting protein, that functions 
as an anchoring protein to recruit Smad2 to the TGF-β receptor complex (Tsukazaki et al. 
1998). The FYVE domain is required to maintain the normal localization of this protein but 
is not involved in mediating interaction with Smads. The C-terminal domain of this protein 
interacts with the TGF-β receptor. As a component of the TGF-β pathway, SARA controls 
the subcellular localization of Smad and brings the Smad substrate to the receptor, 
increasing the efficiency of its phosphorylation (Tsukazaki et al. 1998).  
SARA also contains a phosphatidylinositol 3-phosphate (PI3P)-binding FYVE domain 
(Stenmark et al. 1996), which localizes it predominantly to the early endocytic 
compartment (Stenmark and Aasland 1999). Activated receptors internalized into the early 
endocytic compartment might encounter the SARA-Smad complex there, initiating signals 
from this compartment (Hayes et al. 2002; Panopoulou et al. 2002). Alternatively, small 
amounts of SARA are known to localize to the plasma membrane by binding to the 
receptor; the SARA-Smad complex might encounter activated receptors there, initiating 
signals at this location. Following internalization into the early endosome, signalling could 
then continue in a SARA-enriched environment (Di Guglielmo et al. 2003). 
The isolation of a Drosophila melanogaster homolog of SARA (Sara) in a screen for 
proteins that bind PP1c was already reported (Bennett and Alphey 2002; Colland et al. 
2004). The disruption of the identified PP1c-binding motif in Sara reduced its ability to bind 
PP1c. The expression of this non-PP1c-binding mutant resulted in hyperphosphorylation 
of the type I receptor and stimulated expression of a target of TGF-β signalling (Bennett 
and Alphey 2002). These data demonstrate that the relevant substrate of PP1c is the type 
I receptor or some intracellular element upstream of the type I receptor. The only known 
upstream element, however, is the type II receptor kinase. This phosphorylates the type I 
receptor, but its own kinase activity is constitutive (Wrana et al. 1992; Wrana et al. 1994; 
Massague 1998). Thus, type I receptor is implicated as the relevant substrate of PP1c. 
Smad is thought to dissociate from the complex after phosphorylation, so it is an unlikely 
target for a receptor-bound protein phosphatase. 
The additive effect of loss of PP1 and induction by TGF-β suggests that the key role of 
PP1 bound to Sara is to minimize the uninduced signal. The type II receptor is a 
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constitutively active kinase (Lin et al. 1992), which will occasionally encounter and 
phosphorylate the type I receptor even in the absence of the extracellular ligand (Ventura 
et al. 1994; Chen et al. 1995). It is critical that this background signal be minimized, as the 
system must be able to respond accurately to a very small number of ligand molecules 
relative to the number of receptors. Therefore, it is suggested that the role of PP1c in the 
receptor complex is to antagonize the type II receptor, ensuring that the presence of the 
ligand is required for continued signal transduction (Figure 21). 
 
 
Figure 21 – A model of PP1c in the TGFβ receptor complex. The two known activating 
phosphorylations by the receptor kinases are shown. PP1c has an inhibitory role, suggesting that 
it may antagonize one or both of these kinases. a, In the absence of the ligand, occasional 
phosphorylation and activation of the type I receptor is rapidly reversed by PP1c, leading to very 
low signalling through phospho-Smad. b, In the presence of the ligand, the type II receptor forms 
a stable complex with the type I receptor, which favours phosphorylation of the type I receptor 
over dephosphorylation. PP1c bound to Sara therefore acts as a check for the presence of the 
ligand. This may seem energetically inefficient, but allows tight regulation of signalling. Similar 
instances of complexes containing PP1, its substrate and an antagonistic kinase, and a scaffold 
protein that brings them together, have been described (Printen et al. 1997; Westphal et al. 
1999). SBD, Smad-binding domain; PBD, phosphatase-binding domain; CTD, carboxy-terminal 
domain; NTD, amino-terminal domain, (adapted from Bennett and Alphey, 2002). 
 
By functioning to recruit Smad2 to the TGF-β receptor, SARA is located in an important 
regulatory position in the pathway. Thus, control of SARA localization, protein levels, or 
interactions with Smad2 could potentially modulate TGF-β signalling. 
Recently, it was reported that the TGF-β-induced Smad7 can interact with the growth 
arrest and DNA damage protein 34 (GADD34) (Hollander et al. 1997), which is a 
regulatory subunit of PP1. The Smad7- GADD34 complex was shown to recruit PP1c to 
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TGF-β type 1 receptor, and thereby dephosphorylate and inactivate it (Shi et al. 2004). 
PP1c is recruited to ALK5 via a Smad7-GADD34 complex and then dephosphorylates 
activated ALK5. SARA enhances the recruitment of PP1c to the Smad7-GADD34 complex 
by enhancing the availability of PP1c to the Smad7-GADD34 complex. Which regulatory 
subunit of PP1α holoenzyme cooperates with Smad7 to interact with ALK1 remains to be 
investigated. It was also suggested that Smad7, induced by ALK1 activation, recruits 
PP1α to ALK1 and thereby inhibits TGF-β/ALK1-induced Smad1/5 phosphorylation in 
endothelial cells (Valdimarsdottir et al. 2006).  
The interaction of the isolated positive clones encoding SARA with PP1α was tested in 
SD/QDO/x-α-gal medium and was reconfirmed for all. They also interacted with the other 
PP1 isoforms: PP1γ1 and PP1γ2 (Figure 22). Two PP1 BMs were predicted by 
bioinformatic analysis of the SARA sequence (RVWF / KVIRW) and all three clones have 
both, although the three miss part of the N-terminus and only 247T is in the correct 
reading frame. 
 
 
Figure 22 – Analysis of interaction of the 
isolated positives for the protein SARA with 
various PP1 isoforms: α, γ1 and γ2. The 
interaction was tested in SD/QDO/x-α-gal 
medium. Plus and minus represent the 
positive and negative controls, respectively. 
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3.3.5.3 Dynactin 1  (DCTN1 ) / p150Glued 
 
The gene DCTN1 encodes the largest subunit of dynactin, a macromolecular complex 
consisting of 10-11 subunits ranging in size from 22 to 150 kD. Transcript variant 1, of this 
gene, consists of at least 32 exons and encodes a larger isoform than variant 2. This 
isoform contains three binding domains: microtubule (N-terminus), dynein and Arp-1 (C-
terminus). Transcript variant 2 lacks exons 1-5, but contains intron 5 sequence. The intron 
5 sequence introduces an alternative translation start site, which is located 12 nucleotides 
immediately upstream of exon 6.  
Two clones out of the 298 positives were identified as dynactin by data base searching 
(Table 10). Both align with regions of the sequence common to the two splice variants 
(NM_004082 and NM_023019;), thus it is not possible to know to which one they 
correspond (Figure 23). 
 
Table 10 – Independent Dynactin clones isolated in the YTH screen. 
First Nucleotide 
Isoform 1 (NM_004082)                     Isoform 2 (NM_023019) 
Positive clones 
1819  (in frame) 3021  (out of frame) 171T 
2350  (out of frame) 3552  (out of frame) 138T 
 
Dynein is the major molecular motor protein responsible for a variety of microtubule-based 
minus-end–directed movements of vesicles and organelles, as well as several steps in 
mitosis (Paschal and Vallee 1987; Hirokawa et al. 1990; Karki and Holzbaur 1999; Mallik 
and Gross 2004; Pilling et al. 2006). The dynein/dynactin complex is essential for a 
diversity of cellular trafficking events, such as vesicular trafficking from the endoplasmic 
reticulum to the Golgi and lysosomal motility (Caviston and Holzbaur 2006).  
Dynactin (Figure 23) binds to both microtubules and cytoplasmic dynein. It is involved in a 
diverse array of cellular functions, including ER-to-Golgi transport, the centripetal 
movement of lysosomes and endosomes, spindle formation, chromosome movement, 
nuclear positioning, and axonogenesis. Understanding the role of dynactin in dynein 
function has recently become more important with the realization that these proteins may 
be targets in human neurodegenerative diseases (Hafezparast et al. 2003; Puls et al. 
2003). Yet, in spite of the importance of this issue, definitive evidence on the in vivo role of 
dynactin in dynein attachment to membranes does not exist. 
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MAQSKRHVYSRTPSGSRMSAEASARPLRVGSRVEVIGKGHRGTVAYVGAT 50 
-------------------------------------------------- 
                                                                                    
LFATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDG 100 
-------------------------------------------------- 
                                                                                    
ADTTSPETPDSSASKVLKREGTDTTAKTSKLRGLKPKKAPTARKTTTRRP 150 
----------------------------------MMRQAPTARKTTTRRP 16 
                                    ::************               
 
KPTRPASTGVAGASSSLGPSGSASAGELSSSEPSTPAQTPLAAPIIPTPV 200 
KPTRPASTGVAGASSSLGPSGSASAGELSSSEPSTPAQTPLAAPIIPTPV 66 
************************************************** 
 
LTSPGAVPPLPSPSKEEEGLRAQVRDLEEKLETLRLKRAEDKAKLKELEK 250 
LTSPGAVPPLPSPSKEEEGLRAQVRDLEEKLETLRLKRAEDKAKLKELEK 116 
************************************************** 
 
HKIQLEQVQEWKSKMQEQQADLQRRLKEARKEAKEALEAKERYMEEMADT 300 
HKIQLEQVQEWKSKMQEQQADLQRRLKEARKEAKEALEAKERYMEEMADT 166 
************************************************** 
 
ADAIEMATLDKEMAEERAESLQQEVEALKERVDELTTDLEILKAEIEEKG 350 
ADAIEMATLDKEMAEERAESLQQEVEALKERVDELTTDLEILKAEIEEKG 216  
************************************************** 
 
SDGAASSYQLKQLEEQNARLKDALVRMRDLSSSEKQEHVKLQKLMEKKNQ 400 
SDGAASSYQLKQLEEQNARLKDALVRMRDLSSSEKQEHVKLQKLMEKKNQ 266  
************************************************** 
 
ELEVVRQQRERLQEELSQAESTIDELKEQVDAALGAEEMVEMLTDRNLNL 450 
ELEVVRQQRERLQEELSQAESTIDELKEQVDAALGAEEMVEMLTDRNLNL 316  
************************************************** 
 
EEKVRELRETVGDLEAMNEMNDELQENARETELELREQLDMAGARVREAQ 500 
EEKVRELRETVGDLEAMNEMNDELQENARETELELREQLDMAGARVREAQ 366  
************************************************** 
SFAAGLVYSLSLLQATLHRYEHALSQCSVDVYKKVGSLYPEMSAHERSLD 700 
SFAAGLVYSLSLLQATLHRYEHALSQCSVDVYKKVGSLYPEMSAHERSLD 566  
************************************************** 
 
KRVEAAQETVADYQQTIKKYRQLTAHLQDVNRELTNQQEASVERQQQPPP 550 
KRVEAAQETVADYQQTIKKYRQLTAHLQDVNRELTNQQEASVERQQQPPP 416  
************************************************** 
 
ETFDFKIKFAETKAHAKAIEMELRQMEVAQANRHMSLLTAFMPDSFLRPG 600 
ETFDFKIKFAETKAHAKAIEMELRQMEVAQANRHMSLLTAFMPDSFLRPG 466  
************************************************** 
 
GDHDCVLVLLLMPRLICKAELIRKQAQEKFELSENCSERPGLRGAAGEQL 650 
GDHDCVLVLLLMPRLICKAELIRKQAQEKFELSENCSERPGLRGAAGEQL 516  
************************************************** 
 
FLIELLHKDQLDETVNVEPLTKAIKYYQHLYSIHLAEQPEDCTMQLADHI 750 
FLIELLHKDQLDETVNVEPLTKAIKYYQHLYSIHLAEQPEDCTMQLADHI 616  
************************************************** 
 
KFTQSALDCMSVEVGRLRAFLQGGQEATDIALLLRDLETSCSDIRQFCKK 800 
KFTQSALDCMSVEVGRLRAFLQGGQEATDIALLLRDLETSCSDIRQFCKK 666  
************************************************** 
 
IRRRMPGTDAPGIPAALAFGPQVSDTLLDCRKHLTWVVAVLQEVAAAAAQ 850 
IRRRMPGTDAPGIPAALAFGPQVSDTLLDCRKHLTWVVAVLQEVAAAAAQ 716  
************************************************** 
 
LIAPLAENEGLLVAALEELAFKASEQIYGTPSSSPYECLRQSCNILISTM 900 
LIAPLAENEGLLVAALEELAFKASEQIYGTPSSSPYECLRQSCNILISTM 766  
************************************************** 
 
NKLATAMQEGEYDAERPPSKPPPVELRAAALRAEITDAEGLGLKLEDRET 950 
NKLATAMQEGEYDAERPPSKPPPVELRAAALRAEITDAEGLGLKLEDRET 816  
************************************************* 
 
VIKELKKSLKIKGEELSEANVRLSLLEKKLDSAAKDADERIEKVQTRLEE 1000 
VIKELKKSLKIKGEELSEANVRLSLLEKKLDSAAKDADERIEKVQTRLEE 866  
************************************************** 
 
TQALLRKKEKEFEETMDALQADIDQLEAEKAELKQRLNSQSKRTIEGLRG 1050 
TQALLRKKEKEFEETMDALQADIDQLEAEKAELKQRLNSQSKRTIEGLRG 916  
************************************************** 
 
PPPSGIATLVSGIAGEEQQRGAIPGQAPGSVPGPGLVKDSPLLLQQISAM 1100 
PPPSGIATLVSGIAGEEQQRGAIPGQAPGSVPGPGLVKDSPLLLQQISAM 966  
************************************************** 
 
RLHISQLQHENSILKGAQMKASLASLPPLHVAKLSHEGPGSELPAGALYR 1150 
RLHISQLQHENSILKGAQMKASLASLPPLHVAKLSHEGPGSELPAGALYR 1016  
************************************************** 
 
KTSQLLETLNQLSTHTHVVDITRTSPAAKSPSAQLMEQVAQLKSLSDTVE 1200 
KTSQLLETLNQLSTHTHVVDITRTSPAAKSPSAQLMEQVAQLKSLSDTVE 1066  
************************************************** 
 
KLKDEVLKETVSQRPGATVPTDFATFPSSAFLRAKEEQQDDTVYMGKVTF 1250 
KLKDEVLKETVSQRPGATVPTDFATFPSSAFLRAKEEQQDDTVYMGKVTF 1116  
************************************************** 
 
SCAAGFGQRHRLVLTQEQLHQLHSRLIS 1278 
SCAAGFGQRHRLVLTQEQLHQLHSRLIS 1144 
**************************** 
 
Figure 23 – Alignment of the amino acid sequence of the two isoforms of Dynactin using a 
CLUSTAL W multiple sequence alignment. PP1 binding motifs are highlighted in blue colour. The 
first amino acid of the positive clones is highlighted in red colour. (Isoform 1: NM_004082.2; 
isoform 2: NM_023019.1).   
 
A key gap in the understanding of dynein function is how this motor protein interacts with 
membrane compartments. The multiprotein complex  dynactin is a candidate factor 
proposed to link dynein to membrane compartments (Schroer 2004). Although the original 
work on dynactin suggested that highly purified dynein could mediate vesicle attachment 
to microtubules in the absence of dynactin, a more recent and relatively small number of 
in vitro experiments have led to the generally accepted model that the attachment of 
dynein to membrane vesicles requires dynactin (Waterman-Storer et al. 1997; Karki and 
Holzbaur 1999; Muresan et al. 2001). 
 An alternative model suggests that dynein light and intermediate chain subunits may link 
dynein to other membrane associated proteins independently of dynactin (Tai et al. 1999; 
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Tynan et al. 2000; Yano et al. 2001). In this competing view, dynactin plays a role in 
regulating or coordinating dynein functions such as processivity (King and Schroer 2000).  
Phosphorylation may directly modulate enzymatic or motor activity. Phosphorylation of 
dynein or of an accessory factor may also regulate the affinity of the motor with its cargo, 
the organelle which is being transported. Studies on the microtubule motor kinesin have 
provided evidence for both types of regulatory mechanisms (Sato-Yoshitake et al. 1992; 
Hollenbeck 1993; Matthies et al. 1993; McIlvain et al. 1994). 
It should be noted that, when examined in whole-cell extracts, a significant fraction of the 
p150 isoform does not bind to microtubules (Tokito et al. 1996). The differential affinity 
may reflect differences in the posttranslational modification of the dynactin complex. The 
binding of the related polypeptide CLIP-170 to microtubules has been shown to be 
modulated by its phosphorylation state (Rickard and Kreis 1991);  p150 may be regulated 
in a similar manner. It was determined that p150Glued is a phosphoprotein (Farshori and 
Holzbaur 1997), although the effects of phosphorylation on the affinity of p150Glued for 
microtubules has yet to be determined. It has been proposed that the phosphorylation site 
of CLIP-170 may map to a cluster of serine residues near the microtubule-binding motif 
(Pierre et al. 1992) and p150Glued also has a number of serine residues adjacent to the 
microtubule-binding motif. 
The interaction between dynein and dynactin becomes attenuated with aging, although it 
remains unclear why several studies have shown that the activity of dynein was affected 
by phosphorylation of its subunit (Dillman and Pfister 1994; Lin et al. 1994; Allan 1995; 
Niclas et al. 1996). Other studies have shown that aging affects the activity of protein 
phosphatases in brain (Norris et al. 1998; Jiang et al. 2001; Jouvenceau and Dutar 2006), 
and it was also reported that the activity of protein phosphatases decreased in 
Alzheimer’s Disease brains (Gong et al. 1993; Gong et al. 1995; Ladner et al. 1996; 
Vogelsberg-Ragaglia et al. 2001). Then, age dependent alterations in the activity of 
protein phosphatases or other unknown modulator might affect the dynein-dynactin 
interactions. Recent findings suggest that aging attenuates the dynein-dynactin interaction 
(Kimura et al. 2007), representing one of the risk factors for age-related impaired dynein 
function and even for accumulation of disease proteins.  
Dynactin 1 has two potential PP1 BMs (KIKF / KVTF) as determined by bioinformatic 
analysis, but the clones isolated only have the one nearest to the C-terminus. The 
interaction of the two clones with PP1α was supported when tested in SD/QDO/X-α-Gal 
medium; the same being true for the two other PP1 isoforms tested (Figure 24). These 
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results suggest that it is precisely the PP1 binding motif KVTF, nearest to the C-terminus, 
that is functionally active. 
 
 
Figure 24 – Analysis of interaction of the 
isolated dynactin positives with the various 
PP1 isoforms: α, γ1 and γ2. The interaction 
was tested in SD/QDO/x-α-gal medium. Plus 
and minus represent the positive and 
negative controls, respectively. 
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3.3.5.4 Chr9orf75 
 
Chr9orf75 was the most abundant positive clone in the YTH screen with a total of 45 
clones, corresponding to approximately 15% of all positives isolated (Table 11). The 
mRNA (NM_173691) corresponding to this ORF record is supported by experimental 
evidence; however, the coding sequence is predicted. 
 
Table 11 – Independent Chr9orf75 clones isolated in the YTH screen. 
First Nucleotide Positive clones 
- 90  (out of frame) 40T, 41T  
-15  (out of frame) 91T, 151T, 170T 
102  (in frame) 13T 
184  (out of frame) 209T 
189  (in frame) 100T, 169T 
201  (in frame) 117T, 186T 
206  (out of frame) 181T 
274  (out of frame) 65T, 223T 
325  (out of frame) 104T, 110T, 190T 
373  (out of frame) 43T, 74T, 84T, 139T, 154T, 221T, 228T, 
239T, 272Q 
374  (out of frame) 142T, 172T 
375  (in frame) 129T 
496  (out of frame) 180T 
577  (out of frame) 53T 
622  (out of frame) 148T, 149T 
670  (out of frame) 105T, 155T, 164T, 199T, 232T, 235T, 237T, 
265Q, 267Q, 292Q, 298T 
701  (out of frame) 150T 
 
Chr9orf75 was described as a PP1 interactor but there is no knowledge of its physiologic 
function (Trinkle-Mulcahy et al. 2006). The nucleotide and the corresponding amino acid 
sequence of Chr9orf75 are presented in Figure 25. 
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                            ccgggaccccgagtgccactccagcctcaccc 
cctgccagtgccactcctagccagcgccagtgcgtctccgcagccaccagcaccaacgaa 
ctccttcaccgtccacccccggggtctgcaccgcggcgcgggcgcccgcctgctctccaa 
cgggcactcggcccctgagccccgggccggccctgccaaccgcctcgcgggctccccgcc 
tgggtcgggacagtggaagccaaaggtggagtcgggggatccctccctccacccgccccc 
cagccccgggaccccgagtgccactccagcctcaccccctgccagtgccactcctagcca 
gcgccagtgcgtctccgcagccaccagcaccacgactccttcgagatacggccggccccc 
aagccagttatggagaccatccccttgggggacctccaggcccgggcgctggccagcctc 
          M  E  T  I  P  L  G  D  L  Q  A  R  A  L  A  S  L  
cgcgcaaactctcgaaattctttcatggtcatccccaagagcaatgcctccggggctcct 
 R  A  N  S  R  N  S  F  M  V  I  P  K  S  N  A  S  G  A  P   
cctcctgaggggaggcagtccgtggagctgccaaagggagacctgggcccggcctccccg 
 P  P  E  G  R  Q  S  V  E  L  P  K  G  D  L  G  P  A  S  P   
agccaggagctcggatcccagccggtgcctggaggggatggtgcgcctgccctcgggaag 
 S  Q  E  L  G  S  Q  P  V  P  G  G  D  G  A  P  A  L  G  K  
agccccctggaggtcgaggcacagtgggcagtcgaggagggggcctgtcccaggacagcc 
 S  P  L  E  V  E  A  Q  W  A  V  E  E  G  A  C  P  R  T  A   
accgccctcgctgaccgggctattaggtggcagaggccgtcctcaccgccccccttcctg 
 T  A  L  A  D  R  A  I  R  W  Q  R  P  S  S  P  P  P  F  L   
ccggctgcttcggaagaagctgagcctgctgagggcctcagggttcctggcttggccaag 
 P  A  A  S  E  E  A  E  P  A  E  G  L  R  V  P  G  L  A  K   
aatagccgggaatatgtgaggccggggctgcctgtcaccttcatcgatgaggtagactcg 
 N  S  R  E  Y  V  R  P  G  L  P  V  T  F  I  D  E  V  D  S 
gaggaggccccccaagcagccaaactaccctacctcccgcaccctgccaggcctctgcac 
 E  E  A  P  Q  A  A  K  L  P  Y  L  P  H  P  A  R  P  L  H  
cctgccaggcccgggtgcgtggcagagcttcagccccggggcagcaacaccttcacagtg 
 P  A  R  P  G  C  V  A  E  L  Q  P  R  G  S  N  T  F  T  V   
gtgcccaagaggaagccagggactctgcaggaccagcacttcagtcaggccaacagggag 
 V  P  K  R  K  P  G  T  L  Q  D  Q  H  F  S  Q  A  N  R  E   
cctcggccacgggaggccgaggaggaggaggctagttgcctcctggggcccacgttgaag 
 P  R  P  R  E  A  E  E  E  E  A  S  C  L  L  G  P  T  L  K  
aagcgctaccccaccgtgcatgagatcgaggtgattggcggctacctggccctgcagaag 
 K  R  Y  P  T  V  H  E  I  E  V  I  G  G  Y  L  A  L  Q  K   
tcctgcctcaccaaggctggctcctcaagaaagaagatgaagatctccttcaacgacaaa 
 S  C  L  T  K  A  G  S  S  R  K  K  M  K  I  S  F  N  D  K   
agcctgcagaccacatttgagtacccttccgagagctccctagagcaggaggaagaggtg 
 S  L  Q  T  T  F  E  Y  P  S  E  S  S  L  E  Q  E  E  E  V   
gaccagcaggaggaggaggaggaggaggaggaggaagaggaagaggaggaagagggatcc 
 D  Q  Q  E  E  E  E  E  E  E  E  E  E  E  E  E  E  E  G  S   
ggctcagaggagaagccctttgcactcttcctgccccgggccacgtttgtgagcagcgtg 
 G  S  E  E  K  P  F  A  L  F  L  P  R  A  T  F  V  S  S  V   
agacccgagagctctcggctgccagagggtagctcaggcctgtccagctacaccccgaag 
 R  P  E  S  S  R  L  P  E  G  S  S  G  L  S  S  Y  T  P  K 
cactctgtggccttcagcaagtggcaggagcaggcgctggagcaggccccgagggaggca 
 H  S  V  A  F  S  K  W  Q  E  Q  A  L  E  Q  A  P  R  E  A   
gagcccccgcccgtggaggccatggtgagatgcgggggagtggagcgctggggggagtct 
 E  P  P  P  V  E  A  M  V  R  C  G  G  V  E  R  W  G  E  S   
gacacccgggcgagcccatgtgtccacattctgtcctctcactttcagctcacacccgcc 
 D  T  R  A  S  P  C  V  H  I  L  S  S  H  F  Q  L  T  P  A   
agtcagaatgacctctcggacttccgcagcgagccagccctgtatttctaagcccagcac 
 S  Q  N  D  L  S  D  F  R  S  E  P  A  L  Y  F 
tgccaggaccaaggctgagcccagctgtgggagtcccggaagctgggcagtagccaggga 
ctactgcacccgcttctgccttgtttggcctcactgtatcccacccacccctcctggccc 
tggaagcagctagggtgcctcctgccatcggggccaggtctgggtctcactccccggccc 
tggtttgggagggtccaagggggaagtggggtggggaactgcctgtgggtgagtgccagg 
ggcctgctgggtggtggccatctgcgacccggcagggggctgtgcagattctgcacctgg 
ccattccctgtcctgtctcctcagcctgcctcacagtggccatggggtgtcggggtgaag 
ggctgtcccagctacttgtcctctgcaggaccctaagcccctgcccgcagcccacatgcc 
ctctgtgatgagtggcgtctttcctgcctctgatgatggactcaataaacagcactggac 
aaggct 
 
Figure 25 - Nucleotide and 
corresponding amino acid 
sequence of Chr9orf75. PP1 
binding motifs are highlighted in 
blue color (positions 103-107 and 
269-275 in a.a. sequence).The 
first nucleotide of Chr9orf75 
transcript variant 1 (NM_173691) 
is in green and the first 
nucleotides of the several positive 
clones are highlighted in red 
color. Upstream of the first 
nucleotide of transcript variant 1 
(green), are the 90 nt derived 
from clones 91T, 151T and 170T.  
 
 
Of all the 45 positives obtained for this protein five contained 15 (clones 91T, 151T and 
170T) and 90 (clones 40T and 41T) nucleotides upstream of the first nucleotide of the 
sequence present in the Genbank entry. However, a very recent update of the Chr9orf75 
Genbank entry describes a new transcript variant, transcript variant 2, starting at an 
upstream ATG codon (NM_173691.3). Transcript variant 1 (in Figure 25) lacks a segment 
in the 3' coding region, compared to variant 2, which results in a shorter protein (isoform 1, 
in Figure 26). The two proteins are encoded in the same reading frame.  
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Chr9orf75_isoform1  ------------------------------------------------------------ 
Chr9orf75_isoform2  MLLEAERRRGGGAAGARLLERYRRVPGVRALRADSVLIIETVPGFPPAPPAPGAAQIRAA 
                                                                                 
 
Chr9orf75_isoform1  ------------------------------------------------------------ 
Chr9orf75_isoform2  EVLVYGAPPGRVSRLLERFDPPAAPRRRGSPERARPPPPPPPPAPPRPPPAAPSPPAAPG 
                                                                                 
 
Chr9orf75_isoform1  ------------------------------------------------------------ 
Chr9orf75_isoform2  PRGGGASPGARRSDFLQKTGSNSFTVHPRGLHRGAGARLLSNGHSAPEPRAGPANRLAGS 
                                                                                 
 
Chr9orf75_isoform1  ------------------------------------------------------------ 
Chr9orf75_isoform2  PPGSGQWKPKVESGDPSLHPPPSPGTPSATPASPPASATPSQRQCVSAATSTNDSFEIRP 
                                                                                 
 
Chr9orf75_isoform1  -----METIPLGDLQARALASLRANSRNSFMVIPKSNASGAPPPEGRQSVELPKGDLGPA 
Chr9orf75_isoform2  APKPVMETIPLGDLQARALASLRANSRNSFMVIPKSKASGAPPPEGRQSVELPKGDLGPA 
                         *******************************:*********************** 
 
Chr9orf75_isoform1  SPSQELGSQPVPGGDGAPALGKSPLEVEAQWAVEEGACPRTATALADRAIRWQRPSSPPP 
Chr9orf75_isoform2  SPSQELGSQPVPGGDGAPALGKSPLEVEAQWAVEEGACPRTATALADRAIRWQRPSSPPP 
                    ************************************************************ 
 
Chr9orf75_isoform1  FLPAASEEAEPAEGLRVPGLAKNSREYVRPGLPVTFIDEVDSEEAPQAAKLPYLPHPARP 
Chr9orf75_isoform2  FLPAASEEAEPAEGLRVPGLAKNSREYVRPGLPVTFIDEVDSEEAPQAAKLPYLPHPARP 
                    ************************************************************ 
 
Chr9orf75_isoform1  LHPARPGCVAELQPRGSNTFTVVPKRKPGTLQDQHFSQANREPRPREAEEEEASCLLGPT 
Chr9orf75_isoform2  LHPARPGCVAELQPRGSNTFTVVPKRKPGTLQDQHFSQANREPRPREAEEEEASCLLGPT 
                    ************************************************************ 
 
Chr9orf75_isoform1  LKKRYPTVHEIEVIGGYLALQKSCLTKAGSSRKKMKISFNDKSLQTTFEYPSESSLEQEE 
Chr9orf75_isoform2  LKKRYPTVHEIEVIGGYLALQKSCLTKAGSSRKKMKISFNDKSLQTTFEYPSESSLEQEE 
                    ************************************************************ 
 
Chr9orf75_isoform1  EVDQQEEEEEEEEEEEEEEEGSGSEEKPFALFLPRATFVSSVRPESSRLPEGSSGLSSYT 
Chr9orf75_isoform2  EVDQQEEEEEEEEEEEEEEEGSGSEEKPFALFLPRATFVSSVRPESSRLPEGSSGLSSYT 
                    ************************************************************ 
 
Chr9orf75_isoform1  PKHSVAFSKWQEQALEQAPREAEPPPVEAMVRCGGVERWGESDTRASPCVHILSSHFQLT 
Chr9orf75_isoform2  PKHSVAFSKWQEQALEQAPREAEPPPVEAMVRCGGVERWGESDTRASPCVHILSSHFQLT 
                    ************************************************************ 
 
Chr9orf75_isoform1  PASQNDLSDFRSEPALYF 
Chr9orf75_isoform2  PASQNDLSDFRSEPALYF 
                    ****************** 
 
Figure 26 – Alignment of the amino acid sequence of the two isoforms of Chr9orf75 using a 
CLUSTAL W multiple sequence alignment. PP1 binding motifs are highlighted in blue colour. 
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Since Chr9orf75 has two potential PP1 BMs (RAIRW / KISF), several clones were 
selected for analysis of interaction with PP1. Clones 13 and 100 have the complete coding 
sequence of the corresponding protein in the correct frame. Clones 40 and 170 are also 
complete clones, but out of frame, and with 90 and 15 nucleotides more, respectively, 
than the predicted sequence for Chr9orf75. Clone 150 does not have the RAIRW PP1 BM 
and is out of frame, and clone 148 misses part of that PP1 BM and is also out of frame. All 
have the second PP1 BM corresponding to the aminoacids KISF.  
All clones tested were found to interact with PP1α, as expected, but also revealed a 
positive interaction with PP1γ1 and PP1ү2 (Figure 27). Light blue colonies also represent 
positive interactions that took longer to turn blue in the presence of X-α-GAL. Interestingly, 
the fact of some clones being incomplete or out of frame was not sufficient to impede 
interaction with the PP1 isoforms. 
 
 
Figure 27 – Analysis of interaction of the 
protein Chr9orf75 with the PP1 isoforms: α, γ1 
and γ2, by yeast co-transformation. The 
interaction was tested in SD/QDO/x-α-gal 
medium. Plus and minus represent the 
positive and negative controls, respectively. 
 
Almost all of the PP1 interacting proteins contain a degenerate RVxF-motif. The 
Chr9orf75 protein has two PP1 BMs predicted by bioinformatic analysis of its sequence. 
However, while the predicted KISF motif has a sequence very similar to the PP1 BMs that 
usually are present in the PP1 binding proteins, the other one BM (RAIRW) differs more 
from the known PP1 BMs and is less likely to be physiologically functional. 
 
 
 
 
 
 
 
 
 
PP1α 
+ 
- 
PP1γ1 
PP1γ2  
       13T  40T 100T 148T 150T 170T 
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3.3.6 Analysis of Chr9orf75 and PP1 interaction 
 
3.3.6.1 pC9orf75-GFP expression in HeLa Cells 
 
The cDNA corresponding to Chr9orf75 was subcloned into the pEGFP vector in frame 
with the GFP (Green Fluorescent Protein) protein. Thus, the GFP-tag was used as a 
biological marker, overcoming the need for an antibody against Chr9orf75. It was an 
important resource, allowing the employment of several techniques described below, by 
expression of pC9orf75-GFP fusion protein in human HeLa cells, a cervical cancer cell 
line (Figure 28). 
 
 
 
A 
 
 
B 
Figure 28 – pC9orf75-GFP expression in HeLa cells. The lanes correspond to non transfected 
(NT) cells and cells transfected with 0,5 µg, 1 µg and 2 µg of pC9orf75-GFP DNA. A. Immunoblot 
analysis of pC9orf75-GFP in lysates of transfected HeLa cells, using an antibody against the 
GFP tag. B. Immunoblot analysis of endogenous PP1α levels with increasing amounts of 
transfected Chr9orf75. Detection was performed with an anti-PP1α antibody (CBC2C). 
 
The expression of pC9orf75-GFP in HeLa cells was successful and as can be observed in 
Figure 28A pC9orf75-GFP fusion protein transfection revealed two bands, when the anti-
GFP antibody was used. The immmunoreactive proteins have apparent molecular mass 
of 86,6 kDa and 66,4 kDa, respectively. As the theoretical molecular mass of the 
Chr9orf75 protein is 47,3 kDa and the GFP-tag has approximately 30 kDa, the expected 
molecular mass for the fusion protein would be around 77 kDa. The observed higher 
molecular mass protein (86,6 kDa) probably represents the full length fusion protein. The 
abnormal migration observed may be due to post-translational modifications of the 
protein. The smaller band has a corresponding molecular mass of 66,4 kDa that may 
result  from proteolytic cleavage of the higher molecular mass protein.  When the 
immunoblot was probed with an anti-PP1α antibody, an apparent increase of PP1α 
cellular protein levels could be observed with increasing amounts of transfected pC9orf75-
GFP.  
 
NT   0,5µg  1µg   2µg 
75 kDa Chr 9 orf 75 
NT   0,5µg  1µg   2µg 
37 kDa PP1α 
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3.3.6.2 Co-immunoprecipitation of Chr9orf75 with PP1 
 
With the purpose of confirming and provide an ex vivo evidence for the interaction of 
Chr9orf75 with PP1, immunoprecipitation of protein extracts obtained from HeLa cells 
transfected with pC9orf75-GFP was performed, using highly specific anti-PP1α (CBC2C) 
and anti-PP1γ (CBC3C) antibodies. Proteins from cells lysates and immunoprecipitates 
(IPs) were separated on a 10% SDS-PAGE gel and transferred to a nitrocellulose 
membrane, immunobloted with anti-GFP and anti-PP1 antibodies and developed by ECL 
(Figure 29).  
 
A 
 
 
B 
 
 
Figure 29 – Co-immunoprecipitation of Chr9orf75 with PP1. Immunoblot analysis of HeLa cells 
tranfected with pC9orf75-GFP (or APP-GFP, as a control) and immunoprecipitated with anti-
PP1α and anti-PP1γ1antibodies. A. Membrane immunoblotted with anti-GFP antibody. B. 
Membrane immunoblotted with anti-PP1α (CBC2C) and anti-PP1γ (CBC3C) antibodies. NT, non-
tranfected cells; APP, cells transfected with APP-GFP; Chr9orf75, cells transfected with 
pC9orf75-GFP; IP Ab, immunoprecipitation antibody; and IB Ab, immunoblot antibody. 
 
150 kDa 
100 kDa 
75 kDa 
NT   APP     Chr9orf75   NT   APP     Chr9orf75   
Lysates IPs 
APP-GFP 
    pC9orf75-GFP 
CBC3C CBC2C IP Ab: 
CBC2C CBC3C CBC3C CBC2C IB Ab: 
Lysates IPs 
PP1α 
CBC3C CBC2C 
PP1α PP1γ PP1γ 
IB Ab: 
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From the analysis of Figure 29 it is obvious that Chr9orf75 co-immunoprecipitates with 
PP1α and PP1γ. Appropriate controls were included in parallel: immunoprecipitation from 
non-transfected cells and from cells transfected with APP (Alzheimer’s amyloid precursor 
protein). 
In agreement with the observed in Figure 28, two bands were again observed for 
pC9orf75-GFP construct, with the previously refered molecular mass.  Since protein 
degradation is an unlikely explanation, given the use of protease inhibitors during the 
process of immunoprecipitation, this observation leads to believe that the complete protein 
may have been cleaved in vivo. This cleavage must occur on the N-terminus side of the 
protein, since the GFP tag is on the C-terminus and detection was achieved with an anti-
GFP antibody. This experiment clearly shows that Chr9orf75 interacts with PP1 isoforms α 
and γ, in agreement with the yeast co-transformation assays (Figure 27). This interaction 
is likely to be direct, given the presence of a canonical PP1 binding motif (KISF) in the 
Chr9orf75 protein.  
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3.3.6.3 Overlay assay of Chr9orf75 with PP1 
 
In order to further confirm the interaction of Chr9orf75 with PP1, a blot overlay analysis 
was performed. For this purpose, protein extracts from pC9orf75-GFP transfected HeLa 
cells were loaded on a 10% SDS-PAGE gel and transferred to nitrocellulose membrane. 
Lysate from non-transfected cells was used as negative control. The membrane was 
incubated with PP1γ1 (1 µg/mL; purified in our laboratory by A. P. Vintém), immunobloted 
with the anti-PP1γ1 antibody (CBC3C) and developed by ECL (Figure 30). 
 
 
 
 
Figure 30 – Overlay assay of Chr9orf75 
with PP1γ1. The total protein amounts of 
HeLa cell lysate loaded on each well are 
indicated on top. NT, lysate from non 
transfected cells; Chr9orf75-GFP , lysate 
from cells transfected with the pC9orf75-
GFP construct. 
 
The results obtained from this experiment confirm that, as expected, the interaction of the 
Chr9orf75 protein with PP1γ1, must be direct (i.e. without the need for a bridging protein). 
Again, these results are in agreement with the presence of a functional PP1 BM in 
Chr9orf75.    
 
 
 
 
 
 
 
 
 
 
 
 
 
75 kDa 
50 µg       25 µg       50 µg       100 µg 
Chr9orf75-GFP NT 
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3.3.6.4 Subcellular localization of Chr9orf75 in HeLa cells 
 
With the purpose of studying the subcellular localization of Chr9orf75, HeLa cells were 
transfected with the pC9orf75-GFP construct. The expression of the fusion protein allowed 
the analysis of its subcellular localization and its co-localization with PP1α. HeLa cells 
were transfected with the referred plasmid and subjected to immunocytochemistry with the 
anti-PP1α antibody, detected with anti-rabbit Texas Red-conjugated antibody. Confocal 
fluorescence microscopy analysis revealed that pC9orf75-GFP distribution is almost 
exclusively nuclear and apparently excluded from nucleolar structures (Figure 31). 
Specific nucleoli markers, or co-localization with PP1γ1 (enriched in nucleoli), should 
clarify this observation. 
 
 
 
Figure 31 – Subcellular localization of pC9orf75-GFP and co-localization with PP1α. A, nucleic 
acids were stained using DAPI (blue). B, green fluorescence of the exogenous pC9orf75-GFP 
protein. C, endogenous PP1α (red) detected with anti-rabbit Texas Red-conjugated antibody. D, 
nuclear co-localization of PP1α and Chr9orf75 can be observed in the merge (yellow/orange). 
Bar, 10 µm. 
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Around 68% of the pC9orf75-GFP population has an exclusively nuclear distribution, while 
in 32% of the population pC9orf75-GFP was found not only in the nucleus of HeLa cells, 
but also distributed throughout the cytoplasm (Figure 32). Of note is that neither of these 
two distribution patterns was apparently dependent on the levels of transfection. 
 
 
 
Figure 32 – Subcellular localization of pC9orf75-GFP and co-localization with PP1α. A, nucleic 
acids were stained using DAPI (blue). B, pC9orf75-GFP green fluorescence. C, endogenous 
PP1α (red) detected with Texas Red-conjugated anti-PP1α antibody. D, co-localization observed 
in the merged image (yellow/orange). Bar, 10 µm. 
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Cells with high pC9orf75-GFP cytoplasmic distribution exhibited a less rounded 
morphology; around 90% of this population (Figures 32 and 33), and pC9orf75-GFP could 
also be observed in the plasma membrane and in fillopodia-like structures (ROIs in Figure 
33). Very interestingly, while in non-transfected cells cytoplasmic PP1α is not observed in 
the plasma membrane (under the conditions used), Chr9orf75 cytoplasmic presence 
relocates PP1α to the referred structures (Figure 32 and 33), where they co-localize. 
 
 
 
Figure 33 – Subcellular localization of pC9orf75-GFP and co-localization with PP1α. A, nucleic 
acids were stained using DAPI (blue). B, pC9orf75-GFP green fluorescence. C, endogenous 
PP1α (red) detected with Texas Red-conjugated anti PP1α antibody. D, co-localization observed 
in the merged image (yellow/orange). ROI, Region of interest. Bar, 10 µm. 
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Co-localization analysis using an anti-PP1α antibody revealed a high degree of nuclear 
pC9orf75-GFP/PP1α co-localization. Interestingly, PP1α nuclear staining apparently 
increased in pC9orf75-GFP transfected cells, in comparison to non-transfected cells, in a 
pC9orf75-GFP dose-dependent manner (Figure 34). Nonetheless, in the more highly 
transfected cells not only the nuclear abundance of PP1α increases but its cytoplasmic 
amounts also appear to increase slightly, suggesting that PP1α protein levels may be up-
regulated by Chr9orf75. 
 
 
 
Figure 34 – Subcellular localization of pC9orf75-GFP and co-localization with PP1α. A, nucleic 
acids were stained using DAPI (blue). B, pC9orf75-GFP green fluorescence. C, endogenous 
PP1α (red) detected with Texas Red-conjugated anti PPα antibody. D, co-localization observed in 
the merged image (yellow/orange). Bar, 10 µm. 
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3.4 DISCUSSION 
 
 
The involvement of PP1α in diverse cellular processes is correlated with its binding to a 
diverse set of regulatory subunits. Using the YTH system, new PP1α interactors from 
human brain were identified in order to gain insight into the various roles of PP1α in 
several cellular processes, brain function and neurodegeneration.  
The 1.72×107 human brain cDNA clones screened originated 298 positive clones, two of 
which were assigned as false positives, while the others correspond to 74 different 
proteins. Of those 20 are known PP1 interactors and 41 are putative proteins so far never 
associated with PP1. The results obtained validated the method as a promising approach 
to understand the multiple functions of the PP1α catalytic subunit, being a method of 
choice to screen a large number of proteins for putative interactions. The identification of 
all the positive clones obtained in the screen was an established objective of the analysis 
since the beginning of this study. This strategy turned out to be very successful because 
several novel and interesting PPα interacting proteins could be identified, which would 
never be found if only the more abundant positives were studied. Some “bonafide”, 
previously characterized, PP1 binding proteins were identified in this screen, like Nek2A 
and spinophilin. These findings validated the YTH technique, by confirming that 
expression of the reporter genes was due to a specific interaction between the bait protein 
(PP1α) and the identified library protein. 
Some of the positive clones isolated encoded proteins found to be fused out of frame to 
the GAL4-BD. It would therefore be expected that the wrong reading frame might code for 
an artificial protein that would not bind PP1α. This was the case even for some of the well 
known PP1 binding proteins identified. Thus, the fact that several “bonafide” PP1 
regulators were fused to the GAL4-BD in a wrong reading frame strongly suggests that 
the correct protein might still be produced by a well known mechanism in yeast, called 
programmed translational frame shift or translational recoding (Shah et al. 2002). Some 
specific sequences, 7 nucleotides long, are known to induce ribosomal frame shifting. This 
is a directional and reading frame specific event. Several programmed frame shift 
heptanucleotides have been identified: CUU-AGG-C, CUU-AGU-U and GGU-CAG-A 
(Shah et al. 2002). So it is concluded that translational recoding may be a feasible 
explanation for these observations. Moreover, this mechanism could be enhanced 
because of the use of selective media without some amino acids. Thus, the yeast 
translation machinery might be using alternative codons favouring the activation of the 
nutritional reporter genes, allowing growth in the selective media. 
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In what concerns PP1α and brain associated cellular events, this screen provided a large 
amount of data that will be useful in the search for brain-specific PP1α binding proteins 
that may be used in therapeutic and diagnostic approaches regarding neurodegenerative 
disorders and aging. 
For example two novel interactors for PP1α were described, dynactin-1 and synphilin-1A, 
which assign new roles to PP1α in physiological processes such as cellular processes 
involving the motor protein dynein and might suggest its involvement in 
neurodegenerative disorders. Interactions with two previously known PP1 interactors were 
also described: SARA and Chr9orf75. The first associates PP1α with the TGF-β receptor 
signalling pathway while for the second no function is yet assigned. The interaction 
between PP1α and these four proteins was confirmed by co-transformation in yeast strain 
AH109, were interactions with other PP1 isoforms were also analysed. In all cases 
quantitative analysis would be the logical next step, in order to better understand the 
strength of the interactions among these proteins and the different PP1 isoforms.  
The interactions should also be confirmed by other biochemical approaches such as 
immunoprecipitation, overlay or pull-down assays. A more detailed analysis of binding to 
PP1 was performed for Chr9orf75, the most abundant interaction identified on the screen 
and also the least characterised. Very recently, a new transcript variant was described for 
this protein but at the time of this study, the only isoform known was the shorter one. 
Positive clones 40T and 41T contain 90 nucleotides upstream of the first nucleotide 
presented in the Chr9orf75 Genbank entry and considered at the time of analysis, and 
clones 91T, 151T and 170T contain 15 nucleotides upstream. These results are now 
corroborated by the update of the Genbank information, since the new isoform (isoform 2) 
described has a longer 5` sequence. 
The various techniques used revealed that the corresponding Chr9orf75 protein may 
occur as a precursor protein, given that it suffers a proteolytic cleavage near its N-
terminus. This apparent cleavage originates a fragment reduced in ≈ 20 kDa, which 
corresponds to approximately 178 aminoacids (Figure 35). This being the case, the 
smaller protein fragment lacks the most N-terminal PP1 BM, but conserves the canonical 
motif, thus being still able to bind PP1. This was confirmed by all the binding assays used: 
yeast co-transformation, immunoprecipitation and overlay. As a result, the simplest 
interpretation of this results indicates that the binding likely occurs directly and not through 
binding to a third bridging protein.  
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METIPLGDLQARALASLRANSRNSFMVIPKSNASGAPPPEGRQSVELPKGDLGPASPSQELGSQPVPGGD 
GAPALGKSPLEVEAQWAVEEGACPRTATALADRAIRWQRPSSPPPFLPAASEEAEPAEGLRVPGLAKNSR 
EYVRPGLPVTFIDEVDSEEAPQAAKLPYLPHPARPLHPARPGCVAELQPRGSNTFTVVPKRKPGTLQDQH 
FSQANREPRPREAEEEEASCLLGPTLKKRYPTVHEIEVIGGYLALQKSCLTKAGSSRKKMKISFNDKSLQ 
TTFEYPSESSLEQEEEVDQQEEEEEEEEEEEEEEEGSGSEEKPFALFLPRATFVSSVRPESSRLPEGSSG 
LSSYTPKHSVAFSKWQEQALEQAPREAEPPPVEAMVRCGGVERWGESDTRASPCVHILSSHFQLTPASQN 
DLSDFRSEPALYF 
 
Figure 35 – Analysis of the observed Chr9orf75 protein forms. A The two detected forms of the 
Chr9orf75 protein: the full-length 86,6 kDa protein on the top and the cleaved one below, 
originating a shorter fragment of about 66,4 kDa. Cleavage occurs N-terminally and leads to the 
loss of approximately 178 aminoacids and one of the PP1 BMs (indicated in light green and 
purple). GFP, C-terminal tag. B The estimated position of cleavage in the aminoacid sequence of 
Chr9orf75 protein is underlined and the PP1 BMs highlighted in green and purple 
 
Although both this fragments can bind PP1 the higher abundance of the full-length protein 
in transfected cells (Figures 27 and 30), contrast the smaller fragment enriched in the co-
immunoprecipitates (Figure 28A). This suggests that either the Chr9orf75 N-terminally 
truncated form is the favoured PP1 binding partner, or that proteolitic cleavage occurred 
during the immunoprecipitation. As previously mentioned, Chr9orf75 exists as full-length 
and an N-terminal truncated protein. In all of the analyses performed the C-terminus was 
detected using the GFP antibody, and it would be very interesting to be able to analyse if 
the two protein forms are targeted to different subcellular compartments. 
Another important validation of the putative interactions discovered with the YTH system 
is the confirmation of co-expression of the two binding partners either in the same cell-
type or in the same subcellular compartment. A condition for in vivo interaction of two 
proteins is their simultaneous presence in the same subcellular compartment. It is, 
therefore, important to determine the subcellular localization of these proteins, the 
N C 
N C 
86,6 kDa  
66,4 kDa  GFP 
GFP 
PP1 BMs 
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particular structures to which they associate and the processes where they are involved. 
With this intent, the subcellular distribution and co-localization with PP1α was evaluated 
for Chr9orf75. The expression of the protein Chr9orf75 fused to GFP in HeLa cells 
revealed that Chr9orf75 is mainly nuclear, and co-localizes with PP1α in this subcellular 
compartment. Increasing expression of Chr9orf75 enhances the amount of PP1α in the 
cell, although it remains to verify if this is due to a gene transactivation effect or to an 
alteration on mRNA/protein half-life. Furthermore, cytoplasmic/plasma membrane 
localization of Chr9orf75 recruits PP1α  to the same subcellular compartments (Figures 32 
and 33).    
It will be of crucial interest to perform functional assays for both the nuclear and the 
cytoplasmic Chr9orf75 pools.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of Human Brain Protein Phosphatase 1α Interacting Proteins Using the Yeast Two Hybrid System 
 
 
   Mestrado em Microbiologia Molecular 2008 
Centro de Biologia Celular  105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4  FINAL CONCLUSIONS 
 
Characterization of Human Brain Protein Phosphatase 1α Interacting Proteins Using the Yeast Two Hybrid System 
Mestrado em Microbiologia Molecular 2008 
106   Centro de Biologia Celular 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of Human Brain Protein Phosphatase 1α Interacting Proteins Using the Yeast Two Hybrid System 
 
 
   Mestrado em Microbiologia Molecular 2008 
Centro de Biologia Celular  107 
The regulation of the subcellular localization of signalling pathway components is a key 
determinant in the effective initiation and maintenance of signalling cascades. Regulation 
of signal transduction pathways through protein/protein interactions can thus make 
possible the activation of a particular pathway by co-localizing protein kinases and 
phosphatases with their downstream substrates. Therefore, the identification and 
characterization of the proteins implicated in neuronal pathways are imperative as a mean 
to understand these cellular events and associated pathologies. 
PP1 is involved in several important physiological processes, such as cell cycle control, 
apoptosis, transcription, motility, metabolism and memory, regulating them through the 
dephosphorylation of multiple key substrates. This plasticity of PP1 is due to interaction 
with diverse regulators and targeting subunits that function as inhibitors, substrate 
specifiers and substrate targeting proteins. 
Several previously known PP1 regulator proteins were identified in the screen here 
described, among them are Nek2, spinophilin and ASPP1, thus validating the method 
used. Also, other less characterised PP1 interactors were also found, like SARA and 
Chr9orf75. Additionally, proteins known in other contexts were here identified as putative 
PP1 regulators and some had the interaction reconfirmed.  That was the case for 
dynactin-1 and synphilin-1A. Even more interesting was the fact that a great number of 
the proteins identified were completely new proteins. These results provide new 
perspectives of PP1α function in the human brain and several neuronal processes and 
validate the Yeast Two-Hybrid System as a tool to understand the roles played by PP1 in 
several cellular regulatory events.  
The majority of the recovered clones encoded partial cDNA sequences but each showed 
specific interaction with PP1α in the YTH system. The large number of totally new putative 
PP1α binding proteins opens new fields of study. The uncharacterized proteins need to be 
further analysed in order to identify their functions, allowing new roles to be attributed to 
PP1α, not only in human brain processes but also in other cellular functions. For the 
known proteins it is also needed a more comprehensive study in order to establish their 
binding and regulation by PP1α. That is already ongoing in our laboratory with synphilin-
1A, dynactin-1 and SARA. 
Chr9orf75, a totally uncharacterized protein and the most abundant positive in this screen, 
was further studied and some further insights were obtained: protein physiological form, 
binding to PP1 and subcellular localization. Chr9orf75 was detected in two protein forms, 
a full-length protein and a smaller form, apparently resulting from N-terminal cleavage. 
Both proteins forms bind strongly to PP1, through a canonical PP1 BM. In HeLa cells 
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Chr9orf75 was most often found enriched in the nucleus, but also distributed throughout 
the cytoplasm, and could also be observed in the plasma membrane and in fillopodia-like 
structures. Cellular co-localization of Chr9orf75 with PP1α was observed and, apparently, 
increasing amounts of Chr9orf75 concomitantly increase nuclear and cytoplasmic 
abundance of PP1α.  
For therapeutic approaches a complete understanding of PP1 regulation is essential for 
the development of drugs that interfere with PP1 function. Of all mammalian tissues, the 
brain expresses the highest levels of protein kinases and phosphatases. Phosphatases 
play important roles in numerous physiological and cellular events and exist in 
macromolecular signalling complexes in association with specific regulatory subunits. 
PP1c subunits are thought to always occur associated with regulatory and scaffold 
subunits that change PP1c conformation, targeting it to distinct subcellular locations and 
regulate its activity and substrate specificity. So, since such PP1 regulatory proteins are 
often tissue or cell type specific (unlike PP1c itself), they should provide much better and 
specific targets for therapeutic and diagnostic approaches. For this reason PP1 
holoenzymes are potential drug targets to be investigated for pharmacological intervention 
and diagnosis in disease.  
The PP1α interactome thus defined constitutes an important extension of the knowledge 
of PP1α physiological involvement in various brain processes. The number of proteins 
known to bind and regulate PP1α has been significantly extended and this may hopefully 
lead to significant insights into PP1α regulation. Given the number of protein 
phosphatases and phosphoprotein substrates encoded in the human genome, a large 
number of PP1 interacting proteins certainly remain to be discovered. In conclusion, the 
results obtained opened new and interesting insights that will need to be explored in detail 
in the future. 
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I. CULTURE MEDIA AND SOLUTIONS 
 
 
 
LB (Luria-Bertani) Medium 
 
To 950 mL of deionised H2O add: 
LB 25 g 
Agar 20 g (for plates only) 
Shake until the solutes have dissolved. Adjust the volume of the solution to 1 liter with 
deionised H2O. Sterilize by autoclaving. 
 
 
SOB Medium 
 
To 950 mL of deionised H2O add: 
25,5 g SOB Broth 
Shake until the solutes have dissolved. Add 10mL of a 250mM KCl (prepared by 
dissolving 1.86g of KCl in 100 mL of deionised H2O). Adjust the pH to 7.0 with 5N NaOH. 
Adjust the volume of the solution to 1 liter with deionised H2O. Sterilize by autoclaving. 
Just prior to use add 5 mL of a sterile solution of 2M MgCl2 (prepared by dissolving 19 g of 
MgCl2 in 90 mL of deionised H2O; adjust the volume of the solution to 1000 mL with 
deionised H2O and sterilize by autoclaving). 
 
 
SOC Medium 
 
SOC is identical to SOB except that it contains 20 mM glucose. After the SOB medium 
has been autoclaved, allow it to cool to 60ºC and add 20mL of a sterile 1M glucose (this 
solution is made by dissolving 18 g of glucose in 90 mL of deionised H2O; after the sugar 
has dissolved, adjust the volume of the solution to 1 L with deionised H2O and sterilize by 
filtration through a 0.22-micron filter). 
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Yeast Media 
 
10X dropout solution (DO10X) 
 
This solution contains all but one or more of the following components: 
 
             10X concentration (mg/L)    SIGMA # 
L-Isoleucine     300       I-7383 
L-Valine     1500      V-0500 
L-Adenine hemisulfate salt   200      A-9126 
L-Arginine HCl    200      A-5131 
L-Histidine HCl monohydrate             200      H-9511 
L-Leucine     1000      L-1512 
L-Lysine HCl     300      L-1262 
L-Methionine     200      M-9625 
L-Phenylalanine    500      P-5030 
L-Threonine     2000      T-8625 
L-Tryptophan                200      T-0254 
L-Tyrosine     300      T-3754 
L-Uracil     200      U-0750 
 
10X dropout supplements may be autoclaved and stored for up to 1 year. 
 
 
YPD medium 
 
To 950mL of deionised H2O add:  
50 g YPD 
20 g Agar (for plates only) 
Shake until the solutes have dissolved. Adjust the volume to 1 L with deionised H2O and 
sterilize by autoclaving. Allow medium to cool to 60ºC and add glucose to 2% (50mL of a 
sterile 40% stock solution).  
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SD synthetic medium 
 
To 800mL of deionised H2O add:  
6.7g Yeast nitrogen base without amino acids (DIFCO)  
20g Agar (for plates only) 
Shake until the solutes have dissolved. Adjust the volume to 850mL with deionised H2O 
and sterilize by autoclaving. Allow medium to cool to 60ºC and add glucose to 2% (50mL 
of a sterile 40% stock solution) and 100mL of the appropriate 10X dropout solution. 
 
2X YPDA 
 
Prepare YPD as above. After the autoclaved medium has cooled to 55ºC add 15mL of a 
0.2% adenine hemisulfate solution per liter of medium (final concentration is 0.003%). 
 
 
Solutions 
 
50X TAE Buffer 
 
242 g Tris base 
57.1 mL glacial acetic acid 
100 mL 0.5M EDTA (pH 8.0) 
 
TE Buffer (pH 7.5) 
 
10 mM Tris-HCl (pH 7.5) 
1 mM EDTA, pH 8.0 
 
Loading Buffer (LB) 
 
0.25% bromophenol blue 
30% glycerol 
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STET 
 
8% Sucrose 
5% Triton X-100 
50 mM Tris-HCl (pH 8,5) 
50 mM EDTA 
 
 
Competent Cell Solutions: 
 
Solution I (1L) 
 
9.9 g MnCl2.4H2O 
1.5 g CaCl2.2H2O 
150 g glycerol 
30 mL KHAc 1M; 
adjust pH to 5.8 with HAc, filter through a 0.2µm filter and store at 4ºC 
 
Solution II (1L) 
 
20 mL 0.5M MOPS (pH 6.8) 
1.2 g RbCl 
11g CaCl2.2H2O 
150 g glycerol;  
filter through a 0.2µm filter and store at 4ºC  
 
 
Miniprep Solutions: 
 
Solution I 
 
50 mM glucose 
25 mM Tris.HCl (pH 8.0) 
10 mM EDTA 
 
 
Characterization of Human Brain Protein Phosphatase 1α Interacting Proteins Using the Yeast Two Hybrid System 
 
 
   Mestrado em Microbiologia Molecular 2008 
Centro de Biologia Celular  127 
Solution II 
 
0.2 N NaOH 
1% SDS  
 
Solution III 
 
3 M potassium acetate 
2 M glacial acetic acid 
 
Midiprep Solutions 
  
Cell Resuspension Solution 
 
50 mM Tris-HCl (pH 7.5) 
10 mM EDTA 
100 µg/mL RNAase A  
 
Cell Lysis Solution  
 
0.2 M NaOH 
1% SDS 
 
Neutralization Solution 
 
4.09 M Guanidine hydrochloride (pH 4.8) 
759 mM potassium acetate  
2.12 M Glacial acetic acid 
 
Column Wash Solution 
 
60 mM potassium acetate 
8.3 mM Tris-HCl (pH 7.5) 
0.04 mM EDTA 
60 % ethanol 
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SDS-PAGE and Immunobloting Solutions  
 
LGB (Lower Gel Buffer) 
 
To 900 mL of deionised H2O add:  
181.65 g Tris  
4 g SDS  
Mix until the solutes have dissolved. Adjust the pH to 8.9 and adjust the volume to 1L with 
deionised H2O. 
 
UGB (Upper Gel Buffer) 
  
To 900 mL of deionised H2O add:  
75.69 g Tris  
Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 1L with 
deionised H2O. 
 
30%Acrylamide/0.8% Bisacrylamide 
 
To 70 mL of deionised H2O add: 
29.2 g Acrylamide  
0.8 g Bisacrylamide  
Mix until the solutes have dissolved. Adjust the volume to 100mL with deionised H2O. 
Store at 4ºC. 
 
Loading Gel Buffer 
 
250 mM Tris-HCl (pH 6.8) 
8% SDS 
40% Glycerol 
2% 2-mercaptoethanol 
0.01% Bromophenol blue 
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1X Running Buffer 
 
25 mM Tris-HCl (pH8.3) 
250 mM Glycine 
0.1% SDS 
 
1X Transfer buffer 
 
25 mM Tris-HCl (pH8.3) 
192 mM Glycine 
20% Methanol 
 
1X TBS  
 
10 mM Tris-HCl (pH 8.0) 
150 mM NaCl 
 
1X TBST 
 
10 mM Tris-HCl (pH 8.0) 
150 mM NaCl 
0.05% Tween 
 
Membrane Stripping Solution 
 
2% SDS 
62.5 mM Tris-Hcl (pH= 6.7) 
100 mM  β-Mercaptoethanol 
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Yeast Two-Hybrid Solutions 
 
Yeast plasmid rescue – Breaking buffer 
 
2 % Triton X-100 
1 % SDS 
100 mM NaCl 
10 mM Tris-HCl (pH 8.0) 
 
Solutions for preparation of yeast protein extracts 
 
 Protease inhibitor solution 
 
Always prepare solution fresh just before using. Place on ice to prechill. To prepare 688µl 
add in a microfuge tube: 
66µl Pepstatin A (1 mg/mL stock solution in DMSO) 
2µl Leupeptin (10.5 mM stock solution) 
500µl Benzamidine (200 mM stock solution) 
120µl Aprotinin (2.1 mg/mL stock solution) 
 
 PMSF (phenylmethyl-sulfonyl fluoride) stock solution (100X) 
 
Dissolve 0.1742g of PMSF in 10mL isopropanol. Wrap tube in foil and store at RT. 
 
 Cracking buffer stock solution 
 
To 80mL of deionised H2O add:  
48g Urea  
5g SDS 
4mL 1M Tris-HCl (pH6.8) 
20µl 0.5M EDTA  
40mg Bromophenol blue  
Mix until the solutes have dissolved. Adjust the volume to 100mL with deionised H2O. 
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 Cracking buffer 
 
To prepare 1.13mL add in a microfuge tube: 
1 mL Cracking buffer stock solution (recipe above) 
10 µl β-mercaptoethanol  
70 µl Protease inhibitor solution (recipe above) 
50µl 100X PMSF stock solution 
 
 
Immunoprecipitation solutions 
 
Lysis Buffer 
 
50 mM Tris-HCl (pH 8) 
120 mM NaCl 
4% CHAPS 
 
Lysis Buffer + Protease inhibitors 
 
Add to 4 mL of Lysis buffer the following quantities for a final volume of 5 mL: 
23,8 µl Pepstatin A (1 mg/mL stock solution in DMSO) 
0,72 µl Leupeptin (5 mg/mL stock solution) 
180 µl Benzamidine (200 mM stock solution) 
43,2 µl Aprotinin (2.1 mg/mL stock solution) 
176 µl PMSF 100X 
 
Washing solution 
 
50 mM Tris-HCl  
120 mM NaCl  
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Cell Culture Solutions and Immunocytochemistry  
 
PBS (1x) 
 
For a final volume of 500 mL, dissolve one pack of BupH Modified Dulbecco’s Phosphate 
Buffered Saline Pack (Pierce) in deionised H2O. Final composition: 
8 mM Sodium Phosphate   
2 mM Potassium Phosphate  
40 mM NaCl  
10 mM KCl  
Sterilize by filtering through a 0.2 µm filter and store at 4 ºC 
 
1 mg/mL Poly-L-ornithine solution (10x) 
 
To a final volume of 100 mL, dissolve in deionised H2O 100 mg of poly-L-ornithine (Sigma-
Aldrich, Portugal).  
 
4% Paraformaldehyde Fixative solution 
 
For a final volume of 100 mL, add 4 g of paraformaldehyde to 25 mL deionised H2O. 
Dissolve by heating the mixture at 58 ºC while stirring. Add 1-2 drops of 1 M NaOH to 
clarify the solution and filter (0.2 µm).  
Add 50 mL of 2X PBS and adjust the volume to 100 mL with deionised H2O. 
 
Complete MEM + GLUTAMAX 
 
For a final volume of 500 mL, add:  
50 mL (10% v/v) Fetal Bovine Serum (FBS) (Gibco BRL, Invitrogen)  
5 mL Non-Essential aminoacids (100x) 
100 U/mL penicillin 
100 mg/mL streptomycin 5 mL 
FBS is heat-inactivated for 30 min at 56 ºC. For cells maintenance, prior to pH adjustment 
add 100 U/mL penicillin and 100 mg/mL streptomycin [10 mL Streptomycin/ 
Penicilin/Amphotericin solution (Gibco BRL, Invitrogen) 
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MEM  + GLUTAMAX Components     
 
Amino Acids:                                                   Concentration (mg/L) 
L-Alanyl-Glutamine 406 
L-Arginine hydrochloride 126 
L-Cystine 24 
L-Histidine hydrochloride 42 
L-Isoleucine 52 
L-Leucine 52 
L-Lysine hydrochloride 73 
L-Methionine 15 
L-Phenylalanine 32 
L-Threonine 48 
L-Tyrosine 10 
L-Valine 46 
Vitamins: 
Choline chloride 1 
D-Calcium pantothenate 1 
Folic Acid 1 
Niacinamide 1 
Riboflavin 0.1 
Thiamine hydrochloride 1 
i-Inositol 2 
Inorganic Salts: 
Calcium Chloride (CaCl2.2H2O) 264 
Magnesium Sulfate (MgSO4.7H2O) 200 
Potassium Chloride 400 
Sodium Bicarbonate 2200 
Sodium Chloride 6800 
Sodium Phosphate monobasic 
(NaH2PO4.2H2O) 
158 
Other components: 
D-Glucose 1000 
Phenol Red 10 
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II. BACTERIA AND YEAST STRAINS 
 
 
 
 E. coli XL1- blue: recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac[F’ proAB 
lacZ∆M15 Tn10(Tetr)] 
 
 S. cerevisiae AH109: MATa, trp1-901, leu2-3, 112 ura3-52, his3-200, gal4∆, gal 80∆, 
LYS2:: GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-
lacZ, MEL1 
 
 S. cerevisiae Y187: MATα ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4∆, 
met-, gal 80∆, URA3:: GAL1UAS-GAL1TATA-lacZ, MEL1 
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III. PLASMIDS 
 
 
 
 
 
 
 
pACT2 (Clontech) map and MCS. Unique sites are coloured blue. pACT2 is used to generate a 
hybrid containing the GAL4 AD, an epitope tag and a protein encoded by a cDNA in a fusion 
library. The hybrid protein is expressed at medium levels in yeast host cells from an enhanced, 
truncated ADH1 promoter and is target to the nucleus by the SV40 T-antigen nuclear localization 
sequence. pACT2 contains the LEU2 gene for selection in Leu- auxotrophic yeast strains. 
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pAS2-1 (Clontech) map and MCS. Unique sites are coloured blue. pAS2-1 is a cloning vector used 
to generate fusions of a bait protein with the GAL4 DNA-BD. The hybrid protein is expressed at 
high levels in yeast host cells from the full-length ADH1 promoter. The hybrid protein is target to the 
yeast nucleus by nuclear localization sequences. pAS2-1 contains the TRP1 gene for selection in 
Trp- auxotrophic yeast strains. 
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pEGFP-N1 vector map and MCS (Clontech). This eukaryotic exppression vector was used to 
express pC9orf75-GFP fusion protein in HeLa cells. 
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IV. PRIMERS 
 
 
 
Primer Sequence (5’:::: 3’) 
Nt 
No. 
MT 
(ºC) 
GAL4 AD TACCACTACAATGGATG  17 48 
GAL4 BD TCATCGGAAGAGAGTAG  17 50 
Amplimer 3’ (reverse)  ATCGTAGATACTGAAAAACCCCGCAAGTTCAC                       32 84 
C9orf75-F4 CCCGGAATTCCGATGGAGACCATCCCCTTG 30 96 
C9orf75-R5 ACGCGTCGACGTGAAATACAGGGCTGGCTC 30 96 
pEGFP-N1-FW GTAGGCGTGTACGGTGGGAG 20 54 
pEGFP-N1-RV GCCGTCCAGCTCGACCAGG 19 60 
 
 
 
 
